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ABSTRACT 
 
Pharmaceutical advertising involves the advertising of medicines, medical devices, and 
healthcare services.  A review of available international literature indicates the belief that 
pharmaceutical advertisements negatively affect healthcare decisions made by consumers.  
Very little research has been conducted to determine how consumers in South Africa (SA) 
are affected by pharmaceutical advertisements.   
 
This study aimed to determine how consumers in the Nelson Mandela Metropole (NMM) 
perceive pharmaceutical advertisements.  More specific objectives included the 
investigation of legislation in SA employed in pharmaceutical advertisements, the 
interpretation and misinterpretation of the advertisements, and the identification of 
problematic areas in this form of advertising.   
 
South African legislation applied to pharmaceutical advertisements was investigated by 
means of a literature review.  A qualitative research design was also used to achieve the 
aim and objectives.  This included a focus group consisting of six randomly selected 
participants in the NMM.  A consumer survey, consisting of a 100 consumers obtained 
from 10 randomly selected community pharmacies within the NMM, supported the 
findings of the qualitative techniques.  The themes identified in the focus group were 
incorporated into a questionnaire used in the consumer survey.  Three randomly selected 
pharmaceutical advertisements were also decoded to interpret the components employed 
in each.   
 
The results determined that pharmaceutical advertising is a marketing tool that 
incorporates various emotional and psychological techniques to persuade consumers.  It 
was also evident that consumers can misinterpret pharmaceutical advertisements.  
Various legal and ethical problems were identified in pharmaceutical advertisements.  
These results showed that pharmaceutical advertisements have the possibility of 
negatively affecting consumers’ healthcare decisions and warrants further investigation.  
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CHAPTER 1 
INTRODUCTION 
 
1.1   BACKGROUND TO THE STUDY   
 
Society has become a place in which people are exposed to thousands of advertisements 
on a daily basis.  When watching television, listening to the radio, or opening a magazine 
or newspaper, people will be exposed to advertisements of various products or services.    
 
Advertising is a marketing tool that, as a result of consumers being bombarded with 
advertisements, has become a more acceptable form of communication.  It is a lucrative 
marketing tool as can be proven by the advertising expenditure figures of large 
multinational companies.  In the United States of America (USA), five of the leading 
advertisers spent a total of $12,723.1 million dollars in 2001 alone.  General Motors 
Corporation spent the most on advertising, a total of $3,374.4 million dollars.  Two of 
these five companies were pharmaceutical companies.  Proctor and Gamble spent the 
second most on advertising in 2001 with $2,540.6 million dollars, while Pfizer spent fifth 
most with $2,189.5 million dollars (Belch & Belch, 2004: 17).  As these figures only 
consist of advertising expenditure in the USA, it can be guessed that global spending on 
advertising will provide staggering figures. 
 
Most people believe that advertising is a form of communication with the “express 
purpose of selling a product or service”.  Enormous advertising budgets can therefore 
result in only one thing – large sales figures (Vilanilam & Varghese, 2004: 4).  This 
belief is reflected when looking at the value of well-known brands in the world in 2002, it 
was determined that the Coca-Cola® brand is worth $69.6 billion dollars, the Microsoft® 
brand is worth $64.1 million dollars, and the well-known cigarette brand, Marlboro®, is 
worth $24.2 billion dollars (Belch & Belch, 2004: 15).   
 
Although it is believed that advertising is only used to sell products or services, 
Vilanilam and Varghese (2004: 4) believe that advertising cannot buy or sell but can only 
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influence the consumer and help the seller.  In this statement, “only influence the 
consumer” lays the moral and ethical dilemma when advertising pharmaceutical products.   
 
Ray Moynihan and Alan Cassels (2005: ix), in their book, Selling Sickness How Drug 
Companies Are Turning Us All Into Patients, believe that pharmaceutical advertising has 
become an “aggressive” advertising tool that, today, is not just targeted at the sick but 
even more so at the healthy and well.  Moynihan and Cassels (2005: x) also stated that 
the purpose of pharmaceutical advertising is to “exploit our deepest fears of death, decay, 
and disease”.  Here, they used examples of common complaints that were transformed 
into “frightening” conditions in the media:  shyness is now labelled as a social anxiety 
disorder, everyday sexual difficulties are seen as sexual dysfunction, and premenstrual 
syndrome (PMS) is called pre-menstrual dysphoric disorder (PMDD) (Moynihan & 
Cassels, 2005: x).  Their argument is that there is money to be made in telling healthy 
people that they are sick (Moynihan & Cassels, 2005: x).   
 
Patrick Holford and Jerome Burne also support the idea that pharmaceutical advertising is 
more about money than about providing healthcare information.  They provided a 
comparison of “good” medicines versus “profitable” medicines.  Holford and Burne 
(2006: 6) defined good medicines as medicines that work, in other words, medicines that 
relieve pain and remove the cause.  Good medicines are also safe with minimal side 
effects and are not expensive.  Most importantly, it is practical to use.  Conversely, 
profitable medicines are expensive and designed to relieve symptoms but not its cause.  
This ensures that patients keep on taking it.  Furthermore, profitable medicines are also 
synthetic to ensure patentability.  The major difference between good medicines and 
profitable medicines is that profitable medicines are supported by multi-million dollar 
marketing campaigns (Holford & Burne, 2006: 6).            
 
A similar tendency can also be seen in South Africa (SA).  Whenever a magazine is 
opened, a pharmaceutical advertisement can be seen in which a product is glamorised as 
being the next miracle.  In many of the local newspapers found within the Nelson 
Mandela Metropole (NMM) this is evident as well-known advertisements for ointments 
and creams are often seen claiming that it has cured a cancer patient.  Advertisements 
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from the pharmaceutical industry also glamorise their treatments as the only solution 
available to consumers’ problems.    
 
Recently, advertisements of a highly addictive consumer product, alcohol, have received 
negative publicity from regulatory authorities in SA as it portrays images of social 
acceptability.  It was suggested that advertisements for alcohol should rather be 
“educational and spell in clear detail the side effects” thereof (South African Human 
Rights Commission, 2004).  Also, cigarette advertisements are no longer seen in public.  
In accordance with the Tobacco Products Control Amendment Act No. 12 of 1999, such 
advertisements may no longer appear in the public eye (Department of Health, 2006).  It 
may be argued that similar regulations should apply to pharmaceutical advertisements as 
medicines can be as harmful as alcohol or cigarettes if used incorrectly or inappropriately.      
 
This study sets out to determine how consumers in the NMM perceive pharmaceutical 
advertisements.  By doing so, it may become apparent that there is the possibility that 
pharmaceutical advertisements can be misinterpreted or even the possibility that 
consumers may be deceived.  To determine this, the legal aspects of pharmaceutical 
advertising in SA should also be concentrated on.  Due to time constraints, it will be a 
nearly impossible feat to focus on all the mass media types in which pharmaceutical 
advertisements can be published.  For this reason, this study focused only on 
pharmaceutical advertisements found in print media.      
 
In SA various acts, codes and guidelines that deal with advertising laws in general exist, 
also pertaining to pharmaceutical advertisements.  The Advertising Standards Authority 
(ASA) of SA provides various guidelines regarding advertising of pharmaceutical 
products.  The ASA is also the only Authority in SA that regulates all forms of 
advertisements (ASA, South Africa, 2004).  The SA government also has a Marketing 
Code that provides various guidelines for the advertising of medicines (Code of Practice, 
2004).  Also, the Medicines and Related Substances Act 101, as amended, contains 
various Regulations dealing with the advertising of medicines (Pharmaceutical Society of 
South Africa Pharmacy Law Compendium, 2005).  The study investigates the various 
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legal issues to determine what the legal requirements for pharmaceutical advertisements 
in print form are.   
 
According to Guy Cook (1992: xvi) advertisements do not only have a sales theme but 
also a deeper social and psychological theme.  For this reason the study will also focus on 
various psychological principles employed in advertising to assist in determining how 
consumers may perceive pharmaceutical advertisements.  The field of Psychology is a 
discipline that consists of many theories and principles.  It should therefore be realised 
that this is not an in-depth psychological study but rather a study that selectively uses 
various psychological theories and principles that can be applied in the understanding of 
consumer behaviour and how consumers perceive and interpret pharmaceutical 
advertisements.   
 
Various researchers in the fields of Communication and Sociology, for example Michael 
Schudson (1993), Judith Williamson (2005), Jean-Marie Floch (2001), and many others, 
have proven that advertising is a persuasive form of communication.  Kenneth Clow and 
Donald Baack (2005: 120) boldly stated that advertisements have one common goal and 
that is to persuade.  Advertising is not seen just as communication but as mass 
communication as it transmits a message to a “large, heterogeneous and anonymous 
group of people” (Vilanilam & Varghese, 2004: 11).  William Wells and colleagues 
(1989: 280) furthermore proved that persuasion is also concerned with emotions.  The 
study looks at these activities employed in advertisements and determine whether this 
also holds true for pharmaceutical advertisements.   
 
Another activity, semiotics, assists in understanding the various components employed in 
pharmaceutical advertisements.  Simply put, semiotics is the study of signs and symbols, 
what they mean, and how they are used (Oxford Advanced Learner’s Dictionary, 1989: 
1150; Concise Oxford English Dictionary, 2006: 1308).  George and Michael Belch 
(2004: 142) stated that semiotics has an important role to play in marketing 
communication.  Semiotics assists marketers in their understanding of how consumers 
may interpret words, gestures, myths, signs, symbols, products or services employed in 
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advertisements (Belch & Belch, 2004: 142). In this study semiotics is used to identify and 
provide meaning to the various components employed in advertisements. 
 
Also of importance is to look at the colours employed in pharmaceutical advertisements.  
Wells and colleagues (1995: 474) stated that colours used in advertisements have 
meaning.  They stated that colour provides realism, establishes moods, builds identity, 
and attracts attention.  Wayne Hoyer and Deborah MacInnis (2001: 1992) added that 
colour affects people physically, psychologically and emotionally.  Therefore, in this 
study the psychological and symbolic meanings of colours employed in pharmaceutical 
advertisements are considered to a degree.       
 
When applying semiotics to advertisements another process plays a role, namely 
decoding.  Judith Williamson (2001) saw communication, in this case advertisements, as 
a simple decoding process.  In this context, decoding is simply seen as the interpretation 
of the components of advertisements (Myers, 1997: 53).  By incorporating semiotic 
criteria and the interpretation of colour, decoding can provide meaning to the components 
employed in pharmaceutical advertisements.  
 
By looking at these various activities in pharmaceutical advertisements it will be possible 
to gain an understanding of how consumers perceive and interpret pharmaceutical 
advertisements.   
 
1.2   MOTIVATION FOR THE STUDY 
 
As a result of consumers being bombarded with advertisements on a daily basis, 
advertising has become a lucrative marketing tool aimed at informing consumers about 
various products and services (Wells, et al., 1995: 16).  Similarly, pharmaceutical 
advertisements advertise medicines and healthcare related services directly to consumers.   
International studies indicated that pharmaceutical advertisements do indeed have an 
impact on the sales of medicines and on the prescribing patterns of medicinal 
practitioners (Deselle, 2004: 3; Toop, et el., 2003).  However, it is also evident that 
advertisements influence consumers by means of persuasion and emotion (Clow & Baack, 
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2005: 120; Wells, et al., 1995: 280).  Little research exists on the psychological effect 
pharmaceutical advertisements have on consumers.  To date, no such studies have been 
conducted in SA.   
 
Research in this field is therefore needed to determine the psychological effect of 
pharmaceutical advertisements on consumers.  Ultimately, such studies will determine if 
pharmaceutical advertisements are a valuable communication tool to educate consumers 
about their healthcare needs.        
 
1.3   PRIMARY AIM AND OBJECTIVES OF THE STUDY 
 
The primary aim of the study is to identify consumers’ perceptions of pharmaceutical 
advertisements. 
 
The more specific objectives of the study are to: 
 
• identify the various laws and ethical guidelines pharmaceutical advertisements have 
to adhere to in SA; 
• compare these laws and ethical guidelines to the standard set by the WHO;  
• compare these SA laws and guidelines with that of three international countries 
(Australia, New Zealand, and Canada);  
• identify the consumers’ interpretations of pharmaceutical advertisements in SA and 
identify if possible misinterpretation  can occur; and  
• to identify problematic areas in pharmaceutical advertisements that requires further 
investigation.   
 
 
1.4   CHAPTER LAYOUT     
 
In Chapter one the background of the study, the problem definition, and the primary aim 
and objectives were outlined.  Chapter two provides an overview of advertising and all 
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the concepts involved.  There is also focused on pharmaceutical advertisements in 
general as well as the psychological aspects employed in advertisements.   
 
Chapter three focuses on semiotics.  Various semiotic concepts will be described and 
many illustrations will be used to explain its usefulness in the decoding of pharmaceutical 
advertisements.  There is also focused on the interpretation of various colours used in 
advertisements.  Advertisements are used to illustrate the use of these concepts.     
 
Chapter four provides an in-depth look at SA legislation employed in pharmaceutical 
advertisements.  There is also focused on how SA legislation compare with guidelines 
provided by the WHO as well as how this legislation compare to that of Australia, New 
Zealand and Canada.  An investigation into these legal aspects is also conducted.     
 
Chapter five describes the activities employed in the empirical part of the study.  This 
includes the selection of participants for the focus group and for the consumer survey, the 
planning of various activities to conduct the focus group and consumer survey, data 
collection procedures, as well as ethical considerations employed.  In addition to these 
procedures, measures to ensure trustworthiness in the focus group are provided.  Criteria 
are also provided for the decoding of selected pharmaceutical advertisements.     
 
The results obtained from the empirical part of this study are presented in Chapter six. 
Chapter seven provides a more detailed discussion of the results obtained.  Limitations of 
the study are also provided.  Possible recommendations are provided to resolve the 
problematic areas identified in pharmaceutical advertisements.  Finally, future research 
possibilities are provided.   
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CHAPTER 2 
ADVERTISING  
 
2.1 INTRODUCTION 
 
Billions of people worldwide are exposed to advertisements on a daily basis (Wells, et al., 
1995: 16).  Consumers are bombarded by advertisements in print form found in 
magazines, journals, and newspapers, on television and radio, as well as those seen in-
store.  Pharmaceutical companies usually use advertising as a marketing tool to inform 
their consumers (healthcare professionals and the lay public) about a vast array of goods 
such as medicines, medical devices, and even healthcare-related advice.  In this chapter 
the evolving role of advertising and its various forms will be focused on as well as its role 
in the pharmaceutical environment.             
 
Due to the persuasive nature of advertising it can be assumed that advertisements can 
affect consumers on a psychological level, especially when dealing with health-related 
matters.  Therefore the psychological tools employed in advertisements and how these 
may affect the consumer will also be focused on.             
 
2.2 EVOLUTION OF ADVERTISING 
 
The beginning of advertising can be traced back 3000 years with a sign of selling wine 
from ancient Babylonia, or with trade fairs in ancient China during the Western Zhou 
Dynasty (Landa, 2004: 2).   Due to the widespread illiteracy before the age of print, most 
messages were delivered by criers who stood on street corners or at ancient sport contests.  
They usually shouted out the wares of the sponsor to the audiences (Landa, 2004: 2; 
Wells, Burnett & Moriarty, 1995: 22).  During these ancient periods information rather 
than the persuasive type of advertising, as seen today, was the objective of these 
commercial messages (Wells, et al., 1995: 23).  
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Mass media was said to be invented by Johannes Gutenberg who started the Gutenberg 
printing press in 1448 in Germany (Landa, 2004: 3).  This caused its popular rise in 
Europe allowing the widespread distribution of information to the public – the beginning 
of mass media (Landa, 2004: 3).  The term advertising was only introduced in 1655 
(Wells, et al., 1995: 24).    
 
It is assumed that modern advertising had its rise in the 18th century or towards the end of 
the 17th century (Vilanilam & Varghese, 2004: 1).  The use of advertising escalated in 
such a way during this era that India’s first newspaper, the Bengal Gazette which rolled 
off the press for the first time on 29 January 1780, only carried advertisements on its 
front page.  This practice of publishing advertisements on the front page continued for 
over a century in England and India (Vilanilam & Varghese, 2004: 3).  Print 
advertisements, such as those appearing in these newspapers, mainly promoted books and 
also medicines, which became much sought after as disease ravaged Europe.  However, 
even during these times false advertising and so-called “quack” advertisements became a 
problem which resulted in the regulation of advertising content (Advertising, 2006).  
Figure 2.1 and Figure 2.2 indicate two pharmaceutical advertisements found in the 1800s.  
 
                                            
 
Figure 2.1    Advertisement for Shepherd Medicine found in Baltimore in 1840 
(Source: Helfand, 1998) 
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Figure 2.2   Advertisement of Vegetable Pills in Philadelphia in 1849 
(Source:  Helfand, 1998)    
 
In the 19th century, as the economy grew at an alarming rate, the need for advertising 
developed at the same pace.  Classified advertisements became very popular in the USA 
and its success led to the growth of mail-order advertising.  Figure 2.3 illustrates a 
pharmaceutical advertisement of 1935 in China.   The 1960s saw advertisements 
becoming much more tempting to consumers by focusing more on brand positioning 
(Advertising, 2006).      
 
In the late 1980s and early 1990s advertising overwhelmed television in which even 
specialty channels, such as home shopping channels (for example, the Homemark® 
channel in SA) which dedicates 24 hours to uninterrupted advertising, were developed.  
Marketing through the Internet also started a new era in advertising during this period.  
At the turn of the 21st century, search engines such as Google®, revolutionised online 
advertising.  This type of interactive advertising, contrary to belief, emphasises 
contextually relevant, so-called unobtrusive advertisements that are intended to help, 
rather than inundate the user (Advertising, 2006).   
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Figure 2.3   Chinese advertisement of Bayer Aspirin® in 1935 
(Source:  Zargaj-Reyolds, 2007)   
 
It was thought that advertising in SA had its history from the time that the first settlers 
arrived in the Cape Colony.  Advertising posters were preserved and included the auction 
of slaves amongst other things (Brewer, 1998: 19).  In 1800 the Cape Town Gazette was 
founded, followed by The SA Commercial Advertiser and the South African Journal in 
which advertisements were very prominent (Brewer, 1998: 19).  In later years 
opportunities for advertising were realised by enterprising businessmen which resulted in 
the birth of the advertising agent.  Their role was first believed to be that of acting as a 
representative for the media rather than as a representative of the advertiser.  There were 
some advertising agents or agencies who sold space on behalf of one or several 
publications but evidence suggests that the first agencies existed to ply their talents to 
traders in respect of their writing and artistic skills (Brewer, 1998: 20).  As time passed, 
the broking business in SA became more “cut-throat” as more competitive services were 
introduced which, today, have become the cornerstones of advertising agencies.  These 
competitive services included services such as copywriting and artwork (Brewer, 1998: 
20).  
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In more recent times advertising has become more persuasive in nature (Eisenberg, 2004; 
Preston, 2005: 5; Raven, 2004: 9).  Advertisements are designed and interpreted in a 
more scientific and psychological manner by using a variety of techniques.  
 
2.3 ADVERTISING AS MARKETING TOOL    
   
Chris Brewer (1998: 7), a SA expert in advertising representing the Media Association of 
South Africa (MASA), defined advertising in the following over-simplified way:  
“Advertising is created and produced in order to effect a coming-together of two minds 
sharing a common purpose; one wishes to sell and the other wishes to buy”.  Bob 
Garfield (2003: 3), advertising’s leading international critic, refers to advertising in a 
humoristic way in his book and describes it as “fundamentally nothing more complex 
than communicating a selling idea to a prospective customer”.   
 
Advertising can thus be defined in various ways.  Twenty seven years ago advertising 
was defined by Louis Kaufman (1980: 3) as “any form of nonpersonal presentation of 
goods, services, or ideas for action, openly paid for, by an identified sponsor”.  In 2004 
Tellis (2004: 9) defined advertising as “any paid message that a person or organisation 
delivers to consumers in order to make its offer”.  Kaufman (1980: 3) actually based his 
definition on the definition provided in the Journal of Marketing, volume 12, number 2, 
published in October 1948.  Therefore, whether advertising was defined recently or even 
58 years ago, Bob Garfield’s simplistic way of giving meaning to the word “advertising” 
holds true:  “selling an idea to a prospective customer”. 
 
2.3.1   Fundamentals of advertising  
 
In essence, to understand the fundamentals of advertising, the American Marketing 
Association (AMA) identified four components in its definition of advertising, namely 
(Belch & Belch, 2004: 16; Vilanilam & Varghese, 2004: 5): 
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• payment; 
• non-individual source or nonpersonal communication; 
• identifiable source or sponsor; and 
• ideas, products, and/or services. 
 
The paid aspect of advertising in the AMA’s definition reflects the fact that the space or 
time for an advertising message generally must be bought (Belch & Belch, 2004: 16).  
However, there are situations where advertising can be free, such as in publicity.  This 
may occur when the media takes an interest in ideas, services, and/or even goods which 
they consider to be useful to the public (Vilanilam & Varghese, 2004: 6). 
 
The non-individual source or nonpersonal communication component refers to the 
transmission of the advertising message through the involvement of mass media (Belch & 
Belch, 2004: 16; Vilanilam & Varghese, 2004: 6).  Mass media involves, for example 
television, radio, and print media such as magazines and newspapers (Clow & Baack, 
2005: 61; Truter, 2006: 82; Vilanilam & Varghese, 2004: 10).    
 
The identifiable source or sponsor is the advertiser who pays for the advertising message 
transmitted to the audience.  Another type of sponsorship is when an organisation or 
company sponsors, for example, a specific event like a high school rugby match.  The 
organisation or company would provide money to, for example, organise the event but in 
turn gets exposure (Clow & Baack, 2005: 161). 
 
The final component, ideas, products, and services refer to what is advertised by the 
advertiser or sponsor.  All advertisements deal with one or more of these three concepts.  
The concept of advertising an idea is different than advertising a product or service.  
AIDS awareness campaigns in which the government tries to warn the public on the 
dangers of HIV/AIDS can be seen as an example of an idea advertisement (Vilanilam & 
Varghese, 2004: 7).   
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2.3.2   Promotional mix        
 
The marketing mix consists of the following well-known four p’s:  product, place, price, 
and promotion (Belch & Belch, 2004: 8; Clow & Baack, 2005: 104).  Advertising, 
however, forms part of one of the six elements of the promotional mix which also include 
direct marketing, sales promotion, personal selling, publicity, and interactive/Internet 
marketing (Belch & Belch, 2004: 16).  This can be illustrated by the diagram in Figure 
2.4.  To understand advertising’s role in the promotional mix it is important to know what 
the other five elements entail and how advertising complements them.    
  
ONAL MIX 
  
 
 
Figure 2.4   The promotional mix  
(Source: Belch & Belch, 2004: 16) 
 
2.3.2.1   Direct marketing  
 
Direct marketing is a form of advertising by which an organisation communicates 
directly with target customers in order to generate a response and/or a transaction (Belch 
& Belch, 2004: 18).  This is a method of marketing that enhances loyalty to a brand or 
company rather than to a retailer.  Direct marketing programs have the ability to generate 
greater profits due to the absence of middle channel members (the middlemen) (Clow & 
Baack, 2005: 61).  
 
Mass media often forms part of direct marketing campaigns.  It is also known as mass 
communication as a message can be sent to many consumers at one time (Clow & Baack, 
2005: 61).  Mass media consists of broadcast media (television and radio) and print 
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media (newspapers, magazines, direct mail, and billboards) (Belch & Belch, 2004: 143).  
However, the most common forms of mass media used in direct marketing are television, 
radio, magazines, and newspapers (Clow & Baack, 2005: 61).   
 
(i)   Broadcast media 
 
Television is a unique and powerful advertising medium as it contains the elements of 
sight, sound, and motion to create a variety of advertising appeals and executions (Belch 
& Belch, 2004: 286).  Radio, in contrast, has a limited sense-appeal as it only contains the 
element of sound.  This broadcast medium, despite its setback, remains an excellent 
reminder and support medium that is estimated to “touch the lives” of nearly all South 
African adults (Brewer, 1998: 222).   
 
Television, however, is the most highly desirable advertising medium due to its rate of 
exposure to consumers.  In a survey conducted in 1987 by the South African 
Broadcasting Corporation (SABC) it was identified that the average person in SA 
watches 3.48 hours of television per day and 24.36 hours per week (Brewer, 1998: 218).  
The Television Audience Measurement Survey (TAMSTM) conducted by the South 
African Advertising Research Foundation (SAARF) over a 12 month period (July 2002 to 
June 2003) also indicated that adults in SA watched television an average of 3.01 hours 
per day and 21.07 hours per week.  This survey also indicated that 67.3% (20.023 million) 
of the adults in SA watched television on a daily basis during this period (South African 
Research Foundation, 2007).  These figures show that television is an excellent medium 
to reach many consumers with a single message (Clow & Baack, 2005: 62).  
 
Radio does not have the same degree of consumer exposure as television, but can still be 
used to convey strong advertising messages as it is a constant companion in peoples’ cars, 
at home, and even at work (Belch & Belch, 2004: 351; Clow & Baack, 2005: 62).  This 
broadcast medium, however, has no reference capability for listeners and they are often 
also unable to cope with all the detail present in, for example, advertisements (Brewer, 
1998: 223). 
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Figures identified by the Radio Audience Measurement Survey (RAMSTM) conducted by 
SAARF over a 12 month period (January 2002 to December 2002) indicated that SA 
adults listened to the radio an average of 27.12 hours per week.  In a similar survey done 
between July 2002 and June 2003, it was found that SA adults listened to radio an 
average of 29.54 hours per week (South African Advertising Research Foundation, 2007).  
These figures indicated that during these times SA adults spent more hours in a week 
listening to the radio than watching television.   
 
(ii)   Print media 
 
Newspapers generally appear daily (for example, Die Burger, The Herald, Daily 
Despatch) or weekly (for example, Sunday Times and Rapport).  This print medium is 
mostly regionalised which allows for more flexibility and accuracy in target marketing 
(Brewer, 1998: 208).  Newspapers are the largest advertising medium in terms of its total 
advertising volume.  However, this medium has fallen behind television and magazines 
as a medium for national advertisers.  In the USA it was found that only four and a half 
percent of the estimated $144 billion dollars spent on national advertising in 2002 was 
spent on national advertising in newspapers (Belch & Belch, 2004: 425).   
 
As a result of newspapers having a sense of “urgency” in its nature, it creates a healthy 
environment for an “urgent” type of advertisement, for example, an announcement of a 
sale (Brewer, 1998: 208).  For this reason it is usually community pharmacy 
advertisements that appear in newspapers and not direct-to-consumer pharmaceutical 
advertisements.  In comparison with other media types, it is generally more cost-effective 
to advertise in newspapers (Brewer, 1998: 208).   
 
However, the disadvantages of this print medium are that it has poor reproduction quality 
and a short “shelf-life”.  Poor reproduction quality is as a result of newspapers having a 
poor paper quality and also because of the limited use of colour.  If the visual appearance 
of a specific print advertisement is of importance, newspapers should not be the print 
medium of choice (Belch & Belch, 2004: 420).  Newspapers have a short life span as 
they are generally not kept for longer than a day.  This results in advertisements only 
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having an impact on the day of publication with repeat exposure highly unlikely (Belch & 
Belch, 2004: 420; Brewer, 1998).  
 
According to the All Media and Products Survey (AMPSTM) conducted during a 12 
month period by SAARF (January 2002 to December 2002), 17.1% of SA adults read any 
newspaper on a daily basis whereas 30.8% read weekly newspapers.  From July 2002 to 
June 2003 there was an increase in these figures with 18.6% of SA adults reading 
newspapers on a daily basis while 31% read weekly newspapers.  These results also 
indicated that there was an increase in daily readership in both males and females as well 
as in the age group, 16 – 34 years (South African Advertising Research Foundation, 
2007).            
 
In contrast to these disadvantages, magazines have excellent reproduction quality and a 
much longer life span than newspapers (Brewer, 1998: 208; Wells, et al. 1995: 353).  
Magazines use high quality paper for printing and many colours are used.  This print 
medium has the longest life span of all the media as readers will often page more than 
once through a magazine (Brewer, 1998: 208).  Magazines also have a very high reach 
potential due to a large pass-along to friends, family, customers, and colleagues (Wells, et 
al., 1995: 353).  Therefore, in contrast to newspapers, advertisements in magazines will 
have a much longer impact on consumers resulting in increased repeat exposure. A 
disadvantage may be that most magazines circulate nationally and are not geographically 
specific (Brewer, 1998: 353).  This, however, makes them an excellent medium to expose 
consumers to direct-to-consumer pharmaceutical advertisements.  
 
The AMPSTM was also conducted and revealed that in the 12 month period, January 2002 
to December 2002, there were 40.1% adult readers of any magazines (weekly and 
monthly magazines) in SA.  There was only a slight increase in these figures for July 
2002 to June 2003, with 40.7% (12.112 million) SA adult readers of any magazines.  The 
AMPSTM also found that in this period the average of any magazine title (weekly or 
monthly publication) read by a SA adult was 3.19 titles (South African Advertising 
Research Foundation, 2007). 
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2.3.2.2   Interactive or Internet marketing  
 
Interactive or Internet marketing is a form of marketing that has developed from the 
advances in technology.  As the Internet was developed, along came advertising and 
marketing.  Interactive media allows for a back-and-forth flow of information where 
users can participate in and also modify the form and content of information they receive 
in real time (Belch & Belch, 2004: 20).  Where traditional forms of marketing 
communication, such as advertising, are usually one-way in nature, this form of 
marketing allows for a more interactive participation from the consumer (Belch & Belch, 
2004: 20).  Interactive advertising, along with direct marketing, has the greatest potential 
for establishing intimacy, initiating dialogue between brand and consumer, as well as for 
the gathering of information.  Interactive advertising’s main advantage is therefore its 
ability to create dialogue, where in contrast, print media and television deliver a more 
passive monologue (Landa, 2004: 219).  After exposure to such a form of marketing, the 
consumer can now alter information and images, respond to questions, make inquiries, 
and make purchases.  The Internet is a medium that can be used to execute all elements of 
the promotional mix (Belch & Belch, 2004: 20).     
 
This form of marketing began with banner advertisements that appeared across computer 
screens as people visited the World Wide Web.  Following this were interstitial 
advertisements, or the so-called popups (Clow & Baack, 2005:  98).  These 
advertisements are viewed as controversial and offensive by many as they force Web 
browsers to react.  However, it was found that popup advertisements were much more 
effective than banner advertisements.  This led to the development of superstitials that 
work after a browser leaves the Web site or even shuts off the computer in which the 
advertisement will appear the next time the person logs onto the Internet (Clow & Baack, 
2005:  98).   
 
Marketing via the Internet can also be conducted by means of electronic mail (e-mail).  
Nowadays e-mail advertisements are referred to as spam due to the development of a 
strongly negative connotation towards such advertisements (Clow & Baack, 2005: 98).  
Clow and Baack (2005: 99) conducted a worldwide Internet survey on the perceptions 
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towards the use of these various forms of advertising on the Internet and concluded the 
following:  
 
• 24% stated that no form of Internet advertising was intrusive or a turnoff; 
• 40% found popup advertisements to be a turnoff; 
• 28% found e-mail advertisements to be a turnoff; and 
• eight percent found banner advertisements to be a turnoff.  
 
Despite these negative perceptions towards the various forms of advertising on the 
Internet, companies in the USA still continue to use the Internet as a marketing tool.  
Additionally, a recent study in the USA identified the following interesting statistics 
which makes the use of Internet advertising even more appealing to companies in the 
USA (Clow & Baack, 2005: 99.): 
 
• Approximately 42% of Internet users are women and men make up the other 58 %. 
• The average age of Internet users is 34.9 years. 
• More than 65% of Internet users have household incomes of $50 000 or more per 
year, compared to 35% of the USA population as a whole. 
• 75% of Internet users have attended college compared to 46% of the general USA 
population. 
 
The SARF conducted the AMPSTM to determine the Internet usage amongst SA citizens.  
It was estimated that between July 2002 to June 2003 (a 12-month period), 5% (1.496 
million) of SA citizens used the Internet on a monthly basis, 3.8% (1.146 million) used 
the Internet on an average seven day period, while 2.3% (684 000) used the Internet daily 
(South African Advertising Research Foundation, 2007).        
 
2.3.2.3   Sales promotion 
 
Sales promotion, or consumer promotion as it is also known, is a promotional effort 
which supplements or coordinates personal selling to increase sales, but which cannot be 
strictly classified as either.  This is a temporary marketing effort that can generate short-
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term interest in product purchase (Vilanilam & Varghese, 2004: 186).  Belch and Belch 
(2004: 2) divided sales promotion into two major categories:  consumer-orientated and 
trade-orientated activities.  Consumer-orientated sales promotion targets the ultimate user 
of the product or service.  This type of sales promotion includes, for example, rebates, 
contests (see Figure 2.5), premiums, sampling, sweepstakes, and various point-of-
purchase materials.  The aim of consumer-orientated sales promotion is to encourage 
consumers to make an immediate purchase thus stimulating short-term sales (Belch & 
Belch, 2005: 22).  Trade-orientated sales promotion targets the market intermediaries 
(middlemen) such as wholesalers, retailers, and distributors.  Price deals, sales contests, 
promotional and merchandising allowances, and trade shows are some examples of this 
type of promotion.  Its aim is primarily to encourage the trade to stock and promote a 
company’s products (Belch & Belch, 2005: 22).   
  
                                                  
 
 
 
 
 
 
 
 
 
Figure 2.5   Example of a baby competition employed as a consumer-orientated sales 
promotional technique by a South African pharmaceutical company 
(Source: Aspen – What’s News?, 2006: 8)   
 
The major differences between advertising and sales promotion concern their methods of 
appeal and the value they add to the sale of a product or service (Wells, et al., 1995: 593).  
These differences are illustrated in Table 2.1.  
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Table 2.1   Differences between advertising and sales promotion 
   
ADVERTISING  
 
SALES PROMOTION 
 
• Creates image over time 
• Relies on emotional appeals 
• Adds intangible value to the product or 
service 
• Contributes moderately to profitability 
 
 
• Creates immediate action 
• Relies on rational appeal 
• Adds tangible value to the product or service 
• Contributes greatly to profitability 
     
(Source:  Wells, et al., 1995: 594) 
 
2.3.2.4   Public Relations and Publicity  
 
Public Relations (PR) is a management function which has the task of evaluating public 
attitudes, identifies the policies and procedures of an individual or organisation with the 
public interest, and executes a program to earn public understanding and acceptance 
(Belch & Belch, 2005: GL11).  Vilanilam and Varghese (2004: 183) described PR as “all 
activities and attitudes intended to judge, adjust to, influence, and direct the opinion of 
any group or groups of persons in the interest of an individual, group, or institution”.  It 
has three key functions (Clow & Baack, 2005: 133): 
 
• monitoring the internal and external public; 
• providing positive information to each public that reinforces the integrated marketing 
plan and advertising direction; and 
• reacting quickly to any shift in the position of any of the publics from the desired 
position. 
 
Publicity, on the other hand, refers to the communication regarding an organisation, 
service, product, or idea that is not directly paid for or run under identified sponsorship 
(Belch & Belch, 2005: GL11). 
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2.3.2.5    Personal selling   
 
The final element of the promotional mix is personal selling.  Personal selling is a form 
of person-to-person communication whereby a seller tries to assist and/or persuade 
prospective buyers to purchase a company’s product or service or to act on an idea (Belch 
& Belch, 2005: 24).  It involves direct contact between buyer and seller, either face-to-
face or through some other form of telecommunication.  Direct contact not only allows 
for communication flexibility, but also provides immediate and precise feedback to the 
seller (Belch & Belch, 2005: 24).  
 
2.3.3   Main types of advertising  
 
Landa (2004: 41) identified four main types of advertising, namely: 
 
• public service or social advertising; 
• cause advertising; 
• commercial advertising; and 
• guerrilla advertising. 
 
2.3.3.1   Public Service Advertising  
 
Public Service Advertising (PSA) is advertising that serves the interest of the public 
(Landa, 2004: 41).  PSA is a non-commercial form of advertising that is a powerful 
educational tool capable of reaching and motivating large audiences. It deals with issues 
such as AIDS (see Figure 2.6), energy and water conservation, religious recruitment and 
political ideology (Richards, 2004).  This form of advertising is generally sponsored by 
non-profit institutions (see Figure 2.7), civic groups, religious organisations, trade 
associations, or political groups.  In the USA, PSA reached its height during World War I 
and II under direction of its servant government agencies (Advertising, 2006).   
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Figure 2.6   A public service advertisement regarding AIDS 
(Source:  Learn about the campaign: Outdoor Advertisements, 2005)   
 
 
                                   
 
 
 
 
 
     
 
 
 
 
Figure 2.7   The Environmental Protection Agency (EPA), using emotional appeal to 
focus on how environmental pollution can affect the health of children 
(Source:  Landa, 2004: 70) 
 
2.3.3.2   Cause advertising  
 
Cause advertising is a particular category of PSA.  The difference of cause advertising to 
PSA is that its commercial nature is maintained to a degree by its affiliation with a 
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corporation.  Cause advertising is used to raise funds for non-profit organisations, is 
sponsored by corporations and therefore published in paid media (Landa, 2004: 14).   
 
2.3.3.3   Commercial advertising  
 
Commercial advertising is the opposite of PSA. It involves a commercial interest rather 
than advocating a social, political, or religious cause (Richards, 2004).  Commercial 
advertising refers to the selling of brands by informing consumers, brand building, 
promotion of brands, and endearing brands to consumers.  This type of advertising can 
take the form of a single advertisement, a campaign, or brand building in any 
conventional medium type, such as direct response, television, radio, the World Wide 
Web (Internet), or print (Landa, 2004: 41).  It can even be used on media such as bus stop 
benches and the sides of busses, skywriting, wall paintings, trains and its subway 
platforms (Advertising, 2006).   
 
2.3.3.4   Guerrilla advertising  
 
Guerrilla advertising is also known as non-traditional advertising, unconventional 
advertising, or stealth marketing.  When conducted on the Internet it is also known as 
viral marketing (Landa, 2004: 42).  The term ‘guerrilla advertising’ was coined by Jay 
Conrad Levinson (Guerrilla marketing, 2005). Guerrilla advertising is an unconventional 
form of advertising intended to get the maximum results from minimal resources 
(Guerrilla marketing, 2005).  This type of advertising “ambushes” the consumer and 
appears or is placed in unpaid media.  It is often seen in public spaces where 
advertisements do not belong.  Examples of where guerrilla advertising can be found are 
on wine corks, coffee cup sleeves, sidewalk logos, bathroom stalls, or on hotel room keys 
(Landa, 2004: 42).  Figure 2.8 illustrates two examples of guerrilla advertising, an 
advertisement next to a urinal of the movie, Spiderman 2, and an HIV-awareness 
advertisement on a bus shelter.   
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Figure 2.8   Examples of guerrilla advertising   
(Source:  Guerrilla advertising, 2005; Get it in writing, 2007)  
 
Another example of guerrilla advertising can be seen in Figure 2.9.  This is an 
advertisement which misleads the reader into thinking that it concerns a lost puppy, 
thereby attracting the necessary attention.  It is in fact an advertisement for a day care 
centre for dogs.  
 
The reason why advertising has become a force to be reckoned with in the marketing 
world can be attributed to the following three main advantages identified by Belch and 
Belch (2004: 17): 
 
• Creates brand images and symbolic appeals for a company or brand. 
• Acts as a cost-effective method for communicating with large audiences. 
• Ability to strike a responsive chord with consumers when differentiation across other 
elements of the marketing mix is difficult to achieve. 
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 Figure 2.9   Example of a misleading guerrilla advertisement 
 (Source:  Landa, 2004: 232)   
 
2.4 PHARMACEUTICAL ADVERTISING  
 
Pharmaceutical advertising does not differ greatly from that of the conventional type of 
advertising people are exposed to on the daily basis.  The main, and probably the only 
difference, is the fact that pharmaceutical advertisements must comply with the various 
pharmaceutical regulations and ethical considerations regarding advertising.  Each 
country has a set of rules, regulations, and ethical guidelines developed by their 
respective pharmaceutical authorities.  In the USA the Food and Drug Administration 
(FDA) and the Federal Trade Commission (FTC) regulate pharmaceutical advertisements 
(Abood & Brushwood, 1994: 7); in Britain the Royal Pharmaceutical Society of Britain 
and the ASA of the United Kingdom have this responsibility; in SA it is the responsibility 
of the Medicines Control Council (MCC), the South African Pharmacy Council (SAPC), 
and the ASA of SA.     
 
There are two sectors of Pharmacy which have to be distinguished, namely the 
pharmaceutical industry and community pharmacy.  These two fields of Pharmacy each 
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incorporate its own type of advertising.  The pharmaceutical industry, as with any large 
company, will incorporate each element in the promotional mix (refer to Figure 2.4). 
Rutherford (1993: 7) indicated that pharmaceutical marketing tends to resemble industrial 
marketing.  He stated that personal selling is the main promotional tool used by 
pharmaceutical companies, followed by sales promotion (Rutherford, 1993: 7).  Presently, 
these statements can be reinforced by astonishing figures obtained by Moynihan and 
Cassels (2005: 22).  They stated that in the USA alone, there were 80 000 people working 
as sales representatives for various pharmaceutical companies.  These sales 
representatives had an estimated $25 million dollar expenditure per year for sales 
promotional tools to detail their products to doctors, psychiatrists, pharmacists and other 
healthcare professionals (Moynihan & Cassels, 2005: 23).  Advertising and publicity are 
also employed by the pharmaceutical industry to create awareness of their products but to 
a much lesser degree than personal selling and sales promotion (Rutherford, 1993: 7).  
 
The use of advertising in community pharmacies is quite different to that of the 
pharmaceutical industry.  In-store advertisements in community pharmacies are more 
focused on informing and making customers aware of the availability and price of 
products as well as to reinforce any special sales.  Figure 2.10 is an example of a typical 
advertisement used by a community pharmacy in the NMM to advertise a medicine’s 
name, quantity, and product price to the general public.  The selling of consumer goods, 
such as those in community pharmacies, rely more on advertising and sales promotion as 
opposed to personal selling and sales promotion in the pharmaceutical industry 
(Rutherford, 1993: 7).   
 
In community pharmacies advertisements are usually self-designed.  These types of 
advertisements are often colourful and creative.  It usually advertises a special promotion 
or informs the customer of the price of a new product.  Community pharmacies may in 
some instances also employ consumer-orientated sales promotion to sell their products.  
This type of sales promotion is more directed at front shop merchandise such as 
cosmetics, toiletries, alternative treatments, and unscheduled medicines.  Consumer-
orientated sales promotion such as rebates, premiums, and sampling of scheduled 
medicines are (as from 2 May 2002) banned in SA in accordance with Section 18A of the 
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Medicines and Related Substances Amendment Act 59 of 2002 (South African 
Pharmaceutical Manufacturer’s Association, 2004).  In many community pharmacies 
competitions such as baby and mother-and-child photo competitions are still used to 
create awareness and support of the particular pharmacies.  
 
 
        
 
 
 
 
 
 
Figure 2.10   Example of a typical community pharmacy advertisement 
(Source:  Die Burger, 2007: 3) 
 
Mass media is also employed in community pharmacies.  However, independent 
community pharmacies use smaller community and regional newspapers to advertise 
their products and services. In the NMM community pharmacies will advertise in, for 
example, The Herald, Die Burger, Apple Express, and UD News which appears daily.  
Chain store community pharmacies such as DisChem, Clicks, and Shoprite have large 
advertising budgets and will therefore advertise nationally and may use television, radio, 
and national newspapers like Rapport and Sunday Times to advertise. 
 
2.4.1   Direct-to-consumer advertising    
 
Direct-to-consumer (DTC) advertising is defined as the promotion of prescription drugs 
by pharmaceutical companies by means of mass media (for example, newspapers, 
magazines, television (see Figure 2.11), and Internet marketing (see Figure 2.12)) which 
are directed at the general public (Abood & Brushwood, 1994: 186; SourceWatch, 2006; 
Wilkes, Bell & Kravitz, 2000: 111).  DTC print advertising is defined as “a space that is 
bought by a company in a newspaper or magazine publication targeted to patients or 
consumers, or a direct mail communication paid for and disseminated by a company to 
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patients or consumers, for the purpose of presenting information about one or more of 
the company’s medicines” (Pharmaceutical Research and Manufacturers of America, 
2005). However, this form of print advertising does not include the sponsorship of 
activities (Pharmaceutical Research and Manufacturers of America, 2005).  DTC 
advertising originated in the USA and its history is illustrated in Figure 2.13.   
   
                                 
 
Figure 2.11   A direct-to-consumer advertisement of the cholesterol-lowering 
medicine, Crestor® seen on television in the USA 
(Source:  Annals of Family Medicine, 2007)  
 
                                 
 
Figure 2.12   Example of an antiretroviral advertisement on the Internet 
(Source:  Drug advertisements, 2001)   
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 1708  Nicholas Boone of Boston placed the  
                                                                                         first advertisement for a patent medicine 
                                                                                                  in an USA newspaper       
Federal Food, Drug and Cosmetic Act 1938   
requires new drugs to be shown safe  
before marketing.  FDA also charged 
with oversight of advertising prescrip- 
tion drugs 
 1951   Durham-Humphrey Amendment chan-  
                                                                                         ging the Food and Drugs Act of 1906 to 
                                                                                         formally distinguish between prescrip-  
Kefauver-Harris Drug Amendments re-                                      tion and OTC medicines       
quires manufacturers to prove effective- 1962           
 ness of medicine before marketing      
                                                                    1970 FDA requires patient package inserts to   
                                                                                                 inform patients about risks and benefits       
 
Few pharmaceutical companies begin Early 1980’s 
marketing to consumers  
 1983  Voluntary FDA moratorium on DTC ad- 
                                                                                         vertising 
 
  FDA moratorium lifted on DTC adverti- 1985 
                                                                                                  sing        
 
 1997   FDA relaxes regulations requiring indi- 
                                                                                                           cations, side-effect and contraindication 
                                                                                                           summaries in advertising, allowing  
                                                                                                           more marketing on television  
                
 
Figure 2.13   Timeline indicating the history of direct-to-consumer advertising in the 
United States of America   
(Adapted from:  SourceWatch, 2006; Wilkes, et al., 2000: 111-114) 
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Although this form of advertising is currently only permitted in the USA and New 
Zealand although the pharmaceutical industry in Canada and Europe are mounting 
lobbying campaigns to gain the approval thereof in these respective countries (DES 
Action Canada, 2002; SourceWatch, 2006; Wilkes, et al., 2000).  It is only a matter of 
time before DTC advertising becomes a familiar sight in SA mass media.  Already 
scheduled medicine advertisements can be seen from time to time in well-known 
magazines directed at the general public, something which is prohibited by SA pharmacy 
law (Pharmaceutical Society of South Africa Law Compendium, 2005: MRE – 50).   
 
One of the reasons DTC advertising is prohibited in most industrialised countries is that 
public safety measures have to be linked to the prescription-only status of medicines 
(DES Action Canada, 2002).    
 
2.4.1.2   Views towards direct-to-consumer advertising 
 
There are two schools of thought regarding DTC advertising, those with opposing views 
and those who are in favour of such forms of promotion.  Most independent researchers, 
however, view DTC advertising in a negative light.  Table 2.2 indicates the arguments for 
and against DTC advertising. 
 
Ironically, studies indicating the proposed advantages of DTC advertising were paid for or 
sponsored by pharmaceutical companies or advertising agencies.  A survey conducted in 
New Zealand in 2006 validates this bias tendency (Ministry of Health of New Zealand, 2006).  
A sample of 110 people representing members of the public, healthcare professionals, 
pharmaceutical companies, governmental agencies, advertising agencies, and academia were 
asked to view their opinions towards DTC advertising.  As could be expected, the results 
indicated that the largest proportion of participants who were not concerned or opposed to 
DTC advertising were pharmaceutical companies and advertising agencies (Ministry of 
Health of New Zealand, 2006).  
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Table 2.2   Arguments for and against direct-to-consumer advertising  
 
 
ARGUMENTS FOR 
 
ARGUMENTS AGAINST 
 
• Effective as marketing strategy which shows 
exponential growth 
• Allows for interaction with healthcare 
professionals  
• Cultivates a healthy lifestyle 
• Effective in increasing prescription volumes 
• Inform public of new medicines   
• Help patients identify conditions most  
appropriately managed by pharmaceuticals and
reduces under treatment  
 
• Do not show a net benefit to the public health  
system  
• Treat prescription medicines as normal day-to- 
day consumer goods though they can be harmful,  
even when properly used 
• Result in pressure on healthcare professionals to 
prescribe medicines unnecessary   
• Presented in a slant and emotive manner down- 
playing risks and enhancing benefits 
• Do not provide objective information on risks,  
benefits, and options to assist consumers in  
participating in healthcare decisions 
• Promotes medicalisation of normal health and  
the aging process  
     
(Adapted from:  Abood & Brushwood, 1994: 187; Aikin & Swasy, 2003; Deselle, 2004: 3; 
DES Action Canada, 2002;  Ministry of Health of New Zealand, 2006; Stange, 2007: 176; 
Toop, et al., 2003) 
 
2.4.1.3   Forms of direct-to-consumer advertising and products offered      
 
In the USA, and in all probability, in New Zealand, DTC advertisements can take on the 
following forms of advertising (Wilkes, et al., 2000): 
 
(i)   Health-seeking advertising   
 
Health-seeking advertisements are thought to educate consumers about diseases or medical 
conditions.  Such advertisements do not mention the names of the medicine.  Figure 2.14 
illustrates an advertisement that is thought to educate consumers about high cholesterol. 
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Figure 2.14   Health-seeking advertisement regarding cholesterol tests 
(Source:  Mintzes, 2006) 
 
(ii)   Reminder advertising   
 
Reminder advertisements inform patients about the medications available for treatments.  
These advertisements indicate the name of the medicine as well as other minimal information  
but do not mention anything about the medicines’ use, effectiveness, or safety.  Figure 2.15 is 
an example of a controversial reminder advertisement for the treatment of severe acne in 
females that has failed to respond to any other treatments.  This advertisement did not reveal 
the treatment’s true adverse drug reaction profile publicised in various independent studies.  
Studies warned of its potential risk to cause fatal blood clotting (Mintzes, 2004). 
 
(iii)   Product-specific advertising   
 
Product-specific advertisements mention the medication by name, describe its therapeutic 
use(s), and make representations about their effectiveness and safety.  A vast majority of 
DTC advertisements fall within this category.   
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Figure 2.15   Advertisement for the hormonal product, Diane®-35 
(Source:  Mintzes, 2006)  
 
It is also important to understand the categories of products offered to consumers in the form 
of DTC advertising.  DTC advertisements mainly advertise the following three categories of 
medicines (Mintzes, 2004; Wilkes, et al., 2000):   
 
• Lifestyle medicines 
 
Lifestyle medicine advertisements advertise its cosmetic or lifestyle benefits to consumers.  
Such advertisements do not have an impact on the long-term outcome of a serious illness.  
Examples of such advertisements found in the USA are Claritin® (for allergies), Viagra® (for 
impotence), and Propecia® (for hair loss).  
  
• Prevention medicines 
 
Prevention medicines are used to reduce the likelihood that disease complications may occur.  
Examples of such medicines advertised are for conditions such as high cholesterol, 
osteoporosis, and coronary heart disease.   
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• Chronic disease medicines 
 
Chronic disease medicines treat, for example, diseases like diabetes, asthma, anxiety 
disorders, and depression.   
 
2.4.1.4   Direct-to-consumer advertising as marketing tool 
 
It cannot be argued that DTC advertising is an effective marketing tool to reach the masses. 
DTC advertising definitely shows exponential growth as can be proved by various figures of 
such expenditures.  Figure 2.16 illustrates the billions of dollars spent on DTC advertising in 
the USA from 1997 to 2005.  It was estimated that the total percentage increase in DTC 
advertising expenditure for these nine years was 296.4%, whereas the average annual 
percentage increase was 19.6% (SourceWatch, 2006).  Furthermore, Table 2.3 illustrates the 
advertising expenditure of the most heavily promoted medicines in the USA for 2005.  
 
These figures on the DTC advertising expenditure prove that consumers in the USA are 
bombarded by DTC advertisements.  To put the figures (for the year 2000) spent on 
pharmaceutical advertising in perspective, Table 2.4 compares the advertising expenditure of 
the drug, Vioxx® (anti-inflammatory and antirheumatic medicine), to that of other world 
famous consumer products.  What amount of medicine sales resulted from such advertising 
campaigns needs to be seen but it can be assumed that there should be a significant number 
of sales as a result of these enormous expenditures. 
 
The irony of these figures is that in 2004 Vioxx® was withdrawn from the worldwide market 
due to causing life threatening cardiovascular side effects in the USA (Holford & Burne, 
2006: 21).  This was despite warnings from research results that dated back as far as 1998 
which were conveniently and quietly ignored by the manufacturer.  Following this, three 
more trials reinforced the dangers of this medicine but, once again, the findings were ignored 
(Holford & Burne, 2006: 21).  This raises the speculative question that if Vioxx® was not as 
heavily advertised as shown by these figures, over prescribing would have been reduced, 
resulting in fewer deaths related to cardiovascular side effects.      
 
 36
 
 
 
 
      
 
    
 
  
Figure 2.16   Spending on direct-to-consumer advertising in the United States of 
America from 1997 to 2005  
 
(Source:  Adapted from SourceWatch, 2006)     
  
Table 2.3   Most heavily promoted medicines in the United States of America for 
2005 
  
$0.0 $0.5 $1.0 $1.5 $2.0 $2.5 $3.0 $3.5 $4.0 $4.5
1997
1999
2001
2003
2005
YE
A
R
$ BILLION
MEDICATION INDICATION COMPANY $ MILLION 
Lunesta® Hypnotic Sepracor $ 227.3 
Nexium® Anti-ulcer treatment AstraZenica $ 204.9 
Vytorin® Cholesterol-reducing agent Merck / Schering-Plough $ 161.5 
Crestor® Cholesterol-reducing agent AstraZenica $ 158.6 
 
(Source: SourceWatch, 2006) 
  
Table 2.4   Comparison between the advertising costs of Vioxx®, Pepsi®, and Dell 
computers in 2000 
  
PRODUCT ADVERTISED SPENT ON ADVERTISING ($ MILLION) 
Vioxx® $ 160  
Dell computers $ 160 
Budweiser® beer $ 146  
Pepsi® $ 125 
   
(Source:  National Institute of Health Care Management, 2001: 5)     
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Even if there are some positive views for DTC advertising, most independent researchers 
indicate that such a form of advertising is not in the best interest of consumers, healthcare 
professionals, and the public health system.  Kemper and Mettler (2002: 52) stated that 
DTC advertising delivers “spoonful of sugar” messages that promise “quick relief, 
improved health, and longer life” but that it does not provide the consumer with 
important information such as risks, costs, and alternatives for each medicine advertised. 
DTC advertising should firstly be thoroughly investigated before being approved by 
countries where it is still prohibited. 
 
2.5 PSYCHOLOGICAL IMPACT OF ADVERTISING  
 
Walter Dill Scott (whose research commenced in 1901) was one of the first psychologists 
to apply psychology to business practices such as advertising (Kneessi, 2002; Wozniak, 
1999).  The notion of psychology being applied to advertising in fact started before this 
by Harlow Gale, a then psychologist at the University of Minnesota.  Gale started 
utilizing laboratory experiments in the assessment of the attention value of various 
characteristics of advertising in 1896 (Berger, 2000: 4; Wozniak, 1999).  However, no 
significant interest was invested in his studies and therefore no impact on advertising 
practices was made (Wozniak, 1999).   
 
In his research, Scott found that advertising had one major function, that is, to influence 
the minds of people.  He stated that for advertising to be effective it must be able to 
create a thought in the consumer’s mind to purchase the product without raising any 
interfering thoughts.  To achieve this he linked the basic psychological functions of 
memory, habit, volition, instinctive action, attention, feeling, and sympathy to an 
advertisement’s design (Kneessi, 2002; Wozniak, 1999).     
 
With regard to the psychological function, sympathy, Scott realised that consumers 
perceive a similarity between themselves and the advertisement they see and that the 
greater the degree of sympathy drawn from it, the higher its likelihood to influence the 
power of suggestion.  Furthermore, Scott suggested that a person’s feelings can be 
divided into two categories, pleasure and pain.  With pleasure people become suggestible 
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and therefore more likely to see everything in a favourable light.  In contrast to this, pain 
causes people to refuse suggestion.  Pain results in people not being easily influenced as 
well as becoming suspicious towards things proposed.  Scott suggested that it was 
important for these findings to be borne in mind when designing advertisements 
(Wozniak, 1999).   
 
In essence, advertisements should elicit pleasure and not pain.  These early findings 
indicated that psychology plays a specific and definite role in advertising.  This supports 
the notion that it is important to explore the role of psychology in current advertising 
practices.   
 
The section below coincides with the following four aspects regarding the psychological 
impact of advertising: 
 
• consumers’ decision-making processes regarding purchasing; 
• persuasive nature of advertisements and its impact on consumers; 
• role of emotion in persuasive advertising; and  
• preattentive processing of advertisements.    
 
2.5.1   Consumers’ decision-making processes regarding purchasing 
 
To understand the psychological impact of advertising on consumers, focus has to be 
placed on the stages of the consumer decision-making process and the relevant internal 
stages of the psychological process during purchasing.  The stages of these two processes 
can be represented by the basic model illustrated in Figure 2.17.   
 
Problem recognition (see Figure 2.17 (a)), occurs when the consumer perceives a need 
and becomes motivated to solve a problem (Belch & Belch, 2004: 107).  This is not 
always a cognitive event.  A person may or may not actively think of a need but yet still 
experience that need.  The person may, for example, walk past a bakery, smell and see 
some cookies, which may then trigger a desire or need to have them.  They will then act 
on this desire or need by entering the bakery to buy the cookies (Clow & Baack, 2005: 
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129).  When choosing self-medication, the consumer will experience the symptoms of the 
illness, and then attempt to evaluate the severity in order to finally make a decision of 
treating their illness. Pharmaceutical marketers will use this step to, for example, inform 
the consumer that he or she could have a vitamin deficiency (Advertising: An important 
role in responsible self-medication in Canada, 1996).  Once a need has been recognised, 
the person can start searching for information. 
 
(a)  Stages in the consumer decision-making process 
        
 
       Problem                Information          Alternative            Purchase           Post-purchase 
     recognition                 search                 evaluation              decision               evaluation 
        
 
  (b)  Relevant internal psychological processes 
 
 
       Motivation          Perception         Attitude formation         Integration            Learning 
                               
 
 
Figure 2.17   Basic model of consumer decision-making 
(Source: Belch & Belch, 2004: 105) 
 
The second step, information search, usually begins internally where the consumer 
recalls mental images of products that might fulfil his or her needs.  Past experiences of 
how a product has satisfied a need may be used to recall a brand that was used.  If that 
resulted in a positive purchase experience the purchasing decision may be repeated.  The 
information search then stops at the internal level but if it was a negative experience, or if 
the internal search did not yield enough information, the consumer will conduct an 
external search (Clow & Baack, 2005: 95).  The external search will involve the search of 
external sources such as personal sources (for example, friends, relatives, or co-workers), 
public sources (for example, newspaper or magazine articles and television reports), 
personal experience (for example, handling, examining, testing products, or samples 
thereof), and commercial sources (for example, advertising information or the Internet) 
(Belch & Belch, 2004: 112). 
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The next step is alternative evaluation.  During this step the consumer evaluates various 
purchase possibilities (Clow & Baack, 2005: 69).  Criteria will be set to conduct this 
evaluation of various purchase possibilities whereby the benefits of one product can be 
weighed against another (Belch & Belch, 2004: 115; Clow & Baack, 2005: 69).  
 
The fourth step is the purchase decision.  After consumers have evaluated their various 
purchase possibilities, they will develop a purchase intention towards a certain brand 
(Belch & Belch, 2004: 120).  Once consumers are totally satisfied with a specific brand, 
the purchase will occur (Clow & Baack, 2005: 135).  It is important to remember that a 
purchase decision will not always lead to a purchase.  Interventions to the actual purchase 
can occur and can include the attitude of others, anticipated situational influences (for 
example, family income or product cost), as well as unanticipated situational influences 
(for example, poor sales assistance) (Truter, 2006: 16).   
 
The final step in the consumer decision-making process is the post-purchase evaluation.  
The consumer will compare the performance level of the brand purchased to their 
expectations.  If the consumer’s expectation was met, or even exceeded, satisfaction has 
occurred.  If the consumer’s expectation was not met, dissatisfaction has occurred.  
(Belch & Belch, 2004: 120; Truter, 2006: 17)  Post-purchase evaluations affect future 
behaviour of consumers or businesses.  Satisfaction will create additional purchases or 
even positive word-of-mouth communication, whereas dissatisfaction leads to brand 
switching or negative word-of-mouth.  (Clow & Baack, 2005: 126.)  
 
In order to understand why consumers buy, the internal psychological processes (see 
Figure 2.17(b)) of the consumer needs to be focused upon.  Consumers will buy when 
they have a specific motive to do so.  Motivation is based on Maslow’s well publicised 
Hierarchy of Needs which consists of the following five basic levels of human needs, 
arranged in a hierarchy from the most basic needs of a human being (Belch & Belch, 
2004: 109; De Beer, Rossouw, Moolman, Le Roux & Labuschagne, 1998: 214): 
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• Physiological needs, for example, basic level of primary needs to survive.  
• Safety needs, for example, security and safety against physical harm. 
• Social needs, for example, a sense of belonging, and love.  
• Esteem needs, for example, self-fulfilment. 
• Self-actualisation needs, for example, self-development and realisation.     
 
Perception consists of the following processes: (1) how consumers sense external 
information, (2) how they select and attend to various sources of information, and (3) 
how this information is interpreted and given meaning (Belch & Belch, 2004: 113).  
These steps show that perception plays a major role in the second step of the consumer 
decision-making process, information search.  Perception occurs when stimuli are 
registered by one of the following five senses of a human:  vision, taste, smell, touch, and 
hearing (Hoyer & MacInnis, 2001: 92).   
 
With print advertising, all focus will be aimed at the sense of vision. Colour is an 
important factor in visual perception (Hoyer & MacInnis, 2001: 92).  Hoyer and 
MacInnis (2001: 92) found research that suggests that colour determines the visibility of 
stimuli.  Colour used in advertising also has the ability to influence people or consumers’ 
psychological responses and moods (Hoyer & MacInnis, 2001: 92).       
 
Attitude, from an advertising perspective, drives action (Clow & Baack, 2005: 11).  The 
positive or negative feelings consumers may harbour following a purchase are of vital 
importance, especially when marketers want to ensure future sales (Belch & Belch, 2004: 
117; Clow & Baack, 2005: 11).    
 
Integration plays a major role in the third step of the consumer decision-making process, 
alternative evaluation.  It is the way in which a product’s knowledge, meanings and 
beliefs are combined to evaluate two or more alternatives. Analysis of this process 
focuses on the different types of decision strategies consumers use to decide among the 
various purchase alternatives (Belch & Belch, 2004: 119).   
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2.5.2   Persuasive communication 
 
Advertising is a much more persuasive marketing tool today than it was before.  The 
most common goal of an advertisement is to persuade (Clow & Baack, 2005: 120).  It is 
therefore imperative to understand what persuasion is and what role it plays in 
advertising.   
 
Persuasive communication is described as a process by which people attempt to influence 
the beliefs or actions of others (Persuasive Communication, 2007; Locker & Kaczmarek, 
2007: 22).  The Oxford Advanced Learners Dictionary (1994: 924) refers to persuasion as 
“a cause to believe or convince”.  Tellis (2004: 112) defined persuasion in advertising as 
“a change in opinion, behaviour, or attitude due to exposure to the advertisement”.  The 
study of persuasion dates back to the ancient Greeks, who were the first to systematise 
the use of persuasion, calling it ‘rhetoric’.  Aristotle defined rhetoric as “the faculty of 
observing in any given case, the available means of persuasion”.  He stated that 
persuasion can be based on a source’s credibility (ethos), emotional appeals (pathos), or 
logical appeals (logos), or a combination of these (Larson, 2004: 11).   
 
The persuasive process can be illustrated by Figure 2.18 which represents the SMCR 
(source, message, channel, and receiver) model.  This model is similar to the basic 
communication model in that it contains all the components of the latter model, namely a 
source, message, receiver, and feedback (Gard, 2000: 5).  Figure 2.18 portrays how a 
television advertisement persuades consumers. 
 
The SMCR model consists of the following components (Larson, 2004: 16): 
 
• A source (S) (or persuader).  This is the encoder (sender) of the message where the 
code can be verbal or non-verbal, visual or musical, or some other modality. 
• A message (M) which conveys the source’s meaning. 
• A channel (C) carries the message and may also have distracting noise. 
• A receiver (R) (or persuadee), who in turn has the responsibility of decoding the 
message.  The receiver also has to try to sieve out channel noise and adding his or her    
own interpretation.  
 43
 
Figure 2.18   The SMCR model 
(Source:  Larson, 2004: 17) 
 
2.5.2.1   Elaboration Likelihood Model  
 
Advertisements are thought to persuade consumers in various ways.  The psychologists, 
Richard Patty and John Cacioppo, developed a framework in 1985 which illustrates the 
various routes in which consumers can be persuaded by advertisements (Belch & Belch, 
2004: 158; Tellis, 2004: 112; Vidal, 1998).  They have generated a model, the Elaborated 
Likelihood Model (ELM) (see Figure 2.19), which referred to how likely consumers think 
elaborately about advertisements when exposed to them (Belch & Belch, 2004: 158; 
Tellis, 2004: 112).  The ELM model shows that the elaboration likelihood functions via 
two elements, motivation and the ability to process the message (information) of the 
advertisement (Belch & Belch, 2004: 158).  Tellis (2004: 114) defines motivation as “the 
willingness of the individual to evaluate a message”.  It may occur as a result of the 
advertisement being engaging, brand loyalty, the person’s needs and arousal levels, the 
importance of the item advertised, and personal relevance.  Ability refers to the 
consumer’s “competency to engage in the required mental effort” (Tellis, 2004: 114).  
Belch and Belch (2004: 159) states that a consumer’s ability to evaluate a message will 
also depend on whether he or she has the opportunity to do so.            
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PERSUASIVE 
COMMUNICATION 
 
MOTIVATION FOR PROCESSING 
INFORMATION  
                       yes                                
 
                                no 
 
ABLE TO PROCESS INFORMATION? 
 
  PASSIVE PROCESSING 
  yes   no 
        
 
Central 
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route 
     
                                                                                       Passive state of receptivity to 
                                                                                                                       advertisement or not attend to 
                                                                                       it 
   
 
Cognitive 
processing 
 
  
 
 
 
Favourable 
arguments 
predominate 
 
  Unfavourable 
arguments 
predominate 
 
 
 
Positive attitude 
towards adverti- 
sement 
(persuasion) 
 
 
 
Negative attitude 
towards adverti-
sement  
 
 
Figure 2.19   Elaboration Likelihood Model (ELM) 
(Adapted from:  Belch & Belch, 2004: 159; Tellis, 2004: 113; Vidal, 1998) 
 
Whenever a consumer has the motivation to elaborate (process) the message of the 
advertisement, he or she will follow either a central route of persuasion or a peripheral 
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route of persuasion.  This will depend on the consumer having the ability to process the 
advertisement’s message or not (Tellis, 2004: 114).  
 
The central route will be followed when the consumer is cable of processing the 
advertisement’s message.  By following this route the consumer will be persuaded by 
“strong” arguments.  A strong argument has the ability to persuade the consumer by 
appealing to reason and relying on evidence (Belch & Belch, 2004: 159; Tellis, 2004: 112; 
Vidal, 1998).  The consumer will then cognitively process the advertisement’s message 
where, if the argument is favoured, a positive attitude towards the advertisement will be 
formed.  This advertisement will then typically exhibit a persuasive nature.  Conversely, 
when the consumer is not in favour of the advertisement’s message, a negative attitude 
towards the advertisement will be formed.  The advertisement therefore did not succeed 
in its persuasiveness (Belch & Belch, 2004: 159).  
 
The peripheral route will be followed when the consumer lacks the ability to process the 
advertisements’ message (Tellis, 2004: 113).  As the consumer follows this route he or 
she will be more responsive to cues associated with the information provided by the 
advertisement.  Examples of persuasive cues that can be used in the peripheral route are 
the structure of the advertisement, presence and fame of endorsers, the costliness of the 
advertisement, music or imagery used, and the number of arguments included (as 
opposed to the strength of the argument observed in the central route) (Belch & Belch, 
2004: 160).  Such positive cues may result in a consumer forming a positive attitude 
towards the brand of the product advertised even though he or she is unable to process the 
information of the advertisement.  Opposing this are negative cues (for example, low-
budget advertising, endorsers lacking credibility, or advocating extreme positions or 
beliefs) which may result in the consumer rejecting the advertisement without even 
considering the information provided by it (Belch & Belch, 2004: 160; Tellis, 2004: 113; 
Vidal, 1998).      
 
In a situation where the consumer is not motivated to process the advertisement’s 
information as well as not being able to do so, the consumer will enter into a passive state 
of receptivity (passive processing) to the advertisement or he or she will not attend to it.  
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In such a state advertisers can use drama or humour in the advertisement to gain the 
consumer’s attention (Belch & Belch, 2004: 160; Tellis, 2004: 113).  However, Tellis 
(2004: 120) suggested that factors such as ‘mere exposure’ and the use of soft-sell 
messages have a very effective role in attracting the consumer’s attention.  Mere 
exposure refers to the repetitive exposure of a stimulus which can lead to the preference 
of it, even if not remembered.  In advertising such stimuli can, for example, be a certain 
jingle, slogan, or logo.  When a consumer is repeatedly exposed to advertisements 
containing such stimuli, he or she may start liking the stimuli thereby being more 
favourable towards the advertisement (Tellis, 2004: 118).  Soft-sell messages are 
messages which are subtle in nature.  Subtle messages will allow consumers to interpret 
advertisements differently or can result in the advertisement being suggestive by means 
of persuasion.  Advertisements that employ soft-sell messages do not make direct 
requests for action or change (Tellis, 2004: 120).   
 
According to Tellis (2004: 113) the ELM model shows that consumers are not always 
thoughtful nor are they always mindless when making decisions and forming opinions 
about advertisements.  This model is a valuable tool in identifying reasons for the 
inclusion of certain components such as humour, photographs of celebrities, or certain 
logos or slogans in advertisements.   
 
2.5.3   Emotion in advertising 
 
Persuasion is also concerned with emotions (Wells, et al., 1995: 280).  Emotion is a 
mental activity which is defined as a state of arousal, a feeling of any kind – hate, 
jealousy, fear, anger, joy, and love.  The James-Lange theory of emotion stated that 
emotion results from physiological reactions to certain events (Van Wagner, 2007).  A 
person’s feelings about a product, brand or service may be just as important as what he or 
she knows about it (Wells, et al., 1995: 280).  It is an effective and powerful marketing 
tool used as a persuasive communicator in advertising.  Although being distinct from 
thought, it is aroused through a sequence of thoughts triggered by certain stimuli such as 
a sad letter resulting in a feeling of sadness (Tellis, 2004: 147). 
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Emotion is also employed in pharmaceutical advertising.  In her study, Direct-to-
consumer advertising: Healthy education or corporate spin?, Melissa Raven (2004: 9) 
identified the following powerful emotional factors employed in DTC advertisements:   
 
• value of health (peoples’ own health or that of their loved ones); 
• fear of disability and death; 
• responsibility of a person to take care of his or her own health and that of their loved 
ones; 
• self-consciousness, vanity, and shame; and 
• vulnerability of people who, for example, are ageing or ailing.   
 
2.5.3.1   Modes of persuasion by emotion 
 
Advertisements can employ various stimuli to evoke emotion, for example, humour, 
pictures, and a sequence of events.  When a consumer becomes aroused as a result of 
reacting to such stimuli, he or she will take action by means of one of the following 
modes (Tellis, 2004: 148): 
 
(i)   Associative mode 
 
Tellis (2004: 148) describes the associative mode as a method in which emotions are 
aroused by means of stimuli which are only “tangentially related” to a product advertised.  
This means that an advertisement can present, for example in a picture, a scenario that 
arouses a certain emotion without stating the benefits of the advertised product.  Such a 
method attracts the consumer’s attention as well as associating the company’s name with 
that emotion.  Tellis (2004: 149) stated that the associative mode causes persuasion 
through a better recall ability of the name of the brand as well as its association with a 
specific emotion, rather than with the attributes of the brand.  Figure 2.20 illustrates how 
this mode causes persuasion by means of the arousal of an emotion. 
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Figure 2.20   Associative mode of persuasion by emotion 
(Source:  Tellis, 2004: 149) 
 
(ii)   Implicit mode 
 
The implicit mode (see Figure 2.21) involves advertisements which visualise “real” 
characters and interesting “plots” to capture the attention of consumers in order to arouse 
an emotion.  The emotion aroused by such an advertisement lowers their defences against 
its message.  Such advertisements play on the consumer’s emotion by allowing him or 
her to develop empathy towards the characters and eventually believe the message.  
Another important factor to keep in mind is that this mode of persuasion is implicit, 
causing these advertisements not to contain any arguments or product attribute claims. 
 
 
  
Figure 2.21   Implicit mode of persuasion by emotion 
(Source:  Tellis, 2004: 149) 
 
(iii)   Explicit mode 
 
The explicit mode (see Figure 2.22) involves advertisements that employ forms of stimuli 
which make a point and as an end result arouse the consumer’s emotion (sympathy).  
 
                    Message 
 
 
     Stimuli                               Emotions Emotions           
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Conversely to the implicit mode, advertisements employing the explicit mode incorporate 
attribute claims and also provide arguments as support.  Tellis (2004: 148), however, 
points out that “persuasion occurs primarily through the arousal of emotion rather than 
the force of the argument”.  He also explained this mode with the example of an 
antiabortion advertisement which graphically showed the destruction of the foetus thus 
making a strong argument against abortion.  This advertisement made its point not by an 
explicitly strong argument but by the emotion of guilt that results from the consequences 
of abortion.   
   
 
 Argument                Persuasion  Emotions                  
 
 Figure 2.22   Explicit mode of persuasion by emotion   
 (Source:  Tellis, 2004: 149)    
 
It is evident from these three modes how emotion can be employed by advertisers to 
persuade their consumers.  Emotion is also employed in pharmaceutical advertisements to 
achieve the effect of persuasion, especially when dealing with themes such as illness and 
disease.   
 
2.6   PREATTENTIVE PROCESSING OF ADVERTISEMENTS 
 
Another concept that makes an important psychological impact in the processing of 
information, such as advertisements, is preattentive processing.  Hoyer and MacInnis 
(2001: 85) in their book, Consumer Behavior, defined preattentive processing as 
“nonconscious processing of stimuli in peripheral vision”.  This refers to the ability to 
process information from the peripheral vision even if the person is not aware of 
attending to such information.  A person devotes just enough attention to an object in 
peripheral vision to process something about that object.  Due to the amount of attention 
being so limited, the person is not aware that he or she is attending to and processing it 
(Hoyer & MacInnis, 2001: 85).    
 
 50
Preattentive processing of information depends on the following two factors (Hoyer & 
MacInnis, 2001: 85): 
 
• whether stimuli appearing in peripheral vision are words or pictures; and 
• whether stimuli are placed in the right or left visual field, referring to whether it is 
placed to the right or the left side of the object focused on at that time. 
 
This process is therefore based on the physiological phenomenon, hemispheric 
lateralisation.  Hemispheric lateralisation refers to the fact that the brain is divided into 
two hemispheres, the left and right cerebral hemisphere, with each hemisphere having 
specific functions (Solomon, Schmidt & Adragna, 1990: 458; Tortora & Grabowski, 
2000: 471).  This phenomenon can be exhibited by the diagrammatical representation in 
Figure 2.23.     
 
                       
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Figure 2.23   Hemispheric lateralisation  
(Source:  Hoyer & MacInnis, 2001: 86) 
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The right cerebral hemisphere is thought to be best at processing holistic information 
such as music, pictures, spatial information, forming inferences, and drawing conclusions 
(Hoyer & MacInnis, 2001: 86).  Functions such as artistic awareness, recognition of 
emotional content of language, as well as pattern perception are also thought to be 
processed in the right cerebral hemisphere (Tortora & Grabowski, 2000: 471).  The left 
cerebral hemisphere is thought to be best at processing units that can be combined such 
as counting, forming sentences and words, and also processing unfamiliar words (Hoyer 
& MacInnis, 2001: 86).  Tortora and Grabowski (2000: 471) also added functions such as 
reasoning, ability to use and understand sign language, as well as various scientific skills. 
 
When an advertisement or a billboard, for example, is placed on the right side of the 
attended focal (right visual field) (see Figure 2.23), processing of this information takes 
place in the left hemisphere and vice versa (Hoyer & MacInnis, 2001: 85).  Stimuli 
people directly focus on (attended focal) are processed by both hemispheres.  It is 
therefore interesting to realise from the topic of hemispheric lateralisation that stimuli 
such as pictures in advertisements are most likely to be preattentatively processed if 
placed to the left of a magazine article.  This will ensure that this picture can be processed 
by the right hemisphere which is best for processing visual stimuli.  Therefore stimuli 
such as brand names or advertisement claims are most likely preattentatively processed if 
placed in the right visual field in order to be processed by the left hemisphere (adapted 
from Hoyer & MacInnis, 2001: 85).  
 
Although preattentive processing will not be focused upon as such in this study, its 
relevance to the study of advertisements is important, in as much as it may provide 
valuable reasons as to why certain components such as pictures, numbers or words are 
used and placed in certain areas within advertisements. 
 
2.7   CONCLUSION 
 
This chapter identified the fundamental aspects of advertising, its role in the 
pharmaceutical environment, and the psychological impact of advertisements on 
consumers.  Chapter three, Science of advertising, will consist of an in-depth 
 52
investigation into the study of symbols used in advertising, a process called semiotics.  
Together, the information in these two chapters will lay the foundation necessary to 
decode the pharmaceutical advertisements forming the basis of this study.   
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CHAPTER 3 
SCIENCE OF ADVERTISING  
 
3.1   INTRODUCTION 
 
Pharmaceutical advertising has become more than just a way of marketing medication, 
medical devices, or healthcare advice.  It has become a science in its own right where 
more thought is put into this form of advertising.  Advertising in general has become a 
discipline where techniques such as semiotics and colour psychology are used in order 
for the persuasive nature of advertisements to come to the forefront.   
 
As consumers (health care professionals and the general public) are exposed on a regular 
basis to pharmaceutical advertisements, it is of vital importance to have an understanding 
of how techniques such as semiotics and colour psychology are incorporated.  This is 
necessary for the purpose of this study as these concepts assisted in determining whether 
pharmaceutical advertisements have the possibility of being deceptive or misinterpreted.    
 
3.2   SEMIOTICS 
 
Semiotics is a complex concept and has a vast array of similar interpretations which are 
adapted from the concept of Ferdinand de Saussre’s semiology (Myers, 1977: 137).  It 
had its origin from an American philosopher, Charles Saunders Pierce, at the beginning 
of the century (Myers, 1997: 137).   
 
Semiotics is defined as the “study of signs and symbols, especially in writing, and of what 
they mean and how they are used” (Oxford Advanced Learners Dictionary, 1989: 1150; 
Concise Oxford English Dictionary, 2006: 1308).  More formally put by Greg Myers 
(1997: 212) in his book, Words in Ads, semiotics is the academic field devoted to the 
study of a general system of signs.  Jean-Marie Floch (2001: 2), a French semiotician, 
referred to semiotics as a “process that attends to anything that has or could possibly 
have meaning”.  
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Semiotics has unnoticeably advanced into a research form in today’s day and age.  It is 
different from traditional qualitative research.  Qualitative research is an “inside-out 
perspective” in which psychological phenomena are obtained from people.  
Psychological phenomena that can be obtained from qualitative research are, for example, 
perceptions, beliefs, and attitudes of people (Lawes, 2004).  Rachel Lawes (2004), a 
semiotician from Britain, states, however, that semiotics takes an “outside-in” approach.  
Semiotics, in principle, asks how these psychological phenomena “got into the person’s 
head” in the first place (Lawes, 2004).   
 
According to Lawes (2004) perceptions, beliefs, and attitudes come from the surrounding 
culture in which respondents participate.  Semiotics takes the culture as the object of the 
study and not the consumer, as is the case with qualitative research (Lawes, 2004).  In 
semiotic terms culture refers to how people communicate with each other, consciously or 
subconsciously, through, for example, language, visual images, and music (Belch & 
Belch, 2004: 142).  This is relevant to market research as semiotics, therefore, is a 
methodology developed for understanding packaging, advertising, and various kinds of 
marketing literature (Lawes, 2004).  Belch and Belch (2004: 142) stated that semiotics 
plays an important role in marketing communication as it assists marketers in their 
understanding of how consumers may interpret words, gestures, myths, signs, symbols, 
products or services employed in advertising.            
 
Umberto Eco stated that semiotics concerns everything that can be seen as a sign 
(Chandler, 2005a).  Semiotics, however, is not widely institutionalised as an academic 
discipline and for this reason involves many different theoretical structures and 
methodological tools (Chandler, 2005a).  As with semiology, semiotics takes the form of 
words, images, sounds, gestures, and objects (Chandler, 2005a).  Sausure’s semiology is 
a science which studies the role of signs as a part of social life, whereas Pierce believed 
that semiotics was the “formal doctrine of signs” which was closely related to logic 
(Chandler, 2005a; Cook, 1992: 69; Hoenish, 2005).  Pierce also stated that semiotics not 
only referred to signs in everyday speech, but was also concerned with something that 
stood for something else in some respect or capacity to a specific person (Chandler, 
2005a; Cook, 1992: 69).  He also declared that every thought is a sign (Chandler, 2005a).    
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3.2.1   Semiotic concepts 
 
To understand semiotics, various concepts have to be defined.  Terms such as signs, 
denotation and connotation, index, icons, symbols, encoding, and decoding are 
continually employed in semiotic studies and thus need to be defined.     
 
3.2.1.1   Signs   
 
The words semiology and semiotics were derived from the Greek word semeion which 
means sign (Chandler, 2005a).    As people communicate, they operate via an agreement 
about what various images, words, sounds, or gestures mean.  When, for example, a word 
or an image has had some agreed meaning attached to it, it becomes a sign (Lawes, 2004).  
Images, words, sounds, or gestures have no intrinsic meaning and only becomes a sign 
when a person attaches a meaning to them (Chandler, 2005a; Lawes, 2004).  According 
to Saussure anything can be a sign as long as someone interprets it as signifying 
something, referring to or standing for something other than itself (Chandler, 2005a).  
Things are interpreted as signs on an unconscious level by relating such a sign to familiar 
systems of convention (Chandler, 2005a).  
 
Saussure defined a sign as a two-part system which is composed of (Chandler, 2005b): 
 
• A signifier  –  the form which the sign takes, or in a more modernistic view, the 
material (or physical) form of the sign – something that can be seen, touched, smelled, 
heard, or tasted.   
• The signified  –  the concept it represents.   
 
Saussure used Figure 3.1 to explain the relationship between these two concepts and 
signs (Chandler, 2005b).  Figure 3.2 and Figure 3.3 provide an example that simplifies 
the two-part system used to define signs (Chandler, 2005b).  In Figure 3.2 the word tree 
is used to illustrate Suassure’s two-fold system.  The letters used to spell tree is therefore 
seen as the signifier whereas the concept (not the actual image) of the tree will be the 
signified (Chandler, 2005b).  Figure 3.3 identifies the relationship of a sign (the rose) to 
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the signifier (the letters spelling the word rose) and the signified (the concept of a rose) 
(Underwood, 2003).     
 
   
 
 
 
 
 
 
                                    
 
 
 
Figure 3.1   The two-fold system of a sign 
(Source:  Chandler, 2005b) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2   Example that explains the two-fold system of a sign   
(Source:  Chandler, 2005b) 
 
3.2.1.2   Denotation and Connotation         
 
In relation to the concept of a sign, two additional concepts also need to be referred to, 
namely denotation and connotation.  These two concepts describe the relationship 
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between the signifier and the signified.  According to Chandler (2005b), meaning (for 
example, a reader attaching meaning to an advertisement) includes both denotation and 
connotation.   
 
 
                       
  
Figure 3.3   A rose as a sign, signifier, and signified 
(Source:  Underwood, 2003)   
 
Denotation is the basic, most fundamental form of a sign (Underwood, 2003; Semiotics 
and advertisements, 1994).  It is the literal meaning of a sign, for example, the word tree 
literally signifies a kind of plant or the word rose which signifies a kind of flower.  In 
contrast, connotation is referred to as the socio-cultural and personal association of the 
sign (Underwood, 2003).  It is related to, for example, the reader’s class, age, gender, or 
ethnicity.   
 
Connotation can therefore be seen as “signifying signs” used as signifiers for a secondary 
meaning or as the secondary cultural meaning of signs (Chandler, 2005b; Cook, 1992: 
101; Semiotics and advertisements, 1994).  In Figure 3.4 the word rose (applied as 
signifier 1), and picture thereof (applied as signified 1), can again be used as an example 
of connotation where it can have a secondary meaning which signifies passion.   A sign is 
thought to be more open to interpretation in their connotations than their denotations as is 
evident in the example of the word rose (Underwood, 2003).  
 
3.2.1.3   Index, Icon, and Symbols 
     
Pierce suggested three additional types of signs which are found to be useful for the 
analysis of advertisements.  These types of signs are the index, icon, and symbol 
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(Chandler, 2005a; Cook, 1992: 69; Myers, 1997: 137; Underwood, 2003).  Table 3.1 
identifies and provides definitions to each of these three types of signs. 
   
                          
  
Figure 3.4   The rose and its connotation  
(Source:  Underwood, 2003)     
 
Table 3.1   Definition of the three types of signs 
                                            Three additional 
Definition types of signs 
 
 
 
Index (indexical  
sign) 
 
An index is a sign where the signifier is caused by the signified, for 
example, natural signs (smoke which signifies a fire), medical symptoms 
(pain or a rash), and indexical words (‘this’, ‘there’, ‘here’, ‘that’).  With an 
indexical sign the signifier is not arbitrary but physically or casually 
connected to the signified.   
 
 
Icon (iconic sign) 
 
An icon (iconic sign) is a sign in which the signifier is perceived as 
resembling or imitating the signified, for example, a picture or a cartoon. 
 
 
 
Symbol (symbolic 
sign) 
 
A symbol is referred to as an arbitrary or conventional relationship 
between the signifier and the signified.  Symbolic signs are therefore signs 
where this relationship is purely conventional or culturally specific.  
Examples of symbolic signs are language in general (phrases, words, 
punctuation marks), numbers, and traffic signs.  
     
(Adapted from:  Chandler, 2005b; Changing minds, 2007; Cook, 1992: 69; Myers, 
1997: 137; Underwood, 2003) 
 
Myers (1997: 137) explained these terms by means of the following Coca Cola® poster 
advertisement that appeared on a bus shelter:  a cold can (with water droplets on its side) 
of Coca Cola® that almost fills the whole frame with a single questioning word below it – 
“Thirsty?”  Due to a person’s complex process of image processing, the picture of the 
 59
Coke® can is perceived as a can because of the fact that it looks as smooth, cylindrical, 
and shiny as a can.  Because the poster is flat and five feet high, it is realised that it is not 
actually a can but a sign representing a can and therefore known as an iconic (an icon) 
relationship of signifier and signified, a casual relationship of resemblance (Cook, 1992: 
69; Myers, 1997: 139).  The can in the Coca Cola® advertisement showed droplets of 
water on its side thereby indicating to the observer that the can is cold.  The relationship 
between the signifier (the water droplets) and the signified (cold can) is not of 
resemblance because of the fact that these droplets is caused by the cold and therefore 
said to be indexical (an index) (Myers, 1997: 139).  With the word “Thirsty?” the 
signifier consists of eight letter shapes that does not look like thirst and also does not 
result from it.  This signifier is associated with the meaning needing a drink only by a 
convention of English speakers (Myers, 1997: 139).  The connection is thus seen as 
arbitrary and these signs are therefore called symbols (Myers, 1997: 139). 
 
Visual images can consist of all three types of signs identified by Pierce (symbolic-, 
iconic-, and indexical signs), or symbols and signs only, or a symbolic element only 
(Moriaity, 1995).  Table 3.2 illustrates this tendency by the use of everyday signs.  
Professor Moriaity (1995), a specialist in the field of visual communication, stated that in 
the case of, for example print advertising containing pictures, all three types of signs are 
mostly included.  
 
Myers (1997: 139) realised that symbols can only be seen by those who share the same 
culture.  He raised a critical point that iconic and indexical signs are often seen as 
naturally connected to the thing they represent but that these are still seen as signs.  These 
signs are often open to multiple interpretations (Myers, 1997: 139).  If this then is the 
case, signs seen in advertisements, can often be open to multiple interpretations which 
can easily lead to misinterpretation.  
 
3.2.1.4   Encoding and Decoding 
 
Other important concepts to understand in the semiotic process is encoding and decoding.  
The Oxford Advanced Learner’s Dictionary (1989: 395) defines encoding as a method of 
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“putting, for example, a message into code”.  Decoding is defined as a “method of finding 
the meaning of, for example, a message” (Oxford Advanced Learner’s Dictionary, 1989: 
310; Concise Oxford English Dictionary, 2006: 372).  Encoding and decoding form part 
of the basic communication model (Belch & Belch, 2004: 139; Clow & Baack, 2005: 35; 
Du Plessis & Petersen, 2003: 6).  Figure 3.5 illustrates the role encoding and decoding 
plays in the communication process.   
 
Table 3.2   Visual images identifying the type of signs implemented   
    
Example Identification and interpretation of signs 
    The “no smoking” sign consists of a symbolic red circle (the signifier) on a 
white background.  The sign signifies that something is forbidden (the 
signified).  The signified is reinforced by the red bar across the circle which 
represents an indexical sign that states: “You cannot do this (smoke) here”.  
The picture of a cigarette is not an actual cigarette but the white and black 
figure with smoke coming from it resembles a cigarette and is therefore 
said to be the iconic sign.  
      
 
 
To most people this triangle will resemble a road sign meaning “watch out 
for the workers ahead”.  The meaning of the triangle is therefore seen as 
arbitrary and is therefore the symbolic sign.  Inside the triangle is a picture 
that represents a person at work.  Again, since this is only a picture 
resembling a picture of a person at work, it is seen as an iconic sign.  Here, 
culture (especially culture in third-world countries) can play a role in the 
interpretation of the iconic sign.  For example, in some cultures the female 
is the worker of the family and the iconic picture will therefore represent a 
female at work and not a male as will usually be implied.   
  
 
 
 
 
 
This is a sign that will be familiar to all road users as it indicates a speed 
limit not more than 30 kilometres per hour.  It has an arbitrary meaning and 
is therefore seen only as a symbolic sign.   
 
 
(Source:  Chandler, 2005b; Cook, 1992: 69; Myers, 1997: 210; Semiotic and 
advertisements, 1994; Underwood, 2003)   
 
Encoding therefore is a process in which a source (for example, an advertiser) 
incorporates thoughts, ideas, or information into symbolic forms (by means of, for 
example, words, symbols, or pictures) to represent a message that will be delivered to a 
receiver (for example, a consumer) (Belch & Belch, 2004: 141; Clow & Baack, 2005: 
135; Hoyer & MacInnis, 2001: 276).  The receiver, in turn, decodes the message.  This 
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means that the receiver transforms the message he or she received back into thought and 
interprets it (Belch & Belch, 2004: 143; Clow & Baack, 2005: 58; Du Plessis & Petersen, 
2003: 6).   
 
 
Figure 3.5   Basic communication model illustrating the role of encoding and 
decoding  
(Adapted from:  Belch & Belch, 2004: 139; Clow and Baack, 2005: 35; Du Plessis & 
Petersen, 2003: 6)  
 
Contemporary semioticians give a programmatic interpretation of these two concepts.  
They defined encoding as the creation of texts and decoding as the interpretation thereof.  
This interpretation is in actual fact intended to emphasise the importance of semiotic 
codes involved, which then highlights their social functions (Chandler, 2005a).  In 
semiotic terms decoding involves the basic recognition and comprehension of what a text 
says and also the interpretation and evaluation of its meaning with reference to relevant 
codes (Underwood, 2003).   
 
Judith Williamson was the first to use the phrase “decoding advertisements” when she 
published a book with the same title in 1978 (Myers, 1997: 53).  She saw communication 
as a simple decoding process when applying semiotics to advertising (Myers, 1997: 53).  
Her approach was to analyse the real meaning of words and images within 
advertisements, and the real world to which the unreal images of the advertisement refer.  
Williamson’s assumption was that reality is relatively distinct from fiction and also that it 
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is morally superior (Myers, 1997: 63).  This was explained in her book by the analysis of 
two varieties of Chanel® perfumes, Chanel® No. 5 (see Figure 3.6) and Chanel® No. 19.  
In one of these advertisements Catherine Deneuve appeared and in the other, Margaux 
Hemingway.  Williams found both women to be signifiers – Deneuve represented 
“flawless French beauty” whereas Hemingway represented the essence of being a “young  
American” (Myers, 1997: 63; Williamson,2005: 28).  
 
                                                  
                                                         
Figure 3.6    Advertisement of Chanel® No. 5 
(Source: Holmes, 2002) 
 
Figure 3.7 provides a visual explanation of how a reader decodes the Chanel® No. 5 
advertisement.  Williamson suggested that the reader will recognise the face of Deneuve 
as an individual and stated that this actress will be seen as more different than other 
elebrities (Cook, 1992: 64; Holmes, 2002; Williamson, 2005: 27).  The reader will make 
 connection that Deneuve is, for example, beautiful, sophisticated, and elegant.  This is 
ate association that can be made of the perfume.  Therefore, a referent system of 
fferentiated by the signified meaning of the 
tress associated with it (Cook, 1992: 64).  This linkage is created through 
ferentiation which is viewed as “natural”.  According to Williamson (2005: 11) this is 
fundamentally what ideology consists of.  
 
Williamson (2005: 11) said that there is an assumption that what people see in these 
advertisements is natural and that they see the link as part of the way things are.  
c
the
the ultim
differentiation occurs where the product is di
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Furthermore, she said that the “form of advertisements is a part of ideology, and involves 
a false assumption which is the root of all ideology, namely that because things are as 
they are, this state of affairs is somehow natural, and must ‘make sense’ simply because 
it exists” (Williamson, 2005: 11).  Therefore, the assumption the reader makes of this 
advertisement is in effect the idea held (the ideology) of Deneuve, and its link to the 
perfume (Cook, 1992: 64; Hook, 2003).   
 
 
     
Figure 3.7   Decoding of the Chanel® No. 5 advertisement according to Williamson 
(Source: Holmes, 2002) 
 
Williamson furthermore developed a model (see Figure 3.8) to give a clearer 
understanding of how the reader decodes the advertisement, and what the role of the 
producer of the advertisement is.  This model identifies that the reader will form a 
meaning of the advertisement based, mainly, on his or her referent system and ideology 
(Holmes, 2002).   
 
The referent system (see Figure 3.8) is the consumer’s system of signs from which the 
product draws its image.  Advertisers will then appropriate such a referent system to 
generate sign value (Holmes, 2002; Hook, 2006).  Williamson (2005: 97) identified four 
main referent systems which can be identified in advertisements.   
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Figure 3.8   Decoding advertisements model 
(Source: Holmes, 2002)    
 
The four main referent systems identified are (Holmes, 2002; Williamson, 2005: 97): 
 
• Cooking nature 
 
Nature is seen as the primary referent of a culture (Holmes, 2002).  In accordance with 
Williamson’s (2005: 103) theories, advertisements “cook” nature by illustrating the 
transformation of raw materials to the final product.  Figure 3.9 illustrates this raw and 
cooked nature Williamson referred to by using a vitamin advertisement as example.  This 
illustrates the transformation of the “raw” fruit peel into the “cooked” final product (the 
vitamin).  
 
Williamson (2005: 120), however, stated that “cooking nature” does not only refer to 
natural objects but can also refer to sex.  She explained that with sex the cooking does not 
only refer to nature or the view thereof but also of passion and humans’ image thereof.  
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Therefore, sex becomes a referent system that is always referred to or hinted at but it is 
always concealed behind its own references and thus never appears raw (Williamson, 
2005: 120).       
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 3.9   Vitamin advertisement illustrating the referent system, cooking nature 
(Source:  Williamson, 2005: 110) 
 
• Back to nature 
 
This type of referent system returns to what is natural (Williamson, 2005: 123).  Nature is 
used by society in two ways:  with technology in order to create goods, and with ideology, 
to create symbols of what is natural.  These two ways are then juxtaposed so that the 
meaning of nature can be transferred to the goods advertised (Holmes, 2002).  Figure 
3.10 shows how nature (the lemons, honey, and green leaves) is used to reinforce the idea 
that this product is made of natural ingredients.    
 
• Time 
 
Time is a referent system which tells the story of the past and the future in advertisements.  
It places the reader in a specific moment in time by the incorporation of certain sequences 
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into the advertisement (Holmes, 2002; Williamson, 2005: 152).  The advertisement for a 
diuretic medication (see Figure 3.11) can be interpreted as a picture of female farm 
workers, probably in the late 1950s, a time when such medication was not available.  This 
generic medication is, however, now available to the reader.  This advertisement 
illustrates how time can be used as referent system.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10   Advertisement illustrating the use of nature as a referent system    
(Source:  Huisgenoot, 2007: 62) 
 
• Magic 
 
Magic is a referent system which represents the process of “doing things” in the 
advertisement.  It is stated to be a “pivot around which misrepresentation may be 
produced” (Holmes, 2002).  Magic is therefore seen as a transformational referent 
system which assists as a “short cut” between other referent systems (Williamson, 2005: 
138).    
 
 
 
 67
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11   Advertisement incorporating time as referent system  
(Source:  Watson, 2004: 3) 
 
As can be seen from Figure 3.8, ideology has an impact in the formation of the 
consumer’s referent system.  Ideology is a complex process of how the consumer’s 
worldly experiences are structured (Hook, 2003).  It is defined as “a set of ideas held by a 
particular group or person” (Oxford Advanced Learner’s Dictionary, 1989: 616).  
Williamson (2005: 11) suggested that readers of advertisements make the assumption of 
what is seen as being natural.  The ideology therefore presented is then seen as being true.  
Ideologies are therefore codes which reinforce or are congruent with structures of power.  
It creates forms of “common sense” which are observed in everyday life (Holmes, 2002; 
Hook, 2003; Semiotics and advertisements, 1994; Underwood, 2003).  
 
There are five factors that play a role in the development of the referent system which 
affects the reader in attaching a meaning to the advertisement (see Figure 3.8), namely 
appellation, the mirror phase, identity, ego, and desire (Holmes, 2002).  Williamson 
(2005: 40) derived the term appellation from Louise Althusser’s theory of interpellation.  
Interpellation is defined as the way in which ideology “calls out” to readers (Holmes, 
2002).  Appellation therefore occurs when there is an exchange between the reader and 
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the subject of the specific advertisement (Hook, 2003).  The reader is forced to put 
himself or herself in the place of the person being spoken to individually, and if this is 
accepted, their individuality will give the advertisement meaning (Holmes, 2002; Hook, 
2003; Williamson, 2005: 40).   
 
The mirror-phase is a term coined and investigated by the psychoanalyst, Jacques Lacan, 
in 1936 (Changing minds, 2007).  This was identified as a phase in which a baby (six to 
18 months of age) sees himself or herself in the mirror and realises that he or she is 
seeing their own image.  Lacan’s theory established that consciousness is created and not 
inherited.  He identified, via the mirror phase that consciousness is created as a child 
(Williamson, 2005: 60).  The mirror-phase is implemented in modern media by means of, 
for example, showing a picture in an advertisement, allowing the reader to project 
themselves (Changing minds, 2007).  Williamson (2005: 60) also shares the belief that 
the mirror-phase theory plays a role in advertising.  In accordance with Lacan’s theory, 
she states that the child who sees himself or herself in the mirror recognises who he or 
she is and who they are not (Williamson, 2005: 61).  This creates two areas:  the 
imaginary (where someone exists) and the symbolic (where difference exists).  When 
applying this theory to advertising, the images (the imaginary) are capable of 
representing the symbolic (Holmes, 2002).   
 
Identity refers to “who or what a person or thing is” (Concise Oxford English Dictionary, 
2006: 707).  Williamson states that people differentiate themselves from other people by 
what they buy.  She argues that what people buy is linked to their identity.  The Oxford 
Advanced Learners’ Dictionary (1989: 387) also provides a profound definition of the 
term ego and defines it as a person’s “perception or experience of himself in relation to 
other people or the outside world”.  This therefore will have an impact on a reader’s 
ideology. 
   
Desire is an emotion in which the person “wishes for or wants something” (Oxford 
Advanced Learner’s Dictionary, 1989: 325; Concise Oxford English Dictionary, 2006: 
388).  It is the need to possess.  Emotion is triggered when a person sees or thinks about 
something that he or she wants.  Desire is a useful emotion when used in persuasive 
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communication.  As advertising is a form of persuasion, desire can therefore be 
implemented as a useful tool in advertisements (Changing minds, 2007).      
 
The decoding advertisements model (see Figure 3.8) also indicates the role the producer 
of the advertisement has on the encoding thereof and two other factors affecting both the 
producer and the advertisement.  Hermeneutics and semiotic referents are the two factors 
that can affect both the producer and the advertisement (Holmes, 2002).   
 
Williamson (2005: 71) defines Hermeneutics as the “translation of one language to 
another”.  This process involves the cultivation of the ability to understand something 
from someone else’s view point as well as keeping the cultural and social forces 
influencing their outlook.  Williamson uses hermeneutics in the sense of deciphering a 
code or to translate from one language to another.  She explained that the deciphering 
process attempts to provide understanding to the advertisement (Williamson, 2005: 71).  
 
The semiotic referents employed by the producer of the advertisement are borrowed from 
the examples of referent systems and then developed into a more semiotic form.  From 
Figure 3.8 it is evident that the producer also affects both the processes of hermeneutics 
and that of semiotic referents and vice versa (Holmes, 2002).   
 
Williamson’s decoding advertisements model depicts how consumers provide meaning to 
advertisements.  It clearly demonstrates the role semiotics plays in the encoding of 
advertisements.  From this model a strong psychological undertone can be detected.  
   
3.2.2   Application of semiotics in pharmaceutical advertisements 
 
The proceeding section will illustrate how semiotics is applied in pharmaceutical 
advertisements.  There will be focused on the decoding practices employed by the 
following researchers:  Goldman, Montagne, Floch, Ferner, and Scott.  
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3.2.2.1   Decoding by Goldman and Montagne 
 
Goldman and Montagne (1986) focused on the decoding of antidepressant drug 
advertisements.  They critically decoded and analysed the encoding practices employed 
in an advertising campaign led by the pharmaceutical company, CIBA (Goldman & 
Montagne, 1986).  This advertising campaign was for the antidepressant, Ludiomil® 
(active ingredient: maprotiline) that appeared in 1980 (Drug Digest, 2007).  Later on they 
also investigated Mead Johnson’s advertising campaign for another antidepressant, 
Desyrel® (active ingredient: trazodone), which appeared approximately a year after the 
introduction of Ludiomil® (Drug Digest, 2007; Goldman & Montagne, 1986).   
 
Their research indicated that the advertisements used in this campaign employed “highly 
abstract visual metaphors and symbols” to address antidepressants (Goldman & 
Montagne, 1986).  They also stated that these advertisements were designed in such a 
way as to generate carry-over symbols.  Carry-over symbols are cognitive connections 
between named drug entities and the meaning of abstract visual images (Goldman & 
Montagne, 1986).  It must be remembered that a symbol, in accordance with Pierce’s 
semiotic theories, is when a signifier has an arbitrary or conventional association with a 
meaning known to a group or class of people (for example, to English speaking people) 
(Chandler, 2005b; Semiotics and advertisements, 1994; Underwood, 2003).  In essence, 
Goldman and Montagne’s aim was to interpret the visual impact and symbolic meanings 
of these advertisements (Goldman & Montagne, 1986).  
 
Goldman and Montagne also identified the usual layout of antidepressant advertisements 
which can be universally applied to any pharmaceutical advertisement.  They found that 
the layout for these advertisements consisted of the following components (Goldman & 
Montagne, 1986): 
 
• signifying image refers to photographs or artistic drawings which are usually set 
within a frame to set it off; 
• drug name, or name and image of the package design; and 
• a framing caption that connects the meanings of the signifying image and the brand.   
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Their method of analysis of the advertisements that appeared in the Ludiomil® campaign 
can be divided into two categories, visual categories and lexical categories.  The lexical 
category deals with the analysis of the “words or vocabulary of a language” appearing in 
these advertisements whereas the visual category deals with the analysis of pictures to 
illustrate something (Concise Oxford English Dictionary, 2006: 820 & 1616).   
 
The Ludiomil® pre-introductory advertisement (see Figure 3.12) consists visually of a 
face mask protruding from a flat desert-like planer surface with a dewy, red rose growing 
out of this surface directly above the face mask (Goldman & Montagne, 1986).  It can be 
seen that the eyes and face are emphasised, as these body parts are usually seen as the 
most expressive.  This enhances the signifying “power of the expressive dimension”.  The 
visual representation of the vacant, distract stare of the eyes, the serious sombre pursing 
of the lips, and the facial cracks guides the reader in defining the human condition of 
depression (Goldman & Montagne, 1986).   
        
 
 
 Figure 3.12   Pre-introductory advertisement for the antidepressant, Ludiomil® 
 (Source: Goldman & Montagne, 1986)  
 
This image is joined by the lexical component of the advertisement, “For the mind 
depressed...”, as a means of exploiting the expressive code.  It assists the reader in the 
path of defining depression.  In this framing caption there is no verb and the sentence is 
also not closed off allowing the reader to ponder further on this human condition 
(Goldman & Montagne, 1986).  The next phrase, “CIBA is working to improve the 
For the 
mind  
depressed... 
   
CIBA  
is working  
to improve 
the  
treatment.  
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treatment” confirms that this company has been working on developing a newer 
antidepressant.  It alerts professionals about a new drug that will be better than the others 
in its class, as is indicated by the word, “improve”.  As this is a pre-introductory 
advertisement, and due to Ludiomil® not being FDA-approved yet at that time, the 
medicine’s name was not mentioned.   
 
The rose may suggest hope, a new beginning, or personal growth where there was only a 
barren, desert-like depression.  Within the human culture a rose is given for love, 
compassion, or just for something special that may have occurred in someone’s life.    If 
such a connotation is attached to the rose in this advertisement, it could mean emotional 
or spiritual vitality where there was only a parched desiccated soul before (Goldman & 
Montagne, 1986).  Thus, true to Pierce’s definition of a symbol, this red rose can then be 
seen as a symbol (Chandler, 2005b).  According to Goldman and Montagne the rose has a 
cultural image of use as an aesthetically appealing, emotionally uplifting symbol.  
Therefore, this rose’s connotation is that of culture and emotion (Goldman & Montagne, 
1989).    
 
 
Goldman and Montagne also identified a contrast within this advertisement:  a dew-laden 
rose, a life-affirming gesture, against a background of dry, cracked, barren and 
imprisoning crust symbolising a depressed mind.  This contrast thus indicates a promise 
of a new and effective therapeutic treatment for depression (Goldman & Montagne, 
1986).   
 
They also analysed the introductory advertisement for the Ludiomil® campaign (see 
Figure 3.13) and found that the symbolic rose is employed as a carry-over symbol as it 
was used in the pre-introductory advertisement (see Figure 3.12) as well as all the 
upcoming advertisements in this campaign.   In the introductory advertisement the visual 
aspects shifted from the barren, dessert-like representation of depression to a single eye 
surrounded by darkness.  This represents the human eye, again, as a signifying image 
which continues to exploit the reader’s cultural interpretation of the expressivity of the 
eye.  But the eye is surrounded by total darkness which is transformed into a metaphor 
for mental depression.  This is now not just an eye, but the ‘mind’s eye’ which signifies 
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human consciousness and emotion.  The eye is also indicated as a perceptual mechanism 
– its pupil dilated and recording light (Goldman & Montagne, 1986).     
                                                                                                                                                                                                                                                         
  
Figure 3.13   Introductory advertisement of Ludiomil®  
(Source: Goldman & Montagne, 1986) 
   
The lexical components of this advertisement introduce the reader to the new drug, its 
name, as well as the active ingredient, maprotiline HCl (Drug Digest, 2007).  It also 
provides a brief list of key attributes.  Attribute two (“the first tetracyclic antidepressant”) 
and three (“a new generation antidepressant that goes beyond the tricyclics”) are, 
according to Goldman and Montagne, unnecessary.  Attribute three is said to be 
“ideologically loaded” which could lead to readers being mislead.  The phrases, “a new 
generation antidepressant” and “goes beyond” evoke the “referent system of modern 
science”, and play on its legitimacy.  As with the pre-introductory advertisement (“for the 
mind depressed”), this advertisement allows for further interpretation of the phrase “goes 
beyond”.  This phrase is seen as “gratuitous” since there is not much difference between 
Ludiomil® and other tricyclic antidepressants steriochemically.  Ludiomil® is a four ring 
molecular structure where tricyclic antidepressants consist of a three ring molecular 
structure.  Thus the phrase, “goes beyond”, may invite the reader yet again to misleading 
interpretations (Goldman & Montagne, 1986).  
 
Goldman and Montagne found that advertisers of psychotropics (antidepressants) seem to 
prefer the use of “binary oppositions” to convey a meaning of mental health and 
depression.  Their investigation of these two advertisements reinforced this fact by 
identifying the following binary oppositions (Goldman & Montagne, 1986): 
      
New Ludiomil  
maprotiline HCl  
Safety with optimal effectiveness the first tetracyclic antidepressant 
A new generation antidepressant that goes beyond the tricyclics  
Rarely encountered cardiovascular reactions  
Fewer, less severe anticholinergic side effects  
Symptomatic relief within the first week in some patients  
CIBA 
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• the distinction between dryness and moisture (the desert as opposed to the dewy red 
rose) – non-vitality versus vitality seen in the pre-introductory advertisement; and 
• darkness counter posed to lightness – depression versus non-depression seen in the 
introductory advertisement. 
 
In the advertisement following the introductory advertisement of Ludiomil®, the 
advertisement causes the reader to see that, when this antidepressant makes its presence 
felt in its manifestation by the rose, the background lightens as compared to the dark 
background in the introductory advertisement.  It can therefore be seen that these three 
advertisements symbolise therapeutic progress (Goldman & Montagne, 1986).      
 
Goldman and Montagne’s research reinforces Rachel Lawes’s belief that semiotics is a 
study of the consumer’s culture as is the case with the carry-over symbol used in the 
Ludiomil® advertisements (Lawes, 2004; Goldman & Montagne, 1986).  This in fact 
reinforces her understanding that people communicate by means of culture with each 
other through, for example, visual images.  The pharmaceutical company, CIBA, 
therefore communicates culturally to their consumers by means of a visual image, the red 
rose. 
 
3.2.2.2   Decoding by Floch   
 
Another semiotician, the Frenchman, Jean-Marie Floch, also analysed antidepressants.  
He analysed 130 (Floch, 2001: 79) advertisements representing the commercial 
communications on these medicines.  Floch developed a semisymbolic system to analyse 
such advertisements.  A semisymbolic system involves a coupling between expression and 
content of a language representing, in this analysis, discourse about patients, their 
psychological states, as well as restoration of their health (Floch, 2001: 75).  
 
He also found that, on further investigation of the plastic expression and figurative 
dimensions of the visual aspects of these advertisements, that this discourse was 
constructed by means of a specific encoding process.  This type of encoding was formed 
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by linking the category, euphoria versus dysphoria, which represented the overall content 
of these advertisements (Floch, 2001: 75).    
 
Floch identified 12 visual categories that constituted the expressional content of these 
advertisements:  categories of values and colours, of composition, and of techniques or 
styles.  These 12 categories are (Floch, 2001: 75): 
 
• Clear versus dark 
 
As with the Ludiomil® advertisement used by CIBA, the Sédatonyl® advertisement (see 
Figure 3.14) illustrates an anxious and frustrated female, represented in dark (black), 
contrasted by her becoming clear (white).  This colour change occurs as a result of the 
female taking the medicine and developing a ‘piece of mind’.   
    
 
 
 
 
 
 
 
 
 
                  
Figure 3.14   Advertisement of Sédatonyl® 
(Source:  Floch, 2001: 83) 
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• High versus low  
 
In the Sédatonyl® (see Figure 3.14) advertisement, a topological representation is 
provided on paper by means of the top figure, the initial dysphoric state, and a bottom 
figure, the final resultant euphoric state. 
 
• Symmetric
 
The Sédatonyl®  and security that is 
restored by the resem , to an isosceles 
triangle.  The dissymm n and the symmetrical 
form represented by the f
 
• 
 
The Laroxyl® ry by means of a 
 contrasts the shaded area.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
                                
Figure 3.15   Laroxyl® advertisement   
(Source:  Floch, 2001: 89)  
al forms versus dissymmetrical forms 
 advertisement (see Figure 3.14) portrays calm
blance of a yoga position, the “lotus” position
etrical form is represented by the irate woma
emale in the calm, lotus position.   
Shaded versus contrasting  
 advertisement (see Figure 3.15) illustrates this catego
person shaded by a dark cube, whereas a stretched arm
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• Monochromatic versus polychromatic 
 
Floch explained that this category refers to an advertisement where one part is only in 
grey or black tone (one colour) and the contrasting part in bright colours (many colours).  
Figure 3.16 illustrates how this category can be incorporated in an advertisement of an 
antidepressant found in South Africa.  In this advertisement the depressive state is 
depicted by photographs in a grey and black tone, whereas the healthy mental state is 
depicted by a colour photograph.   
 
 
 
 
 
 
 
 
 
 
 
 
 
       
Figure 3.16   Monochromatic and polychromatic aspects incorporated in an 
advertisement for a leading antidepressant medication 
(Source:  Osman, 2006c: 41)  
 
• Continuous lines versus discontinuous lines 
 
The advertisement for Dipiperone® (see Figure 3.17) illustrates a human figure with a 
bird (possibly a dove) holding a twig (which could be an olive branch) in its beak sitting 
on the human’s head.  This image is sketched by using only thin, continuous lines.  The 
continuous lines together with the dove and the olive branch can represent a relative non-
 78
dysphoric (peaceful) state.  Another advertisement may, for example, have the word 
“anxiety” written in jagged (discontinuous) letters reinforcing the word’s meaning.  
  
 
 
 
 
 
 
 
 
 
 
 
      
Figure 3.17   Dipiperon® advertisement  
(Source:  Floch, 2001: 80)  
   
• Thin lines versus thick lines 
 
Floch stated that an advertisement can, for example, consist of a picture drawn in thin 
lines, whereas the medicine’s name is written in thick, dark lines.  This ultimately causes 
the medicine’s name to stand out.  Figure 3.18 illustrates how this category is 
incorporated in an advertisement for an oral anaesthetic ointment sold in South Africa. In 
this advertisement the drawings, as well as all the important attributes, are in bold lines to 
attract attention.   
 
• Definite planes versus vague planes 
 
The Anafranil® advertisement (see Figure 3.19) plays with the perception of depth in 
which a woman is depicted with a vague, blurry face trapped in a house (representing the 
depression) looking through a window wanting to escape (longing for an euphoric or 
calm life).   
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Figure 3.18   An oral anaesthetic ointment depicting the category of thick lines 
versus thick lines 
(Source:  You, 2006c: 56)   
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                    
Figure   3.19   Anafranil® advertisement  
(Source:  Floch, 2001: 82)  
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• Single forms versus multiple forms 
 
In the advertisement, Atrium® 300 (see Figure 3.20), an “anti-tremor tranquiliser for the 
chronic excessive drinker”, a series of brandy snifters were placed in a row, one behind 
another, to provide the multiplied effect of the original, single form.  Here, according to 
Floch, the multiple forms symbolises an alcoholic person losing his or her brandy as a 
result of the alcohol-induced tremors.  This is depicted by the perception of the alcohol 
level in each snifter decreasing from front to back which is as a result of the multiple 
form.    
                 
 
 
 
 
 
 
 
 
 
 
 
                                           
Figure 3.20   Atrium® 300 advertisement  
(Source:   Floch, 2001: 86)   
 
• Simple forms versus complex forms 
 
Floch gave the example of an advertisement promoting the muscle relaxant effect of the 
antidepressant medicine depicted by means of a rope knotted in a complex way and then 
being untied.  The rope therefore represents a group of muscles in a knot (the complex 
form) which can then be untied (the simple form) by the medicine when taken.  Figure 
3.21 illustrates how this category is employed in an advertisement for the treatment of 
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Irritable Bowel Syndrome (IBS).  In this advertisement the bowel is in a knot (the 
complex form).  Here the simple form (bowel untied) that results after taking this 
medicine is not illustrated but left up to the reader’s imagination.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21   Advertisement for the treatment of Irritable Bowel Syndrome 
illustrating the use of the simple versus complex form category  
(Source:  Sales representative handout from Novartis, 2006)   
 
• Pictorial techniques versus graphic techniques 
 
Floch’s explanation for this category was that in some instances a drawing of an anxious 
person can be found in one half of the advertisement, and in contrast to this, a photograph 
of the person enjoying life on the opposite side.    
  
• Layout in conjunction versus layout in disjunction 
 
Pragmazone® 25 (see Figure 3.22) illustrates, in the top half of the advertisement, the 
disjunctive state in which social or family ties are broken.  In contrast to this 
representation, this drug offers to restore the disjunctive state as is depicted by the bottom 
halve of the advertisement where the family is happily together. 
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Figure 3.22   Pragmazone® 25 advertisement  
(Source:  Floch, 2001: 85)   
                              
3.2.2.3   Decoding by Ferner and Scott 
 
Ferner, a consultant physician, and Scott, a principle pharmacist, investigated the covert 
meanings of symbols used by pharmaceutical advertisers to persuade readers of medical 
journals.  They identified the following methods used by pharmaceutical advertisers to 
achieve this goal (Ferner & Scott, 1994): 
 
• Advertising by contagion  
 
When the pharmaceutical advertisers want to inspire a product with a quality desired by 
prescribers or users, they will link such a product to symbols that portrays those qualities.  
In the advertisement of a cephalosporin antibiotic, Zinacef® (see Figure 3.23), a smashed 
clay pigeon was used to portray power, immediacy, and accuracy.  Ferner and Scott 
(1994) suggested that this advertisement represents an antibiotic that will “smash” 
infection.  
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Figure 3.23   Advertisement of Zinacef® illustrating the use of contagion 
(Source:  Ferner & Scott, 1994)  
 
• Polarity of choices  
 
With this technique pharmaceutical advertisers offer a series of limited choices to 
prescribers, often introducing an element of anxiety.  The advertisement for the Hormone 
Replacement Therapy (HRT), Prempak®-C (see Figure 3.24), colourfully illustrates (to 
the left) a blister pack of hormone replacement tablets.  To the right, a black and white 
picture of a wheelchair can be seen.  The two choices illustrated leave the prescriber with 
an unpleasant question: “Would you rather prescribe this drug, or condemn your patient 
to a wheelchair?” (Ferner & Scott, 1994).   
 
• Ourselves and others  
 
In this direct approach, it is illustrated how the targets of advertising, in this case a 
general practitioner, wish to see themselves.  This advertisement for Ciproxin® (see 
Figure 3.25), a fluoroquinolone antibacterial, shows a photograph of a female general 
practitioner presenting her in an attractive, kind but firm, and intelligent way.  Ferner and 
Scott (1994) suggest that people want to aspire to such an image, and now that she relies 
on this antibiotic herself, a persuasive message is created.  
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Figure 3.24   Advertisement of Prempak®-C illustrating polarity of choice 
(Source:  Ferner & Scott, 1994) 
 
                                         
  
Figure 3.25   Advertisement of Ciproxin® illustrating ourselves and others 
(Source:  Ferner & Scott, 1994)   
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Although Ferner and Scott’s research did not delve deeply into the science of semiotics, 
their simplistic findings identified the ease with which symbols in advertisements can 
evoke feelings by having complex and multiple meanings.   In their conclusion they 
stated that components such as visual images, words, colours, and messages implemented 
in pharmaceutical advertisements play an important role in persuading the reader to buy, 
use, or prescribe a given medicine.  
 
3.3   COLOUR PSYCHOLOGY   
 
A wide variety of pharmaceutical advertisements, whether directed at consumers or 
healthcare professionals, employ colour to make these advertisements more attractive and 
appealing.  The advertisement seen in Figure 3.26 illustrates how colours are 
incorporated to create an attractive and appealing advertisement.   The use of colour is a 
marketing skill that employs a wide variety of deeper psychological and symbolic 
meanings and it is therefore of great importance to understand and investigate why 
certain colours are used in advertising. 
 
The late 19th century saw the invention of colour lithography.  In Italy, France, Germany, 
as well as later on in England, posters were a wide-spread form of engaging, colourful 
advertising (Landa, 2004: 3).  Colour, when employed in advertising, is used to provide 
realism, establish moods, build broad identity, and importantly, to attract attention (Wells, 
et al., 1995: 474).  Moreover, John Miner (2007) on his website, Color Secrets Revealed, 
stated that colour will have a dramatic effect on the physical and mental well-being, 
morale, sales, and improving productivity.  It was proven by researchers that 
advertisements employing colour attracts more attention than those without colour (Wells, 
et al., 1995: 474).  Colour is also thought to affect people psychologically, emotionally, 
and physically (Hoyer & MacInnes, 2001: 92).  It is stated that colour has a psychological 
language that speaks to moods and symbolic meanings (Wells, et al., 1995: 474).   
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Figure 3.26   Advertisement incorporating various bright colours 
(Source:  Osman, 2006a: 25) 
 
The most common misconception is that colour is thought only as a purely visual 
phenomenon but colour is light and light is a source of life (Wells, et al., 1995: 474).  
Hoyer and MacInnes (2001: 92) believed that colour is an important factor in visual 
perception.  Colour determines whether people see stimuli.  Sir Isaac Newton found that 
colour is light and that spectral hues are its components (Van Wagner, 2006).  He 
determined this in 1666 when he shone a pure white light through a prism and found that 
the light separates into all of the visible colours.  (Van Wagner, 2006).  In scientific terms 
colour is the principle cue to composition, in other words, it is the first aspect being 
registered when assessing anything (Wright, 2006).  
  
 87
A specific colour can be described according to the following three dimensions (Hoyer & 
MacInnes, 2001: 92): 
 
• Hue  
 
Broadly defined, hue refers to a variety or shade of colour that is dependent on its 
wavelength (Oxford Advanced Learner’s Dictionary, 1989: 607; Concise Oxford English 
Dictionary, 2006: 693).  More scientifically, it refers to the pigment found in that specific 
colour.  Two broad categories or colour hues can be found, namely warm colours (for 
example, red, orange, and yellow) and cool colours (for example, green, blue, and violet). 
 
• Saturation 
 
Saturation, also known as chroma, refers to the richness of the colour.  For example, one 
can refer to a pale pink and a deep pink. 
 
• Lightness 
 
Lightness refers to the depth of tone in the colour.  For example, a saturated pink may 
have a lot of lightness (a fluorescent pink) or a lot of darkness (a mauve).   
 
Colour psychology is the field of study that is devoted to the analysis of the effect of 
colour on human behaviour.  Colour perception is said to be somewhat subjective but 
what holds true is that colour effects have universal meaning (Van Wagner, 2006).  It is 
also difficult to define an exact science for colour psychology as there are subjective 
meanings involved, both at personal and cultural level.  Colour psychologists found that 
warm colours generally encourage activity, excitement, and also reflect a mood of 
brightness and happiness (Hoyer & MacInnes, 2001: 93; Wells, et al., 1995: 475).  Cool 
colours, in contrast, are found to be more soothing and relaxing, and are also found to be 
aloof, calm, severe, reflective and intellectual (Hoyer & MacInnes, 2001: 93; Wells, et al., 
1995: 475). Table 3.3 and Table 3.4 summarise the psychological and subjective meaning 
of the two categories of hues found, namely warm colours and cool colours. 
 88
Table 3.3   Psychological interpretation and symbolism of warm colours 
 
 
COLOUR 
 
 
PSYCHOLOGICAL INTERPRETATION AND SYMBOLISM 
 
 
 
Red 
 
Red is a bright, warm, intense colour that evokes strong emotions and is associated with 
energy, war, danger, strength, power, determination, as well as passion, desire, and love.  It 
is thought to enhance human metabolism, increase the respiratory rate, and also increase 
blood pressure.  Red is often used to evoke erotic feelings (for example, red lips, red nails, 
red-light districts).  It is also a colour that is used as an accent colour to stimulate people to 
make quick decisions.  In Internet advertisements red is often employed for the ‘buy now’ 
or ‘click here’ buttons.  
 
 
 
 
Orange 
 
Orange is an energetic colour that is associated with joy, sunshine, excitement, enthusiasm, 
and warmth.  It also represents fascination, happiness, creativity, determination, attraction, 
success, encouragement, and stimulation.  Orange is thought to increase oxygen supply to 
the human brain, stimulate mental activity, and also produces an invigorating effect.  It is 
also found that orange stimulates appetite due to being associated with citrus fruit.  Due to 
its high visual and attention-drawing abilities, orange is often used to catch attention and 
highlights the most important elements in advertisements.   
 
 
 
 
 
Yellow 
 
Yellow is a bright, warm, and cheeky colour that is associated with joy, happiness, 
intellect, and energy.  Even though yellow is seen as a cheerful colour, people are more 
likely to lose their temper when in yellow rooms. This colour is therefore also known to 
create feelings of frustration and anger.  Research has shown that yellow increases human 
metabolism.  Yellow is also the most visible colour but due to the high amount of light that 
is reflected, it is found to be the most fatiguing colour to the eye.  It is often used in 
advertisements because of its attention getting attributes. 
   
 
 
(Adapted from:  Hoyer & MacInnes, 2001: 92; Nolan, 2003; Van Wagner, 2006; 
Wells, et al., 1995: 474; Wright, 2006) 
 
Other prominent colours observed in pharmaceutical advertisements include black, white, 
pink, and brown.  Table 3.5 identifies the psychological interpretation and symbolism of 
these four colours. 
 
3.3.1   Application of colour in pharmaceutical advertisements 
 
3.3.1.1   Warm colours  
 
The warm colour, orange, can be prominently seen in the advertisement, Orango® (see 
Figure 3.27).  When investigating the reasons for using this colour, the psychological and 
symbolic meanings can be that orange is an energetic colour which is synonymous with 
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energy and immunity.  Energy is provided and immunity is improved by means of 
multivitamins, minerals and anti-oxidants, all of which are found in this product.  When 
looking at the visual representation of the white bubbles, it literally represents the 
dispersible, fizzy action of the tablet but a deeper, psychological and symbolic meaning 
can be that it represents air bubbles, which is supported by the fact that the colour orange 
is thought to increase oxygen supply to the human brain.  Due to the high visibility of this 
colour, the air bubbles which host various vitamins, minerals, and anti-oxidants are 
highlighted in this advertisement.  Orange also represents the citrus fruit, orange, which 
indicates the flavour of the product (Hoyer & MacInnes, 2001: 92; Nolan, 2003; Van 
Wagner, 2006; Wells, et al., 1995: 474; Wright, 2006).   
 
Table 3.4   Psychological interpretation and symbolism of cool colours 
                      
 
COLOUR 
 
 
PSYCHOLOGICAL INTERPRETATION AND SYMBOLISM 
 
 
 
 
Blue 
 
Blue is seen as a masculine colour and thus the colour of choice of men.  It symbolises 
trust, loyalty, wisdom, confidence, intelligence, faith, truth, heaven, and is associated 
with depth and stability.  It is furthermore described as being peaceful, tranquil, secure, 
orderly, and is also linked to consciousness and intellect.  Blue is found to be beneficial 
to the mind and body, hence its slowing effect on human metabolism, lowering effect on 
pulse rate, and body temperature.  Blue also induces a calming effect on the body.  It is 
the least appetising colour and therefore was found to suppress appetite.  
     
 
 
 
Purple 
 
Purple symbolises power, nobility, royalty, luxury, ambition, and wealth.  It also 
represents wisdom and spirituality.  Purple does not often occur in nature and is 
considered to appear exotic or even artificial.  In a study it was found that 75% of the 
participating pre-adolescent children preferred purple above other colours.  Bright purple 
colours are therefore used to promote children’s products, whereas light purple is a good 
choice for feminine products. 
    
 
 
 
Green 
 
Green is the colour of nature and symbolises tranquillity, growth, harmony, freshness, 
health, and fertility.  It is found that green has a strong emotional correspondence with 
safety and is therefore used when advertising medication and medical products.  Green is 
thought to have healing powers.  This colour is also the most restful colour on the human 
eye and can therefore improve vision. 
    
 
(Adapted from:  Hoyer & MacInnes, 2001: 92; Nolan, 2003; Van Wagner, 2006; 
Wells, et al., 1995: 474; Wright, 2006) 
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Table 3.5   Psychological and symbolic interpretation and symbolism of black, white, 
pink, and brown 
 
COLOUR PSYCHOLOGICAL INTERPRETATION AND SYMBOLISM 
 
 
 
Black 
 
Black is a symbol of menace or evil but is also popular as indicator of power.  It is also 
associated with elegance, formality, and mystery.  This colour is often associated with 
death and mourning but in ancient Egypt it represented life and rebirth.  Black is thought 
to have slimming qualities and is therefore often used in fashion.  This colour, when used 
as background colour, can accentuate other colours.    
   
 
 
 
White 
 
White is a bright colour and creates a sense of space or advertising highlights.  It is a 
colour that is associated with light, goodness, purity, virginity, and innocence.  In 
advertising white is associated with coolness and cleanliness.  White is also associated 
with hospitals, doctors, and sterility, and is therefore used to suggest safety when 
promoting medical products.  It is often associated with low weight, low-fat food, and 
dairy products.   
     
 
 
Pink 
 
Pink is a light red that signifies love, romance, and friendship.  It is thought to have a 
calming effect but researchers found that this only occurs with initial exposure to this 
colour.  People who are already aggressive become even more agitated when becoming 
accustomed to this colour.  Pink is associated with feminine qualities and also denotes 
passiveness.  
 
 
 
Brown 
 
Brown is a natural, down to earth colour that evokes a sense of strength and reliability.  It 
is thought to bring warmth, comfort, and security but can also create feelings of sadness 
and isolation.  Brown can often be seen as a sophisticated colour. 
   
 
(Adapted from:  Hoyer & MacInnes, 2001: 92; Nolan, 2003; Van Wagner, 2006; 
Wells, et al., 1995: 474; Wright, 2006) 
 
3.3.1.2   Cool colours 
 
The cool colour, green, can be seen in different saturations within the complementary and 
alternative medicine advertisement, Tranquilyt® (see Figure 3.28).  Green is 
representative of nature as seen by the green leaves appearing in this advertisement.  It 
also symbolises tranquillity and harmony, some of the qualities represented by this 
product and needed by the woman appearing in the advertisement.  This colour also has a 
strong correspondence with safety, something that is needed by this woman as her state 
may cause her to harm herself.  Due to the fact that green symbolises healing, the product 
advertisement depicts a scene where the woman can be healed when using Tranquilyt® 
(Hoyer & MacInnes, 2001: 92; Nolan, 2003; Van Wagner, 2006; Wells, et al., 1995: 474; 
Wright, 2006).    
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Figure 3.28   Tranquilyt® advertisement 
(Source:  You,  2006a) 
 
Figure 3.27   Orango® advertisement   
he Oprah Magazine, 2005) 
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3.3.1.3   Prominent colours  
 
The colour, pink, can be seen in the advertisement for Citro-Soda® (see Figure 3.29).  
This advertisement targets females with urinary tract infections (UTIs) because this is a 
condition that affects up to 40% of females, as is stated in the literature of this 
advertisement.  Femininity comes to the forefront in this advertisement and therefore the 
use of the colour pink.  The word serenity, as is seen in the lexical aspects of the 
advertisement (“feminine serenity” and “serenity restored”), means calm, peaceful, and 
tranquil (Oxford Advanced Learner’s Dictionary, 1989: 1154; Concise Oxford English 
Dictionary, 2006: 1314).  Pink is therefore used because of its calming effect and also 
because it denotes passiveness (Hoyer & MacInnes, 2001: 92; Nolan, 2003; Van Wagner, 
2006; Wells, et al., 1995: 474).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.29   Citro-Soda® advertisement 
(Source:  You, 2006b: 34) 
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As can be seen in Figure 3.29, colour plays an important role in creating awareness but 
also assists in delivering a deeper psychological meaning.  This, together with the 
symbolic interpretation a consumer makes when being exposed to such an advertisement, 
can play a definite role in creating awareness but also in building brand identity.  It is 
therefore important to take the meaning of colour into consideration when decoding 
advertisements.   
 
3.4   CONCLUSION 
 
By having a greater understanding of the scientific techniques such as semiotics and 
colour psychology incorporated in pharmaceutical advertisements, researchers are 
assisted in the process of decoding advertisements.  This will, in turn, help researchers in 
their effort to determine the advantages and disadvantages of pharmaceutical advertising 
forms such as DTC advertising.  By understanding how these techniques are employed in 
the process of advertising, researchers are able to identify the psychological impact (if 
any) of pharmaceutical advertisements on consumers.  These techniques, together with 
each country’s pharmaco-legal system, will aid in giving researchers a more clear 
indication of the legitimacy of pharmaceutical advertisements.  
 
From the discussion in Chapter three, it is evident that semiotics play an importing role in 
the encoding and decoding process of pharmaceutical advertisements.  Hence, this will 
play an important role in the empirical part of the study.   
 
The following chapter will focus on the forensic aspects pharmaceutical advertisements 
have to adhere to in SA.  There will also be focused on the forensic aspects employed in 
pharmaceutical advertisements found in international countries such as Australia, New 
Zealand, and Canada.     
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CHAPTER 4 
FORENSIC ASPECTS OF PHARMACEUTICAL 
ADVERTISING 
 
4.1 INTRODUCTION 
 
It is of vital importance to ensure that pharmaceutical advertisements are not false, 
misleading, deceptive, misinterpreted, and that the correct healthcare advice is dispensed.  
To provide this assurance, the WHO sets ethical criteria for the promotion of medicines 
that can be used as a guide by countries to set their own ethical and legal criteria (World 
Health Organisation Ethical Criteria for Medicinal Drug Promotion, 1988).    
 
Each country, or state as in the USA, has various regulatory bodies setting laws and 
ethical guidelines governing pharmaceutical advertising. Aspects such as the advertising 
of scheduled and unscheduled medication, medical devices, and disease awareness 
campaigns or advertisements are mostly dealt with.  Table 4.1 lists some of the regulatory 
bodies of various countries responsible for the regulation of pharmaceutical 
advertisements.  Most of these regulations and ethical guidelines are aimed at 
pharmaceutical advertisements, the so-called DTC advertisements and those directed at 
various healthcare professionals.  
 
Countries also have self-regulatory authorities, underpinned by statutory authority, 
assisting in reviewing and setting guidelines to assure that pharmaceutical advertisements 
adhere to legal and ethical standards.  For example, advertisements, including those for 
medicines, are regulated and reviewed by the ASA in SA as well as Ireland (Holmes & 
O’Shea, 2006; Legh & Cassim, 2006).  Canada has more than one self-regulatory 
authority responsible for regulating pharmaceutical advertisements, namely the 
Pharmaceutical Advertising Advisory Board and the Research Based Pharmaceutical 
Companies (Hearn, Nagel & McCluggage, 2005; Hearn & Prendergast, 2006).  
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 Table 4.1   Examples of regulatory authorities governing pharmaceutical 
advertising in selected countries 
  
 
COUNTRY 
 
REGULATORY AUTHORITIES 
 
 
 
GREECE 
 
• Civil Code 
• Code of Greek Pharmaceutical Ethics (Pharmacists)  
• Code of Ethics for Physicians  
• Code of Ethics of the Hellenic Association of Pharmaceutical Companies 
(Medicinal products)  
  
 
 
 
IRELAND 
 
• Irish Governmental Authorities (Medical Preparations (Advertising) Regulations 
1999 
• Medicinal Products (Control of Advertising Regulations 2005) 
• Irish Pharmaceutical Health Authority (IPHA) 
• Advertising Standards Authority of Ireland (ASAI) 
• Irish Medicines Board (IMB) 
  
 
ISRAEL 
 
• Ministry of Health 
• Israel Medical Association  
• Medicinal Companies Active in Israel 
   
JAPAN 
 
• Pharmaceutical Affairs Bureau of the Ministry of Welfare 
• Japan Pharmaceutical Manufacturers Association (Codes of Practices for the 
Promotion of Ethical Drugs) 
• Japan Fair Trade Commission 
 
 
RUSSIA 
 
• Russian Law on Medicines 
• Association of International Pharmaceutical Manufacturers (AIPM) 
 
 
 
SPAIN 
 
• Code of Ethics of the National Association of the OTC’s (ANFEP) 
• Advertising Act 
• Royal Decree 1416/1994 
  
UNITED 
STATES OF 
AMERICA 
(USA) 
 
• Various regulatory bodies from each of the 52 states 
• Food and Drug Association (FDA) 
• Federal Trade Commission (FTC) 
 
 
 
VENEZUELA 
 
• Ministerio de Salud y Desarolo Social (Ministry of Health) 
• Junta Revisora de Productos Farmaceuticos del Indstituto Nacional de Higiene 
Rafael Rangel (National Authority Competent for Granting Sanitary Permission) 
• Junta Revisora de Productos Farmaceuticos (NJRPF) 
 
   
(Sources:  Abood & Brushwood, 1994; Antequera & De Bilbao, 2006; Georgopoulou, 
2005;  Holmes & O’Shea, 2006;  Limura & Kubo, 2006;  Melling & Zenin, 2006; 
Pastor & Navas, 2006)   
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4.2 WORLD HEALTH ORGANISATION GUIDELINES FOR PROMOTION      
            OF MEDICINES 
 
The WHO is a specialised agency of the United Nations (UN) which directs and 
coordinates the authority for international public health within the UN System.  The UN 
was established when diplomats gathered in 1945 to discuss the setting up of a global 
health organisation.  This brought the WHO into force on 7 April 1948.  This 
Organisation is financed by contributions from member states and donors such as the 
pharmaceutical industry (About the World Health Organisation, 2006).  One of the 
WHO’s objectives is to set norms and standards as well as promoting and monitoring 
their implementation.  This also includes norms and standards that should be followed in 
pharmaceutical advertising (About the World Health Organisation, 2006).       
 
In 1968 the WHO set ethical criteria for drug promotion which could be used as a guide 
by other countries.  The WHO defines ethics criteria for the promotion of medicines as 
criteria that “lay the foundation for proper behaviour concerning the promotion of 
medicinal drugs, consistent with the search for truthfulness and righteousness” (World 
Consumer Rights Day (WCRD) 2007: Unethical Drug Promotion, 2007).    
 
During this period emphasis was placed on the fact that pharmaceutical advertisements 
should provide information that is scientific, factual, balanced, and without any 
ambiguities.  Here, importance was placed on the fact that these advertisements should 
provide correct information at all times (World Consumer Rights Day (WCRD) 2007: 
Unethical Drug Promotion, 2007).       
 
These criteria were revised in accordance to a conference on The Rational Use of Drugs 
in Nairobi in November 1985.  During this conference a draft, the Ethical Criteria for 
Medical Drug Promotion, was set and adopted by the World Health Assembly in 1988.  
The WHO urged their member states to apply these ethical criteria to develop their own 
national measure as well as to monitor and enforce these measures.  However, the 
problem is that these ethical criteria is merely a guide for countries to follow and are not 
mandatory and therefore do not carry any legal obligation (About the World Health 
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Organisation, 2006; World Consumer Rights Day (WCRD) 2007: Unethical Drug 
Promotion, 2007).  
     
One of the promotional activities to which these ethical criteria apply to is 
pharmaceutical advertising directed at the general public as well as at healthcare 
professionals (About the World Health Organisation, 2006). With regard to 
pharmaceutical advertising directed at the general public, the WHO developed the 
following guidelines which state that these advertisements should contain the following 
(World Health Organisation Ethical Criteria for Medical Drug Promotion, 1988):   
 
• name(s) of the medicine’s active ingredient(s), either as the international non-
proprietary names (INN) or the approved generic name;   
• the pharmaceutical product’s  brand name;  
• name and address of distributor or manufacturer;  
• its major indication(s) for use;  
• any warnings, major contraindications, and precautions the product may have should 
also appear on the advertisement; and  
• where applicable, the selling price should be honestly portrayed on the advertisement. 
 
Furthermore, ethical guidelines for the advertising prescription medicines directed at 
healthcare professionals were also provided by the WHO.  In addition to the criteria that 
should appear in pharmaceutical advertisements directed at the general public, 
advertisements directed at healthcare professionals should also contain (World Health 
Organisation Ethical Criteria for Medical Drug Promotion, 1988): 
 
• Name of ingredients that are known to be problematic should be included in the 
advertisement. 
• Content of active ingredient(s) per dosage form or regimen.   
• Dosage form or regimen of medicines should be mentioned. 
• Approved therapeutic uses of the product should also be present. 
• Reference to scientific literature should also be made. 
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The WHO also made reference to reminder advertisements directed at health care 
professionals.  Criteria included that the medicine’s brand name, INN, or its approved 
generic name should appear on these advertisements.  The name of each active ingredient 
as well as the name and address of the manufacturer or distributor, for the purpose of 
receiving further information, should also appear in pharmaceutical advertisements of 
this nature (World Health Organisation Ethical Criteria for Medical Drug Promotion, 
1988).    
 
It will therefore be important to determine whether member states do use these ethical 
criteria as guidance in developing and enforcing ethical and legal pharmaceutical 
advertising practices.  This will ultimately indicate if these member states share the same 
beliefs that the WHO shares in ensuring that pharmaceutical advertisements provide 
information that is truthful, scientific, factual, balanced, and without any ambiguity.      
 
4.3 FORENSIC ASPECTS OF PHARMACEUTICAL ADVERTISING     
            IN SOUTH AFRICA 
 
4.3.1   Laws and ethical codes governing pharmaceutical advertising practices 
 
Pharmaceutical advertisements in SA are governed by various laws and ethical guidelines.  
The main authorities that govern pharmaceutical advertising are the:  MCC, SAPC, ASA 
of SA, and the SA Government (Department of Health).  
 
 These advertisements are governed by the following regulations and guidelines (Code of 
Practice, 2004; Legh & Cassim, 2006): 
   
• National Drug Policy;  
• Pharmacy Act No. 53 of 1974, as amended; 
• The Good Pharmacy Practice Manual; 
• South African Pharmacy Council Ethical Rules; 
• Advertising Standards Authority Code of Advertising Practices; and 
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• Medicines and Related Substances Act 101 of 1965, as amended, and the Regulations 
announced there under.   
 
The Department of Health published the National Drug Policy (NDP) in 1996.  The NDP 
has been compiled to “...develop fully the potential that drugs have to improve the health 
status within the available resources in a country” (Department of Health, 1996:  i).  It 
consists of 13 chapters each starting with an aim.  Chapter seven, Rational use of drugs, 
is partly directed at pharmaceutical advertisements.  The aim of this chapter is:  “To 
promote the rational prescribing, dispensing and use of drugs by medical, paramedical 
and pharmaceutical personnel and to support the informed and appropriate use of drugs 
by the community.”  The last portion of this aim specifically alludes to the promotion, and 
therefore the advertising, of medicines, “...to support the informed and appropriate use of 
drugs by the community” (Department of Health, 1996: 16).  
 
Subsections falling under Chapter seven deal with education and training, drug 
information, and specifically, advertising and marketing of medicines.  The subsection 
dealing with the marketing of medicines, Advertising and Marketing of Drugs, states that 
the marketing and advertising of medicines should adhere to the NDP as well as comply 
with national regulations and voluntary industry standards (Department of Health, 1996: 
19; Gray & Day, 2000).   
 
The NDP provided guidelines under this subsection to which promotional material 
regarding medicines should adhere to.  Pharmaceutical advertisements therefore have to 
adhere to the following guidelines (Department of Health, 1996: 19; Gray & Day, 2000):   
 
• Statements should not be of a misleading nature. 
• Statements should be verifiable.   
• Its real nature should be evident. 
• All claims should be reliable, accurate, truthful, informative, balanced, up-to-date, 
and in good taste. 
• Claims should be substantiated.   
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The other two subsections discuss the provision of correct pharmaceutical information 
directed at the general public as well as health care professionals to ensure the rational 
use of dugs.  To ensure this among the general public, “...a more critical attitude to 
advertising and commercial information”, must be taken (Department of Health, 1996: 
16; Gray & Day, 2000).   
 
The Pharmacy Act No. 53 of 1974, as amended, published by the SAPC under the 
auspices of the Department of Health, deals with various legal and ethical pharmaceutical 
activities. Topics such as pharmaceutical education, disciplinary powers of the SAPC, 
and the conduct of pharmacists as well as with, although to a limited extent, the 
marketing of pharmaceutical products are dealt with by the SAPC (Pharmaceutical 
Society of South Africa Pharmacy Law Compendium, 2005).  A guideline document, The 
Good Pharmacy Practice Manual, was also published by the SAPC and is relevant to the 
advertising of medicines by the manufacturing pharmacist (Pharmaceutical Society of 
South Africa Pharmacy Law Compendium, 2005).   
 
The SAPC furthermore published a set of ethical rules, the SAPC Ethical Rules, which 
related to acts or omissions with respect to the various disciplinary steps that can be taken 
by them.  There are 23 ethical rules dealing with topics such as dispensing practices, 
advertising, touting, the relationship with colleagues and other health service 
professionals, and various general unethical situations where disciplinary steps may be 
taken (South African Pharmacy Council, 1992).  These ethical rules were published 
separately and are still in use but are currently being reviewed.   
     
The ASA is a self-regulatory authority in SA which has the responsibility of ensuring that 
all forms of advertising, including pharmaceutical advertising, adhere to the ethical and 
legal standards set by the Advertising Standards Authority Code of Advertising Practices 
(“the ASA Code”).  A self-regulatory authority is an authority in which the marketing 
communication industry regulates the content of advertisements on a voluntary basis 
(Pharmaceutical Society of South Africa Pharmacy Law Compendium, 2005).   
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The marketing communications industry consists of the following three participants 
(ASA, South Africa, 2004): 
  
• sponsors of advertisements; 
• advertising agencies responsible for the form and content of the advertisements; and 
• publishing media.   
 
These three participants work together to agree to set standards regarding advertising as 
well as the setting of a corrective system for advertisements failing to meet these 
standards (ASA, South Africa, 2004). 
 
This self-regulatory system in advertising is supported by organisations from various 
parts of the industry, ranging from investment groups, cinema groups, cosmetics and 
toiletries, the Broadcasters Authority, pet food industry, to the pharmaceutical products 
industry.  These organisations are members of the ASA and are thus required to adhere to 
the ASA Code (ASA, South Africa, 2004). 
   
Members representing the pharmaceutical products industry are (ASA, South Africa, 
2004): 
 
• Health Products Association of SA; 
• Hospital Association of SA; and 
• Pharmaceutical Manufacturers’ Association of SA.  
 
This system employed by the ASA operates on the basis of consumers lodging 
complaints with the ASA about a specific advertisement in question.  These claims are 
then quickly and effectively resolved by the ASA Directorate.  If necessary, such a 
complaint may be referred to the Advertising Standards Committee.  In the event of the 
complainant being unsatisfied with the outcome of the investigation, the matter may be 
referred to the Appeal Committee of the ASA.  Whenever the advertiser does not comply 
to the corrective measures to be made, the ASA will place an “Ad-alert” on such an 
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advertisement.  No media, in accordance with the ASA Code, will publish an 
advertisement with an Ad-Alert (ASA, South Africa, 2004).         
 
The following advertising and promotional material are some of the forms of print media 
subjected to the Code in accordance with the Medicines Act (Code of Practice, 2004):   
 
• direct mail materials; 
• booklets; 
• aerial promotions such as hot air balloons; 
• consumer letters; 
• Internet;  
• point of sales material; 
• posters; and  
• outdoor advertisements.  
 
4.3.2   Pharmaco-legal aspects of advertisements 
 
According to Section 1(1) of the Medicines Act regarding definitions, a pharmaceutical 
advertisement is defined as any medicine or scheduled substance which is advertised in 
the form of written, pictorial, or other descriptive matter or verbal statement or reference 
thereof and found in any of the following (Pharmaceutical Society of South Africa 
Pharmacy Law Compendium, 2005: MAE – 6) : 
 
• newspapers, magazines, pamphlets, or other publications;  
• distribution to members of the public; or 
• brought to the notice of the public in any manner whatsoever. 
   
First and foremost, it must be realised that medicines may only be advertised after being 
registered by the MCC.  As soon as the medicinal product has been registered a reference 
or registration number will be awarded which must be visible whenever advertised.  This 
also accounts for complementary and alternative medicines as these may also only be 
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advertised or promoted as self-medication after being registered by the MCC (Legh & 
Cassim, 2006).  
  
The regulations and ethical guidelines are based on Regulation 20 of the Medicines Act 
regarding the publication or distribution of false pharmaceutical advertisements 
(Pharmaceutical Society of South Africa Pharmacy Law Compendium, 2005: MAE – 20).  
Regulation 20(1) states that no person shall (Pharmaceutical Society of South Africa 
Pharmacy Law Compendium, 2005: MAE – 20): 
 
 
“(a)  publish or distribute or in any other manner whatsoever bring to the notice of the public 
or cause or permit to be published or distributed or to be so brought to the notice of the public 
any false or misleading advertisement concerning any medicine; or  
 
(b) in any advertisement make any claim to the effect that the therapeutic  efficacy and effect 
of any medicine is other than that stated by the council...suggest that any medicine should be 
used for a purpose or under circumstances or in a manner other than that stated...”         
  
 
These two subsections of Regulation 20 deals with the fact that no person may publish or 
even distribute pharmaceutical advertisements to the general public that are of false or 
misleading nature.  Furthermore, it states that any claim regarding the medicines’ efficacy, 
effectiveness, and indications, must first be approved by the Council before being 
published.  Subsection (b) therefore supports Subsection (a) in that no false and 
misleading advertisements may be directed at the general public.        
 
It is also of utmost importance to have an understanding of what is meant by false or 
misleading advertisements.  The Federal Trade Commission (FTC) in the USA provided 
a universal meaning and states that false advertisements, in essence, are all those 
advertisements that are untrue.  It was furthermore explained that false advertising also 
includes advertisements that make representations that the advertiser has no reasonable 
basis to believe, even if those representations turns out to be true (Basics in false 
advertising, 2003). Therefore, if there is no basis to believe the truth of a claim, even if 
testing later on found this to be true, such an advertisement will be seen as false (Basics 
in false advertising, 2003). 
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Misleading or deceptive advertisements are an illegal form of advertising that cause 
consumers to have the wrong idea or impression of what has been advertised (ASA, 
South Africa, 2004).  To eliminate misleading advertisements, the ASA in collaboration 
with the Self-Medication Manufacturers’ Association of SA, developed the following 
guidelines for advertising OTC medicines (ASA, South Africa, 2004): 
 
• Suggestion should be made that OTC products are medicines and not foodstuff, 
cosmetics, or any other type of non-medical product.  
• No misleading statements dealing with the nature, ingredients, or indications of such 
products should be made. 
• No direct or indirect suggestion shall be made that the product contains an unknown 
active ingredient. 
• No advertisement should state that a product does not contain an active ingredient or 
ingredients used in the products of competitors other than permitted by the MCC. 
• All claims relating to the speed of absorption, dissolution, distribution, or other 
pharmacokinetic particulars must be in support of evidence.  Such evidence may not 
be extrapolated to claims that products offer improved efficacy, or speed of efficacy, 
without supporting evidence to substantiate such claims.   
• No suggestions should be made claiming that a product’s safety or efficacy is due to 
the fact that it is natural, unless such claims can be substantiated by clinically proven 
results. 
• No claim should state that a product is natural unless all its ingredients are naturally 
occurring, also including herbal products where all its active ingredients must be that 
of plants or extracts of plants.  
• There should not be suggested that the product is side-effect free.  Acceptable claims 
can be made that a specific side-effect is absent (for example, ‘no drowsiness’).  
 
Pharmaceutical advertisements can be prevented from being false or misleading by 
ensuring that these advertisements are (ASA, South Africa, 2004): 
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• balanced, true, and not contain any exaggerated claims; 
• developed in a manner that does not lead to unwarranted anxiety amongst consumers; 
• free of statements that diagnose, provides advice, treatment, or a prescription given 
via correspondence; 
• of a language that is understood and of a nature that are free from fear or distress; 
• free of medical terminology that results in confusion amongst consumers; 
• free of any material that could lead in consumers self-diagnosing conditions such as 
by detailed description or case history; 
• free of any claims guaranteeing a product’s effects or statements suggesting that 
suffering may occur if consumers do nor react to their product’s claims; 
• can include the prevention of symptoms and the use of the product in chronic 
conditions but should be in line with the registered indication; 
• not aimed, principally or exclusively, at children under the age of 16 years, except 
medication listed in Appendix 3.  In this case children may not be shown using the 
product or that they are within reach of this medication without adult supervision.  In 
cases were children can be used in these advertisements, it must be ensured that their 
credibility, loyalty, vulnerability, or lack of experience are not exploited, and should 
also not encourage excessive purchase;  
• free of claims that the medication can improve normal health or that it can effect 
normal health if not used or that celebrities encourage the use of it; 
• free of any misleading, improper, or alarming claims of recovery, or of any 
unsubstantiated claims made by healthcare professionals or scientists; and 
• no incentive scheme for a self-medication product  included.     
 
Sections (1), (2), and (3) of Regulation 45 of the Medicines Act regarding the advertising 
of medicines, also discuss scheduled medicines advertised to the general public 
(Pharmaceutical Society of South Africa Pharmacy Law Compendium, 2005: MRE – 50).  
Regulation 45(2)(a) discusses the advertising of unscheduled as well as Schedule 0 and 
Schedule 1 medicines (Pharmaceutical Society of South Africa Pharmacy Law 
Compendium, 2005: MRE – 50):  
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“Medicines which do not contain a scheduled substance and medicines which contain a 
substance appearing in Schedule 0 or Schedule 1 may be advertised to the general   
public.” 
      
 
Regulation 45(2)(b) identifies how Schedule 2 to Schedule 6 medicines may be 
advertised  (Pharmaceutical Society of South Africa Pharmacy Law Compendium, 2005: 
MRE – 50):   
 
 
“Medicines which contain a substance appearing in Schedule 2, Schedule 3, Schedule 4, 
Schedule 5, or Schedule 6 may be advertised only for the information of medical 
practitioners, dentists, veterinarians, pharmacists and other persons authorised to 
prescribe or in a publication which is normally or only made available to persons 
referred to therein.” 
 
  
Regulation 45(2)(c), however, with regard to Subsection (b), states (Pharmaceutical 
Society of South Africa Pharmacy Law Compendium, 2005: MRE – 50) :   
 
 
“Paragraph (b) shall not be so construed as to prohibit informing the public of the 
prices, names, pack sizes and strengths of medicines which contain a substance 
appearing in Schedule 2, Schedule 3, Schedule 4, Schedule 5 or Schedule 6.” 
 
 
Many examples of pharmaceutical advertisements contravening Regulation 45 of the 
Medicines Act regarding the advertising of medicines can still be found in South Africa. 
Table 4.2 illustrates an advertisement regarding contraceptive medicines directed at the 
general public.  The majority of these contraceptives are either Schedule 3 or Schedule 4, 
thereby contravening Regulation 45(2)(b) but contrary to this Regulation, seems to be 
allowed by Subsection (c).  Table 4.3, in turn, illustrates a pharmaceutical advertisement 
that adheres to Subsection (b).  Subsection (b) and Subsection (c) are controversial and 
seems to contradict each other. 
 
Figure 4.1 consists of a photograph depicting a billboard advertisement of Schedule 2 
codeine-containing analgesics advertised by a community pharmacy.  This also 
contravenes Regulation 45(2)(b), which states that Schedule 2 medicines may not be 
advertised to the general public.  There can also be speculated that the large quantity of 
tablets (100 tablets) advertised, can contribute to analgesic abuse. 
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Table 4.2   Example of an advertisement that is in breach of Regulation 45(2)(b) 
   
 
Oral Contraceptives 
 
Biphasil® 28 
Diane-35® 28 
Femodine® 28 
Femodine® Triopack 
Ginette®-35 28 
Logynon® ED 28 
Melodene® 28 
Microval® 28 
Minerva® 28 
Mirelle® 28 
Nordette® 28 
Nordiol® 28 
Ovral® 28 
Triphasil® 28 
Triodene® 28 
Yasmin® 28 
 
LESS 35% ON THE REST 
 
 
31.95 
88.95 
54.00 
154.00 
56.95 
19.00 
61.95 
29.95 
69.00 
63.95 
39.95 
39.95 
37.95 
32.50 
61.95 
69.95 
 
(Source:  Masango, 2006: 13) 
 
Table 4.3   Example of an advertisement which is permitted  
 
 
 
 
(Source:  Masango, 2006: 13) 
 
Name: 
Strength: 
Size: 
Price: 
 
 
Ultracare 
5mg/5l 
500ml  
R90-00 
 108
               
Figure 4.1   Billboard advertisement in the Nelson Mandela Metropole of a Schedule 
2 codeine-containing analgesic  
(Source:  Knoesen, 2006)     
 
4.3.3   General requirements for pharmaceutical advertisements 
     
Regulation 45(4)(a) and (b) state that a written advertisement for a medicine must contain 
the following (Pharmaceutical Society of South Africa Pharmacy Law Compendium, 
2005: MRE – 51): 
 
• a proprietary name; and 
• an approved name and quantity of each active ingredient in lettering that have 
minimum legibility.  In case of a medicine containing one active ingredient, the 
lettering must not be less than one half the size of the largest lettering used in that of 
the proprietary name. 
 
In addition to this, Regulation 45(4)(c) identified the following which should also be 
included (Pharmaceutical Society of South Africa Pharmacy Law Compendium, 2005 : 
MRE – 51):  
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• Registration number if medicine is registered. 
• Reference number allocated to a medicine in which an application for registration has 
been submitted in terms of Section 14 of the Medicines Act, followed by the words 
“(Act 101/1965)”. 
• When a name, other that the proprietary name is also used, the lettering of the other 
name must be one half the size of that of the proprietary name. 
• Veterinary medicine advertisements must state that it is for veterinary use only. 
• Homeopathic medicine advertisements must state that it must be used according to 
homeopathic principles. 
 
An example of an advertisement directed at the public contravening Regulation 45(2)(b) 
as well as Regulation 45(4)(c) can be seen in Figure 4.2.  Figure 4.2 illustrates that the 
Schedule 2 products, Adco-dol® (codeine-containing analgesics), Allergex® (first-
generation antihistamine containing chlorpheniramine maleate), Buscopan® 
(antispasmodic containing Hyoscine Butylbromide), and Vermox® (antiparasitic 
containing Mebendazole) are being advertised to the public (South African Medicines 
Formulary, 2003).  As these products are all registered with the MCC, none of these 
products state the required registration number.  The advertisement also does not mention 
the active ingredients of each product.   
 
 
 
 
 
 
 
   
Figure 4.2   Example of an illegal advertisement  
(Source:  Advertising pamphlet distributed by a pharmacy in the Nelson Mandela 
Metropole, 2007) 
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4.3.4   Pharmaceutical advertisements directed at healthcare professionals 
 
In addition to Regulation 45 (4), Subsections (a), (b), and (c), the Marketing Code also 
provides the following information which should appear on the advertisement if directed 
to healthcare professionals (Code of Practice, 2004): 
 
• at least one indication of the medicine, a statement of the dosage, method of use, and 
route of administration, which all should be consistent with the package insert; 
• any warning made by the regulatory authorities should be included;  
• concise profile of the medicine’s adverse effects, precautions, and contraindications, 
which all should be consistent with the package insert; 
• scheduling status and pharmacological classification;  
• registration number as well as the name and address of part of the business 
responsible for sale or supply; and  
• a single exit price.   
 
An abbreviated advertisement (an advertisement not longer than an A4 page and which 
only appears in professional publications) requires the following additional information, 
other than the information requested for an advertisement directed at healthcare 
professionals (Code of Practice, 2004):    
 
• name, address, and telephone number of the registered license holder or part of 
business responsible for sale or supply; and   
• a statement that further information is available on request from holder of the 
registration or in terms of the package insert. 
   
4.3.5   Claims in pharmaceutical advertisements 
  
Various rulings were also made by the MCC with regard to certain claims made which in 
turn then requires the specific product to be registered with this Council.  This will also 
result in that that specific product needs to adhere to the regulations as determined by the 
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Medicines Act when being advertised.  Table 4.4 identifies the rulings that were 
published by the MCC. 
 
Table 4.4   Rulings regarding specific claims made in pharmaceutical 
advertisements 
 
 
CLAIMS 
 
RULINGS MADE BY THE MCC 
  
Bacteria 
 
If the claim, ‘removing the bacteria that cause’, appears on the 
packaging of a soap the product must be registered.   
   
 
Pimple treatment and 
treatment of  blemishes 
 
Claims with respect to antibacterial skin cleansers used as pimple 
treatment and treatment of blemishes should be regarded as medicinal 
claims, thereby requiring such products to be registered. 
 
 
 
Stress 
 
A product cannot claim to relieve stress unless registered as a medicine.  
In the event of such claims made, approval must be obtained from the 
MCC. 
 
 
 
Clinical trials 
 
Results obtained from clinical trials can be used in advertisements but 
should not make additional claims other than those registered with the 
Council. 
 
 
(Source: ASA, South Africa, 1994: G-5)   
 
The following words and/or claims are permitted in advertisements (ASA, South Africa, 
1994: G-6): 
 
 
“Fast” and “effective” 
 
 
Such words may not be used in their comparative or superlative form if not approved by 
the MCC. 
 
 
“Mild pain” to “moderate pain” 
 
 
Such phrases may be used in analgesic medicine advertisements but should only refer to 
body aches and pains such as toothache, period pains, headache, and those associated 
with colds, fever, and coughs. 
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“Fatigue”, “tone”, “run-down”, “energy”, “vitality”, “lack 
of  concentration”, “tonic”, and “ability to work” 
 
 
Such words or phrases may be used in advertisements of tonics.  
 
The Code also deals with superlatives which are adverbs or adjectives expressing the 
highest quality degree (Concise Oxford English Dictionary, 2006: 1446).  Superlatives 
are therefore grammatical expressions denoting the highest quality or degree, for example, 
best, worst, wildest, slowest, or most difficult (Code of Practice, 2004).  The code 
illustrated the use of superlatives in advertisements by providing the following examples, 
one which is prohibited from being used and another which is permitted (Code of 
Practice, 2004):   
 
• “The product was ‘the best’ treatment for the condition”.  This statement could 
not be substantiated as there are too many variables to enable such a claim to be 
proven and its use should therefore be prohibited.   
 
• “For this condition this medication is the ‘most widely’ prescribed in SA”. This is 
seen as a simple statement which can be substantiated, if not present in a misleading 
way. 
 
4.3.6   Slimming product advertisements  
   
Advertising of slimming products is also an issue of concern in SA as there is very little 
control enforced on such advertisements.  The reason for concern is raised as some of 
these products may cause unnecessary or even dangerous adverse effects, especially in 
conditions such as hypertension, diabetes, and cardiovascular conditions.  According to 
the Foodstuffs, Cosmetics, and Disinfectant Act, No. 54 of 1972, it is the duty of the 
Department of Health to exercise control over the advertising of slimming products (ASA, 
South Africa, 1994: G11).  
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Two important points raised by the Department of Health are that each slimming 
advertisement’s effectiveness should be linked to an approved kilojoule restricted diet 
and that temporary weight loss caused by fluid loss (sweating) may not be presented as a 
method to slim (ASA, South Africa, 1994: G11).  Table 4.5 identifies additional 
regulations determined by the Department of Health. 
 
Table 4.5   Additional regulations regarding slimming products  
 
 
TOPIC 
 
 
REGULATIONS FOR SLIMMING PRODUCTS 
  
Muscle toning or 
“centimetre loss” 
 
• Exaggerated claims such as “3.6 cm lost in one day” may not be made. 
• Advertisements of muscle toning products may not claim to cause mass 
loss as that can only be achieved by means of exercising.  
    
 
 
Testimonials and 
photographs 
 
• Testimonials and photographs used must be genuine, original, and still 
apply. 
• Testimonial statements or claims made must form part of the copy layout 
and must be substantiated.   
• “Before” and “after” photographs must be dated and signed. 
   
 
 
Claims in fibre and 
slimming 
advertisements 
 
• The claim, “fewer kilojoules are absorbed by the body” is prohibited 
from being used. 
• No reference should be made that fibre has the ability to curb or blunt 
appetite. 
• The claim, “dietary fibre also slows down the absorption of glucose in 
your blood” should not be used as it is seen as misleading. 
   
 
 
Slimming teas  
 
 
Advertisements for slimming teas claiming to have slimming properties are 
considered to be false and misleading but may be advertised if the word, 
“slimming” or such claims are not present. 
 
 
(Source:  Advertising Standards authority of South Africa, 1994: G11)  
  
According to the Medicines Act, the Department of Health found the following claims in 
advertisements for slimming products unacceptable (ASA, South Africa, 1994: G11): 
 
• Claims which states that a slimming product is a medicine 
 
To identify unacceptable claims stating that slimming products are medicines, the term 
“medicine” must first be defined.  In accordance with the Medicines Act (Regulation 1(1) 
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regarding definitions), the term “medicine” is defined as (Pharmaceutical Society of 
South Africa Pharmacy Law Compendium, 2005: MAE – 8): 
   
“...any substance or mixture of substances used or purposing to be suitable for use or 
manufactured or sold for use in –  
 
(a)  the diagnosis, treatment, mitigation, modification or prevention of disease, abnormal physical    
       or mental state or symptoms thereof in man; or  
 
(b)  restoring, correcting or modifying any somatic or psychic or organic function in man, and  
       includes any veterinary medicines."   
  
 
The ASA, however, defines “medicine” in a more simplistic way as substances that 
interfere with the normal physiology of the body.  By keeping these definitions in mind, 
the following claims may not be made in slimming advertisements (ASA, South Africa, 
1994: G11 ): 
 
-  the product melts away fat; 
-  bio-active ingredients are present; 
-  the product increases or speeds up metabolism; and 
-  the product makes fat cells shrink.   
 
• Claims suggesting that other, similar products do not comply with the Act 
 
Examples of such claims include “contains no harmful substances with side effects” and 
“product X is safe”. 
 
Figure 4.3 illustrates a slimming advertisement that claims the product to be safe as well 
as a medicine, “Unique and safe medication”.  The advertisement also claims to 
“Improve Health” without providing proof to the consumer and could therefore be seen 
as being false and misleading, even if found to have such properties when undergoing 
clinical trails.  
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Figure 4.3   Example of a slimming advertisement containing unacceptable claims  
(Source:  UD News, 2007: 3) 
 
4.3.7   Pharmaceutical advertising on the Internet 
 
Pharmaceutical advertisements can be found on Internet websites in SA.  Often these 
advertisements appear as spam on consumers’ computers or it may be received as an e-
mail (see Figure 4.4).   
 
 
  
Figure 4.4  Pharmaceutical advertisement of a Schedule 4 medicine in the form of 
an e-mail 
(Source:  Gray & Day, 2000)  
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Figure 4.5 depicts a pharmaceutical advertisement of a Schedule 2 medicine for the 
treatment of migraine found on an “apparently independent” website.  It was aimed at the 
general public and directed patients to specific trade name medicines.  However, it was 
found to be funded by pharmaceutical industry advertising and made no attempt to 
provide evidence-based or balanced information (Gray & Day, 2000).   
                  
 
 
Figure 4.5   Pharmaceutical advertisement on the Internet directed at the general 
public  
(Source:  Gray & Day, 2000)   
 
The advertising of medicines on the Internet is allowed but such advertisements should 
adhere to the following standards (Legh & Cassim, 2006; Government Gazette, No. 
26572, 2004): 
 
• Any form of promotional material regarding prescription-only medicines or those 
medicines which may not be legally advertised to the general public.  It may only be 
advertised if a password protection scheme is incorporated ensuring that access is 
only obtained by healthcare professionals or the appropriate administration staff only.  
This scheme may also include a “quality seal” or accreditation by a national or 
international organisation.   
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• Medicine advertisements from international pharmaceutical companies put on the 
Internet from within this international country will also be regarded as coming within 
the scope of the Code. 
• Prescription-only medicine advertisements appearing in electronic journals must, 
according to the MCC guidelines, state on each page of the advertisement that it is 
intended for healthcare professionals only.    
 
4.4   FORENSIC ASPECTS OF PHARMACEUTICAL ADVERTISING IN      
        INTERNATIONAL COUNTRIES 
 
To investigate international law regarding pharmaceutical advertising, three countries 
were selected on the basis of the new pricing laws currently being debated in SA.  The 
Pricing Committee in SA determined two methodologies to determine the pricing 
structure to be implemented on medicine (Osman, 2006b: 6).  One of these 
methodologies is to compare the prices of medicines in SA against equivalent products in 
a group of countries with a similar set of medicine regulatory environment.  From this 
group of countries, Australia, New Zealand, and Canada were selected.  By investigating 
the pharmaceutical advertising laws in these countries, similarities and differences 
between SA and these countries, with regard to these laws, can be identified.    
 
4.4.1 Australia and New Zealand 
 
4.4.1.1   Laws and codes governing pharmaceutical advertising practices 
 
On 10 December 2003 Australia and New Zealand formed a joint scheme for the 
regulations of therapeutic goods (Loveday & Williams, 2006).  The agency responsible 
for the implementation of this joint scheme is called “The Australia New Zealand 
Therapeutic Products Authority” (“the ANZTPA”) (Loveday & Williams, 2006).  This 
replaced Australia’s Therapeutic Goods Administration (“the TGA”) and New Zealand’s 
Medicines and Medical Devices Safety Authority (“Medsafe”) (Loveday & Williams, 
2006; Cameron & Stoddart, 2006).  The ANZTPA implemented the Australia New 
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Zealand Therapeutic Goods Code (“the Code”) on 1 July 2006 (Loveday & Williams, 
2006).    
 
It is the responsibility of the ANZTPA to safeguard the health and safety of the public in 
Australia and New Zealand (Loveday & Williams, 2006; Cameron & Stoddart, 2006).  
This will be achieved through the regulation of the following therapeutic goods (Loveday 
& Williams, 2006): 
  
• prescription-only medicines; 
• OTC medicines; 
• complementary medicines; 
• medical devices; and 
• blood products. 
 
Before the ANZTPA came into effect medicinal product advertisements in Australia was 
governed by the TG Act including its legislation, the Therapeutic Regulations 1990 (“the 
TG Regulations”) (Loveday & Williams, 2006).  The TGA was responsible for the 
administration of the TG Act.  The Trade Practices Act 1974 (“the TP Act”), which was 
administered by the Australian Competition and Consumer Commission (“the ACCC”), 
also played a role in the regulation of advertising concerning therapeutic goods.  As the 
TP Act applies to all forms of advertising, this Act will continue to play a role in the 
advertising of therapeutic Goods in Australia (Loveday & Williams, 2006).   
 
A number of Codes of Practices also applied, and will in all probability still apply, to the 
advertising of therapeutic goods in Australia and include the following (Loveday & 
Williams, 2006): 
 
• The Therapeutic Goods Advertising Code (“the TGAC”) which applied to all 
advertisements of therapeutic goods other than those directed at healthcare 
professionals or wholesalers thereof.  
• The Medicines Australia Code of Conduct and supporting Guidelines which dealt 
with the promotion of prescription-only medicines. 
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• The Australian Self-Medication Industry (“the ASMI”) Code of Practice where the 
responsibility fell on the advertising of consumer health products.   
• The Complementary Healthcare Council of Australia (“CHC”) Code of Practice for 
the Marketing of Complementary Healthcare and Health Food Products. 
 
New Zealand in turn relied on the Medicines Act 1981 and the Medicines Regulations 
1984 to regulate the advertising of medicines.  The Medicines Act dealt with the 
manufacturing, sales, and supply of medicines, medical devices, and related products 
(Cameron & Stoddart, 2006).  Other legislation and Industry Code of Practices also 
played a role in the regulation of such advertisements and may continue to do so 
(Cameron & Stoddart, 2006).   
 
The following legislations played a role (Cameron & Stoddart, 2006): 
  
• Fair Trading Act 1986; 
• Consumer Guarantees Act 1993; 
• Gambling Act 2003 (deals with sales promotion schemes); and 
• Medicines (Database of Medical Devices) Regulations 2003.  
 
The following Industry Code of Practices also played a role in the regulation of medicinal 
advertisements in New Zealand (Cameron & Stoddart, 2006): 
 
• Research Medicines Industry Code of Practices (prescription-only medicines) (“RMI 
Code”); 
• Advertising Standards Authority Codes of Practice (“ASA”); 
• Therapeutic Advertising Pre-vetting System (“TAPS”); 
• Medsafe Advertising Guidelines; and 
• Proposed trans-Tasmanian Joint Therapeutic Agency.  
 
The newly implemented Code consists of a Part A and Part B.  Part A contains the 
common obligations and processes to be followed by the advertisers of therapeutic 
products in Australia and New Zealand (ASA, New Zealand, 2005; Australian 
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Government, 2006).  Part B identifies the requirements for the various types of 
advertising for such products.  The various types of advertising included in Part B are 
(ASA, New Zealand, 2005; Australian Government, 2006):   
 
• Advertising of medicines to consumers. 
• Advertising of therapeutic products to healthcare practitioners. 
• Advertising of medical devices to consumers.  
 
In these two countries the phrase “therapeutic goods” are frequently used in 
pharmaceutical advertising.  The Code defines this phrase as (Australian Government, 
2006): 
 
• a product to be taken for therapeutic use; 
• an ingredient or component in the manufacturing of a product for therapeutic use; 
• a container, or part thereof, for a product, ingredient, or component for therapeutic 
use or for the manufacture of such a product; and 
• a product falling within a product class principally being used for its therapeutic 
activity.  
  
The Australia and New Zealand Therapeutic Products legislation set three key 
Advertising Principles which provided the foundation for the Code (Australian 
Government, 2006).  These three principles are aimed at therapeutic product 
advertisements directed at both the general public and at healthcare professionals, as well 
as at medical device advertisements directed at the general public.   Figure 4.6 identifies 
the three key advertising principles to which therapeutic product advertisements have to 
adhere to.    
 
Advertising is defined, according to the Code, in the same way as the TG Act in Australia 
and the Medicines Act in New Zealand.  Advertising is defined as any statement, design, 
or picture directly or indirectly intended to promote the supply or use of the goods (ASA, 
New Zealand, 2005; Cameron & Stoddart, 2006; Loveday & Williams, 2006).  The TG 
Act furthermore described advertising as something which is published or broadcasted 
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and intended to promote the use or supply of the goods (Loveday & Williams, 2006).  
The Medicines Act also explained that medical advertisements are advertisements that 
are likely to cause any person to believe that it relates to any medical device, medicine, or 
treatment (Cameron & Stoddart, 2006).   
 
   
PRINCIPLE ONE 
 Pharmaceutical advertisements have to comply with the 
Therapeutic Products Act(s) and Rules and also the Code 
      
PRINCIPLE TWO 
  Pharmaceutical Advertisements must be represented in a 
truthful and balanced way, and should also not be 
misleading 
     
PRINCIPLE THREE 
  Pharmaceutical advertisements should adhere to a high 
standard of social responsibility 
 
 
Figure 4.6   Key advertising principles therapeutic products should adhere to 
(Source:  Australian Government, 2006) 
 
4.4.1.2   Advertisements directed at the general public and healthcare professionals   
               
The main difference found in the Code between the two countries is when advertising to 
consumers.  In Australia prescription-only medicines, and certain non-prescription 
medicines, are prohibited from being advertised to the general public.  In New Zealand 
such advertisements are allowed, excluding the controlled medicines specifically 
prohibited by the Misuse of Dugs Act 1975 (ASA, New Zealand, 2005; Cameron & 
Stoddart, 2006; Loveday & Williams, 2006).  This is in stark contrast to most of the other 
countries, including SA, where advertisements of prescription-only medicines directed at 
the general public, are strictly prohibited.  Another country where such advertisements 
are allowed is the USA (Mintzes, 2006).  
 
All DTC advertisements for prescription-only medicines appearing in all media in New 
Zealand must be pre-vetted and approved by TAPS (Cameron & Stoddart, 2006).  The 
following should be clearly stated in such print advertisements (Cameron & Stoddart, 
2006): 
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• “Prescription-only medicine”; 
• “Use strictly as directed”; 
• “If any symptoms continue or if you have side-effects, see your doctor, pharmacist, or 
healthcare professional”; and 
• “Consult your doctor if (product name) is right for you”. 
 
The guidelines to which therapeutic goods advertisements should adhere to are in many 
aspects similar as in SA guidelines.  Therapeutic goods advertisements directed at both 
the general public and healthcare professionals should comply with the following 
requirements (ASA, New Zealand, 2005):  
 
• All mandatory information used to encourage responsible use must be included. 
• Sponsorship from any hospital, governmental agency, or other facility provided may 
be referenced in the advertisement.  Such sponsorship must, however, not be 
presented as a product endorsement but rather only be explicitly acknowledged. 
• Should not mislead or deceive, abuse trust, exploit superstitions, or cause unnecessary 
fear. 
• Testimonials used (if not prohibited by law) must, in accordance with the Code, be 
current, typical, authentic, genuine, and also acknowledge any valuable consideration. 
• May not encourage excessive or inappropriate use of therapeutic products. 
• No reference may be made to serious conditions, ailments, diseases, or defects, 
without Agency approval. 
• Products may not be glamourised nor appear to prey on the vulnerability of particular 
audiences.  Vulnerable audiences may, for example, include people who are not 
fluent in the English language; minors (under the age of 18 years); people with 
impaired vision or hearing; people with chronic illnesses, serious illnesses, long-term 
disability, or mental health problems. 
• No implication, statement, or claim may be made that products are safe, or cannot 
cause harm, or are side-effect free.   
• Content should be balanced and truthful and claims made should be valid and 
substantiated in order for consumers to make an informed decision.  
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• Scientific information may be included if presented in an accurate and balanced 
manner and not misleading.   
• Such advertisements should not arouse any unwarranted or unrealistic expectations of 
the product’s effectiveness.   
• Advertisements may not offer to provide a free sample of the product.  This accounts 
exclusively to therapeutic devices and sunscreen preparations.  
• May under no circumstances advertise personal incentives to a pharmacist’s assistant 
or other non-healthcare professional sales person in retail in order to recommend or 
supply therapeutic products. 
• Consumers may not be led to believe that they can self-diagnose or inappropriately 
treat potential serious diseases. 
• Advertisements may not be directed towards minors, except advertisements of some 
of the following products: tampons, condoms and personal lubricants, lip balm, acne 
preparations.  
 
The Code also states what information must be included in the advertisement of 
therapeutic goods.  This is similar to that of the advertising of medicinal products in SA 
but some additional information must be clearly stated on advertisements found in 
Australia and New Zealand.  The information to be found in the advertisements 
pertaining to therapeutic goods is (ASA, New Zealand, 2005): 
 
• trade name; 
• reference to the approved or permitted indication(s) for the use of the goods; and  
• where applicable, a list of ingredients or the following statements should stand out:  
 
 
ALWAYS READ THE LABEL 
 
     except in the case of direct marketing and Internet marketing; 
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• The words 
 
 
 
 
must be prominently displayed; for all claims relating to symptoms of diseases or 
conditions the following words must be stated:  
 
USE ONLY AS DIRECTED 
 
IF SYMPTOMS PERSIST SEE YOUR DOCTOR/HEALTHCARE PROFESSIONAL 
 
or in the case of a Schedule 3 (Pharmacist-only medicines) therapeutic good listed in 
Appendix H of the Standard for the Uniform Scheduling of Drugs and Poisons 
(Australia), the words:  
 
 
 
YOUR PHARMACIST’S ADVISE IS REQUIRED 
 
• Therapeutic goods that can be lawfully advertised and that are available only directly 
from, or on recommendation of a healthcare professional (except Schedule 2 
(Pharmacy medicines) and Schedule 3 medicines) the following statement must be 
visible:   
 
 
YOUR [appropriate healthcare professional] WILL ADVISE YOU WHETHER THIS 
PREPARATION [product name] IS SUITABLE FOR YOU/YOUR CONDITION 
 
• The advertisement’s approval number must be present and prominently displayed in 
the bottom right hand corner of the advertisement.  
 
As a result of the difference between Australia and New Zealand regarding the 
advertising of prescription-only medicines, the following also apply to such 
advertisements (ASA, New Zealand, 2005; Loveday & Williams, 2006): 
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i.  Restricted or pharmacist only medicines (New Zealand) or Schedule 3 medicines 
(Pharmacist-only Medicines) listed in Appendix H (Australia), must contain the 
statement:           
 
 
YOUR PHARMACIST’S ADVICE IS REQUIRED; or AVAILABLE ONLY FROM YOUR 
PHARMACIST 
 
ii.  Schedule 4 medicine (Prescription-only medicines) advertisements in New Zealand 
must contain the statement:     
 
 
PRESCRIPTION MEDICINE, CONSULT YOUR DOCTOR [or other prescriber] TO SEE IF 
THIS MEDICINE IS RIGHT FOR YOU 
 
 
4.4.1.3   Analgesic, vitamin, and weight management advertisements 
 
The code also gives attention to the advertising of certain specific categories such as 
analgesics, weight management products, and vitamins.  In Australia and New Zealand 
analgesics are classified, according to the Code, as those preparations used for the relief 
of minor aches and pains which contains one or more of the following substances (ASA, 
New Zealand, 2005; Australian Government, 2006): 
 
• codeine; 
• paracetamol; 
• other non-steroidal anti-inflammatory drugs; or 
• salicylic acid, its salts and derivatives (including aspirin), and their salts.   
 
The Code, however, excludes preparations for use in self-limiting conditions and which 
contain an analgesic in combination with one or more other active ingredients such as 
cough mixtures and cold tablets (ASA, New Zealand, 2005; Australian Government, 
2006). 
 
 126
Print media advertisements for analgesics must contain the warning statement (Australian 
Government, 2006):   
 
 
USE ONLY AS DIRECTED.  INCORRECT USE COULD BE HARMFUL.  CONSULT YOUR 
HEALTHCARE PROFESSIONAL IF SYMPTOMS PERSIST   
 
Furthermore, it is stated that these advertisements must not imply that the consumption of 
analgesics are safe.  Such advertisements must also not claim that these agents will relax, 
sedate, stimulate, and relief tension (ASA, New Zealand, 2005).   
 
With respect to the advertising of vitamins, such advertisements may not claim the 
following (ASA, New Zealand, 2005; Australian Government, 2006;): 
 
• vitamin supplements are substitutes for good nutrition or a healthy diet; 
• vitamins are superior or more beneficial than dietary nutrients; and 
• normal health may be affected if not taking vitamin supplements. 
 
Weight management advertisements are also of concern and therefore mentioned in the 
Code.  These guidelines provided are similar to that which is provided in SA.  Claims 
made for weight management (weight loss), clothing size loss, measurement reduction, 
and weight control or maintenance must have an appropriate balance between claims and 
references to health energy-controlled diet and physical activity (ASA, New Zealand, 
2005; Australian Government, 2006).  
 
4.4.1.4   Pharmaceutical advertisements on the Internet 
 
No specific guidelines or laws are provided in the Code that deals with the subject of 
Internet advertising.  As this Code is still in its infancy, more attention may be given to 
Internet advertising in the future.  Before the Code came into effect in Australia, Internet 
advertisements where treated as “below the line” advertisements which did not require (in 
practice) approval first before being published, even though such a form of advertising 
fell within the parameters of the advertising definition set by the TG Act (Loveday & 
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Williams, 2006).  Currently, however, Internet advertising of therapeutic goods appearing 
on Australian and New Zealand websites must comply with the Code (Cameron & 
Stoddart, 2006; Loveday & Williams, 2006).  
 
4.4.2   Canada 
 
In Canada pharmaceutical advertisements are regulated by Health Canada and the Food 
and Drugs Act and its regulations.  Health Canada is a national regulatory authority for 
health product advertisements (Health Canada, 2006a).  Health product advertisements 
are defined as any representation by means of, for example, audiovisual- and print media, 
and the Internet for the purpose of promoting directly or indirectly the sale or distribution 
of any health product (for example, vaccines, biological products, natural health products, 
medical devices, and drugs) (Health Canada, 2006b).   
 
Health Canada carries out the following activities (Health Canada, 2006b): 
 
• provides policies which effectively regulates marketed health products; 
• develops guidance documents for the interpretation of the regulated framework; and 
• oversees the regulatory advertising activities. 
 
Only health products that have been authorised for sale in Canada by the Health Products 
and Food Branch (HPFB) of Health Canada may be advertised (Health Canada, 2006b).  
These products can be distinguished from unauthorised products based on an eight-digit 
number preceded by a specific acronym.  Three different acronyms exist and are 
illustrated by Table 4.6. 
 
The Food and Drugs Act (“the Act”) provides the basic criteria for acceptable advertising 
of medicines and medical devices.  Regulations under the Act that plays a role in 
providing these criteria for medicines are the Food and Drug Regulation as well as the 
Natural Health Products Regulations.  Section 1 of the Act defines advertising as (Health 
Canada, 2006b): 
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“Any representation by any means whatever for the purpose of promoting 
directly or indirectly the sale or disposal of any food, drugs, cosmetic, or 
device.” 
 
 
This therefore refers to any message and has the primary purpose of influencing the 
audience that it is directed at.   
 
Table 4.6   Acronyms used to distinguish authorised health products from 
unauthorised health products 
 
 
ACRONYM 
 
DESCRIPTION  
  
NPN 
 
Natural health products bear this acronym which stands for the 
Natural Product Number.   
   
DIN 
 
 
Authorised drugs bear this acronym which stands for Drug 
Identification Number.   
   
DIN-HM 
 
 
Homeopathic medicines bear this acronym which stands for Drug 
Identification Number – Homeopathic Medicines.  
  
 
(Source:  Health Canada, 2006b) 
 
The general rule established by the Act is that no person shall advertise any drug or 
medical device in a manner that is false, misleading, deceptive, or is likely to create 
incorrect impressions regarding its character, value, composition, quantity, merit, or 
safety (Hearn & Prendergast, 2005).  Pharmaceutical advertisements are also prohibited 
from being geared towards the treatment, prevention or cure of any disease, disorder, or 
abnormal physical state listed in Schedule A of the Act.  Schedule A includes a list of 
about 40 conditions (for example, alcoholism, diabetes, epilepsy, heart disease, glaucoma, 
asthma, obesity, gout, sexual impotence, menstrual flow disorders) that are deemed as 
sufficiently serious as to warrant such an exclusion  (Hearn & Prendergast, 2006; Health 
Canada, 2004).  There is also a restriction on the advertising of medicines manufactured, 
sold, or represented for use in the prevention of contraception (Hearn, et al., 2005).    
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Pharmaceutical advertisements also have to apply to various regulations that apply to 
advertising in general.  Such regulations include (Hearn, et al., 2005): 
• Competitors Act; 
• Trade-marks Act; 
• Copy Right Act; and 
• Common Law. 
 
As in SA, Australia, and New Zealand, there are various self-regulatory authorities 
responsible for assisting in the regulating pharmaceutical advertisements.  Table 4.7 
identifies the self-regulatory authorities in Canada and also their main responsibilities. 
 
Table 4.7   Canadian self-regulatory authorities and their responsibilities 
   
SELF-REGULATORY 
AUTHORITY 
 
  
RESPONSIBILITIES 
 
 
Advertising Standards Canada 
(ASC) 
 
 
The ASC is responsible for providing effective self-regulation of 
pharmaceutical advertisements by means of applying the Canadian 
Code of Advertising Standards.  This Authority is also responsible 
for objective and independent review of the copy layout of these 
advertisements by means of the ASC Clearance Services.  
    
 
 
Pharmaceutical Advertising 
Advisory Board (PAAB) 
 
PAAB is an independent review agency with the primary role of 
ensuring prescription medicine advertisements directed at 
healthcare professionals are accurate, balanced, and evidence- 
based.  In accordance to PAAB, all advertisements directed at 
healthcare professionals must comply with the PAAB Code of 
Advertising Acceptance.   
 
 
 
 
Research Based Pharmaceutical 
Companies (Rx & D) 
 
Rx & D is an authority that represents the Canadian research-
based pharmaceutical companies.  Members must comply with the 
Rx & D Code of Conduct as well as the PAAB Code of 
Advertising Acceptance.  Furthermore, Rx & D also provide 
requirements and procedures to healthcare professionals regarding 
relevant educational activities. 
   
 
(Source:  Hearn, et al., 2005; Hearn & Prendergast, 2006)   
 
In addition to the Act’s definition of advertising, the Canadian Code of Advertising 
Standards (ASC Code) also provided a detailed definition of what they classify as 
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pharmaceutical advertising.  The ASC Code defines advertising as (Hearn & Prendergast, 
2005): 
 
 
“...any message in which the content is controlled directly or indirectly 
by the advertisers, expressed in any language and communicated in any 
medium to Canadians, except media other than that from Canada, as 
well as packaging, wrappings, and labels, with the intent to influence 
their choice, opinion, or behaviour.”  
 
 
 
4.4.2.1   Advertisements directed at the general public and healthcare professionals 
               
When referring to pharmaceutical advertisements directed at the general public, 
distinction is made between the advertising of non-prescription medicines and 
prescription-only medicines.  Non-prescription medicines (Schedule II, Schedule III, and 
Unscheduled medicines) may be advertised to the general public, provided that such 
advertisements are subjected to the Act as well as to various other codes, guidelines, and 
laws (Hearn & Prendergast, 2005).  Advertisements of prescription-only medicines 
(Schedule I medicines) are prohibited in Canada (Gardner, et al., 2003; Mintzes, 2006).   
 
Only Schedule F medicines are allowed to be advertised to the general public.  Similar to 
Regulation 45(2), Subsection (c) of the Medicines Act in SA, Section C.01.044 of the 
Canadian Food and Drug Regulations state that only the name, price, and quantity of the 
medicine may appear in such advertisements (Gardner, et al., 2003; Hearn, et al., 2005; 
Hearn & Prendergast, 2005).  Schedule F medicines include medicines containing active 
ingredients such as barbiturates, thyroxin, sulphonamides, phenytoin sodium, as well as 
antibiotics, hormones, and anxiolytics (GST/HST Memoranda Series, 2000: 3).  This was 
done to allow for competition between pharmacies (Gardner, et al., 2003).   However, 
according to Gardner, Mintzes and Ostry (2003), a shift in the interpretation of this policy 
has occurred which resulted in DTC advertisements being published on a daily basis.  
Three types of DTC advertisements, occurring in Canada, are identified and defined in 
Figure 4.7.  
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PRODUCT CLAIM 
ADVERTISEMENTS 
 Pharmaceutical advertisements that contain the products’ 
names as well as their specific therapeutic claims. 
     
REMINDER 
ADVERTISEMENTS 
  Pharmaceutical advertisements that states the products’ names 
without stating their uses.   
     
HELP-SEEKING 
ADVERTISEMENTS 
  
Pharmaceutical advertisements that inform the general public 
about new but unspecified treatment options for conditions. 
   
 
Figure 4.7   Identification of the three direct-to-consumer advertisements found in 
Canada 
(Source:  Gardner, et al., 2003) 
 
All three forms of DTC advertising contravene the Act and are therefore prohibited from 
being published.  According to Gardner, Mintzes and Ostry (2003), however, reminder- 
and help-seeking advertisements are now seen on a daily basis in Canada without any 
legal intervention.  An example of a product claim advertisement can be seen in Figure 
4.8.  This advertisement identifies the medicine for erectile dysfunction, Cialis®, and also 
discloses its well-known controversial therapeutic claim, the so called “36-hours Cialis®”.  
 
Figure 4.9 depicts an example of a reminder advertisement for the medicine, Viagra®, 
used in erectile dysfunction.  In this advertisement it is evident that only the name of the 
medicine, Viagra®, appears without stating its use(s).  Figure 4.10 illustrates an example 
of a help-seeking advertisement which informs the general public about oesophageal 
reflux without specifying the treatment options.  The assumption can, however, be made 
that the treatment information available for oesophageal reflux, may be obtained by 
dialling the toll free number provided.   
 
These three forms of DTC advertising identified (see Figure 4.7) are prohibited by the 
Act in the following two ways (Gardner, et al., 2003; Mintzes, 2006): 
 
• by prohibiting the advertising of prescription-only medicines, regardless of their 
indications; and 
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• by prohibiting the advertising of any medicine to the general public as treatment, 
preventive, or cure for Schedule A diseases.   
   
     
Figure 4.8   Controversial product claim advertisement for the medicine Cialis® 
(Hearn, et al., 2005)  
 
Advertising directed at healthcare professionals are required by the PAAB Code to 
contain the following information (Hearn & Prendergast, 2003): 
 
• brand- or trade name of the medicine;  
• generic name; 
• federal drug schedule; and 
• therapeutic and/or pharmacologic classification. 
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Figure 4.9   Reminder advertisement for the medicine, Viagra® 
(Source:  Hearn, et al., 2005) 
 
Information brochures or advertisements are intended to promote a better understanding 
of a disease and its treatment.  In this case brochures and advertisements may include 
specific drug information yet retaining their non-promotional status under the following 
conditions set out in the TPD Guidelines (Hearn & Prendergast, 2005): 
 
• Overall content must be disease-related rather than product-related. 
• Treatment options (drug and non-drug options) and their risks and benefits must be 
discussed in an objective manner. 
• No emphasis must be placed on a single drug product or its merits. 
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• No reference may be made to any unauthorised medicines other than to mention that 
research is under way, under which the regulatory status should be indicated. 
• No reference may be made to the availability of any unauthorised medicines. 
 
                    
 
Figure 4.10   Help-seeking advertisement for oesophageal reflux 
(Source:  Hearn, et al., 2005) 
 
4.4.2.2   Pharmaceutical advertising on the Internet 
 
Internet advertisements are regulated in the same way as the traditional type of 
advertisements in Canada.  In 2005 the PAAB Code was amended to reflect revised 
standards for appropriate advertising on the Internet which mentioned specific rules for 
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advertising practice such as pop-ups, links, and chat rooms.  This led to the establishment 
of an advisory entitled the Internet Advertising – An Ethical Guidance (the PAAB 
Internet Advisory).  Canada is one of the few countries to implement such guidelines 
(Hearn & Prendergast, 2003).  The difficulty Canadian authorities are faced with is that 
they have no control over any media that originates outside the borders of Canada. 
  
The PAAB Internet Advisory provided the following guidelines when information or 
advertisements directed at healthcare professionals appears on a website (Hearn & 
Prendergast, 2005): 
 
• Access must be restricted to healthcare professionals only via the introduction of 
passwords. 
• Such websites must not be advertised to the general public. 
• Key words for search engines must not be provided so that non-professionals are 
attracted to website.   
• Appropriate terminology and subject matter must be used to emphasise that the 
website is directed at healthcare professionals only. 
 
Health Canada identified problematic areas with respect to “links” on websites.  Linking 
to other websites is permitted provided that their links do not promote the sale of 
Schedule F medicines.  The following example is permissible (Hearn & Prendergast, 
2003): 
 
 
For United States Company X website click here 
 
but the following is not allowed:   
 
 
For information on brand X click here 
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Up to this point in Chapter four the standards provided by the WHO regarding the legal 
and ethical aspects of pharmaceutical advertisements in print form were identified.  
Overviews were also provided of these legal and ethical aspects in SA, Australia, New 
Zealand, and Canada.  Section 4.5 will investigate and compare the legal aspects 
discussed in the preceding overview. 
  
4.5   INVESTIGATION INTO THE LEGAL ASPECTS OF PHARMACEUTICAL  
        ADVERTISING 
 
4.5.1   Introduction   
 
The investigation into the legal aspects of pharmaceutical advertising will consist of three 
sections.  In Section 4.5.2 the guidelines regarding these legal aspects provided by the 
WHO will be compared with that of SA to determine if SA legislation adheres to these 
guidelines regarding pharmaceutical advertising.  Section 4.5.3 will involve the 
comparison of pharmaceutical advertising guidelines of SA, Australia, New Zealand, and 
Canada.  Lastly, Section 4.5.4 will identify problematic areas in SA pharmaceutical 
advertising law.  
  
4.5.2   Comparing guidelines of the World Health Organisation regarding Pharma- 
           ceutical advertising to South African Legislation  
 
Focusing on pharmaceutical advertisements directed to the general public, the WHO 
provided guidelines regarding pharmaceutical advertising that can be employed as norms 
and standards by SA.  From these guidelines one can deduce that the WHO guidelines 
mostly focus on three areas: identification of medicines advertised as well as that of the 
suppliers, pharmacological necessities, and selling prices. With these focus areas in mind, 
the six criteria identified in these guidelines were used to compare the regulations and 
ethical guidelines in SA regarding pharmaceutical advertisements.   
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4.5.2.1   Identification criteria of medicines advertised 
 
Table 4.8 identifies three of the six criteria that should be present in pharmaceutical 
advertisements and whether these are applied to SA legislation.  These criteria focus on 
the identification of the medicines and the manufacturers or distributors thereof.   
  
Table 4.8   Compliance to criteria for the purpose of identifying medicines and the 
manufacturers or distributors thereof in advertisements   
 
 
IDENTIFICATION CRITERIA 
  
 
DOES SOUTH AFRICA COMPLY? 
 
International Non-proprietary Name (INN) or 
approved generic name of active ingredient(s)  
 
  
Yes 
 
Brand name 
 
Yes 
 
Name and address of manufacturer or distributor 
 
No 
 
 
From the results identified in Table 4.8, it is evident that SA legislation does not fully 
comply with the WHO guidelines.  No specific mention is made in Regulation 45(4), 
Subsections (a), (b), or (c) of the Medicines Act regarding the advertising of medicines 
that pharmaceutical advertisements directed at the general public are required to state the 
name and address of the distributor or manufacturer (Pharmaceutical Society of South 
Africa Pharmacy Law Compendium, 2005: MRE – 51).  This requirement is stated in the 
guidelines of the Marketing Code in SA but only with respect to pharmaceutical 
advertisements directed at health care professionals.  During the study, however, it was 
observed that most pharmaceutical advertisements directed at the general public did, in 
most cases, provide some form of address or contact details of the distributor or 
manufacturer at the bottom of the advertisement.   
 
4.5.2.2   Pharmacological norms  
 
Two criteria that are of pharmacological importance to consumers in making informed 
decisions are (1) major indications, and (2) warnings, major contraindications, and 
precautions.  These are listed in the WHO guidelines and should be present in SA 
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pharmaceutical advertisements (World Health Organisation Ethical Criteria for Medical 
Drug Promotion, 1988).  Table 4.9 identifies whether SA regulations adhere to these 
norms. 
 
Both of these pharmacological norms set by the WHO are not listed in SA legislation as a 
requirement for pharmaceutical advertisements directed at the general public.  These 
pharmacological norms are, however, a requirement for pharmaceutical advertisements 
directed at healthcare professionals, as stated by the Marketing Code. 
 
Table 4.9   Compliance to pharmacological norms  
 
 
PHARMACOLOGICAL NORMS 
  
 
DOES SOUTH AFRICA COMPLY? 
 
Major indications 
 
No 
 
Warnings, major contraindications, and precautions 
 
No 
 
Pharmacological factors are of vital importance and, if not the most important, for 
consumers to make an informed decision when wanting to buy medicines seen in 
advertisements.  It can be argued that it is the healthcare professional’s responsibility to 
ensure that customers buying these products from community pharmacies are aware of 
these pharmacological necessities.  However, not all medicines advertised to the general 
public are bought at community pharmacies but are also available at supermarkets and 
corner cafes.  Even if a patient information leaflet is provided with the product, and 
therefore becomes the customers’ responsibility, it is not to say that all these important 
pharmacological necessities will be identified and considered by customers.    
 
Many consumers will buy medicines based on what they have read in advertisements, and 
for this reason alone, it remains an ethical responsibility of the advertiser to identify these 
pharmacological necessities, and ultimately, ensure the safe use of medicines. 
 
 
 
      
 139
4.5.2.3   Selling price 
 
In accordance with this criterion, a pharmaceutical advertisement should, where 
applicable, honestly portray the medicine’s selling price.  This is not stated as 
requirement for pharmaceutical advertisements directed at the general public but is, 
however, stated as guideline in the Marketing Code (Code of Practice, 2004).  Here, the 
Marketing Code states that pharmaceutical advertisements directed at healthcare 
professionals should state a “single exit price”.  
  
It can be concluded that pharmaceutical advertisements directed at the general public in 
SA do not always comply with all the norms and standards set by the WHO.  For 
example, important information such as pharmacological norms, is not a requirement in 
pharmaceutical advertisements directed to the general public in SA.  It should be 
reemphasised that the criteria set by the WHO only serve as a guide for countries to set 
pharmaceutical advertising regulations and ethical guidelines and are not enforceable by 
law.  Even if found that SA does adhere to many of these guidelines, it is not to say that 
this is what is evident in pharmaceutical advertising in print form.  The results obtained in 
this study from the focus group, consumer survey, as well as the decoding process will 
identify to some extent the degree to which these regulations and guidelines are adhered 
to in practice in the pharmaceutical advertisements utilized in this study. 
 
4.5.3   Comparing pharmaceutical advertising regulations of South Africa, Austra- 
            lia, New Zealand and Canada 
 
The focus of the comparison in the section that follows in on how the legislation of each 
of these countries mentioned above define pharmaceutical advertisements, as well as the 
similarities and differences found in the pharmaceutical advertising in print form.  
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4.5.3.1   Definition of pharmaceutical advertisements  
 
It is important to determine how each of these countries defines pharmaceutical 
advertising in order to compare and identify any similarities or differences in 
pharmaceutical advertising regulations in SA.   
 
Figure 4.11 summarises the definition of pharmaceutical advertising provided by 
Australia and New Zealand, whereas Figure 4.12 summarises the definition provided by 
Canada.  Each of these figures also identifies the legislation in which these definitions are 
published in.  
 
 
AUSTRALIA 
AND  
NEW ZEALAND 
   
Therapeutic 
Goods 
Advertising Code 
  Any statement, design, or picture 
directly, or indirectly, intended to 
promote the supply or use of 
goods.  
 
 
Figure 4.11   Definition of pharmaceutical advertising in the legislation of Australia 
and New Zealand  
(Sources:  Advertising Standards Authority, Inc., New Zealand, 2005; Cameron & 
Stoddart, 2006; Loveday & Williams, 2006) 
   
 
  
CANADA 
   
Section 1 of the 
Federal Food and 
Drug Act 
  Any representation by any means 
for the purpose of promoting 
directly or indirectly the sale or 
disposal of any drug or device. 
    
Figure 4.12   Definition of pharmaceutical advertising in the legislation of Canada 
(Source:  Health Canada, 2006) 
 
In essence, the difference between these two definitions is basically in the wording of 
these sentences.  Both of these definitions are broad in defining what specific form of 
advertising may be used to advertise pharmaceutical products.  The Therapeutic Goods 
Advertising Code in Australia refers to advertising as “Any statement, design, or 
picture...intended to promote...”.  This is a vague interpretation and does not provide a 
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clear description of what an advertisement is, only that its intended use is to “promote the 
supply or use of goods”.  This same vagueness of the definition of advertising can be 
seen in Canada’s Section one of the Federal Food and Drug Act which states, “Any 
representation by any means for the purpose of promotion...”.  Again, the word, “any”, 
which appears in both definitions, does not clearly point out what an advertisement 
should entail.   
 
In SA, the Medicines Act defines advertising in a more structured and detailed manner.  
Figure 4.13 provides a reminder of how the Medicines Act defines an advertisement.     
 
 
“Any written, pictorial, visual, or other descriptive matter or verbal statement or 
reference - 
(a)  appearing in any newspaper, magazine, pamphlet, or other publication; (b)  
distributed to members of the public; or (c) brought to the notice of members of the 
public in any manner whatsoever, which is intended to promote the sale of that 
medicine” 
 
 
Figure 4.13   Definition of advertising published in the Medicines Act of South 
Africa 
(Source:  Pharmaceutical Society of South Africa Pharmacy Law Compendium, 
2005: MAE – 6)   
 
This definition is more descriptive than the definitions provided in Australia, New 
Zealand, and Canada.  The Medicines Act determines where pharmaceutical 
advertisements may appear, “...newspaper, magazine, pamphlet, or other publication;...”, 
and at whom it may be directed, “...distributed to members of the public...brought to the 
notice of members of the public...”.  In this regard, the Medicines Act of South Africa 
provides a more detailed and descriptive explanation of what pharmaceutical advertising 
is.   
 
Subsection (c), however, may lead to confusion, “brought to the notice of members of the 
public in any manner whatsoever...”.  The phrase, “in any manner”, may result in a 
generalisation of what manner pharmaceutical products may be advertised.  A rather 
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more specific definition should be provided to ensure that medicines are advertised in an 
ethical manner.  
 
In summary, the definition provided by the Medicines Act of SA can be regarded as more 
structured and explanatory than the definitions provided by the Therapeutic Goods 
Advertising Code and Section one of the Food and Drug Act.   
   
4.5.3.2   Forensic aspects of pharmaceutical advertisements in print form 
 
Various legal aspects, regarding pharmaceutical advertising in each of these three 
countries, were investigated and compared.  Ethical considerations, claims, prescription-
only medicine advertisements directed at the general public, as well as slimming product 
advertisements were focused on.   
 
(a)   Ethical considerations  
 
What is evident in all four countries is that appropriate laws have been established to 
ensure that pharmaceutical advertisements are ethical and legal.  The Food and Drug Act 
of Canada provides a general rule summarising that pharmaceutical products must not be 
advertised in a manner that is false, misleading, deceptive, or likely to create incorrect 
impressions.  Through the application of various laws and ethical guidelines, each of 
these countries adheres to similar principles.   
 
This general rule provided by Canadian law is echoed by the NDP of SA.  The NDP 
states that claims or statements used in pharmaceutical advertisements should be reliable, 
accurate, truthful, informative, balanced, up-to-date, in good taste, not be misleading and 
always be substantiated (Department of Health, 1996: 19).  Similarly, principle two and 
principle three (see Figure 4.6) of the Therapeutic Goods Advertising Code in Australia 
and New Zealand state that pharmaceutical advertisements should be truthful, balanced, 
not be misleading and should also be socially acceptable.  Similar ethical considerations 
were made in the Food and Drug Act of Canada. 
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(b)   Claims  
 
Regulations in these countries focus on various claims allowed in pharmaceutical 
advertisements.  In SA, Australia, and New Zealand specific classes of pharmaceutical 
products are focused on, namely analgesics (pain medication), vitamin supplements, and 
slimming products.  The Therapeutic Goods Advertising Code of Australia and New 
Zealand refers to preparations used to relieve minor aches and pains consisting of more 
than one of the following substances:  codeine, paracetamol, other non-steroidal anti-
inflammatory medicines, or salicylic acid and derivatives such as aspirin.  Print 
advertisements for these analgesic preparations, except those for self-limiting conditions, 
must contain the warning statement, “Use only as directed.  Incorrect use could be 
harmful.  Consult your healthcare professional if symptoms persist.”.  No regulation or 
ethical guideline in SA or Canada stipulates that such a statement should appear in 
advertisements for analgesics.   
 
However, the ASA of SA published Guideline two for medicines which briefly refers to 
words or claims that are permitted in analgesic advertisements.  Claims such as “mild 
pain” and “moderate pain” are permitted in such advertisements but only to claims 
regarding body aches and pains such as toothache, period pain, headache, and those 
symptoms associated with the common cold and flu (ASA, South Africa, 1994: G-6). 
 
Something exclusive to SA legislation, is that the ASA published guidelines to prevent 
OTC medicine advertisements from being misleading.  These guidelines addresses 
exaggerated claims, claims that can lead to unwarranted anxiety among consumers, and 
the use of language that is understood and do contain medical jargon that can confuse 
consumers (ASA, South Africa, 2004).  
 
(c)   Prescription-only medicine advertisements directed at the general public  
 
Of the four countries, New Zealand is the only country where the advertising of 
prescription-only medicines to the general public, the so-called DTC advertisements, is 
allowed.  In Australia, prescription-only medicines and certain non-prescription 
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medicines are prohibited from being advertised to the general public.  SA legislation 
(Regulation 45(2), Subsections (b) and (c)) states that Schedule 2 to Schedule 6 
medicines may only be advertised to the general public for the purpose of providing 
information about the medicine’s name, its price, pack size, and strength (Pharmaceutical 
Society of South Africa Pharmacy Law Compendium, 2005: MRE – 50).  Other 
information regarding these scheduled medicines may only be advertised to healthcare 
professionals.  In Canada, similarly to this regulation, advertisements regarding Schedule 
F medicines may only be advertised to the general public for the purpose of providing 
similar information (Gardner, et al., 2003; Hearn, et al., 2005; Hearn & Prendergast, 
2005).    
        
(d)   Slimming product advertisements  
 
Guidelines are provided in SA, Australia, and New Zealand to regulate slimming 
products.  More emphasis on this topic is placed in SA guidelines than in Australia and 
New Zealand.  Guideline three published by the ASA in SA identifies what are not 
allowed in slimming advertisements, especially with regard to testimonials and 
photographs used, claims regarding fibre supplements, slimming products, muscle toning 
(“centimetre loss”), as well as slimming teas (ASA, 2004: G-11).  
  
In Australia and New Zealand, the Therapeutic Goods Advertising Code stipulates 
similar requirements but in much less detail.  This Code stipulates that claims in such 
advertisements, regarding weight management, clothing size loss, measurement reduction, 
and weight control or maintenance, should be in balance with references to health energy-
controlled diets and physical activity (ASA, New Zealand, 2005; Australian Government, 
2006).               
 
By investigating the legislation of Australia, New Zealand, and Canada and comparing it 
with SA legislation, no major differences were found.  These similarities show that each 
of these countries want to ensure that pharmaceutical advertisements are of the highest 
legal and ethical quality.  
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4.5.4   Problematic areas in South African pharmaceutical advertising law 
 
Three major areas of concern in the regulation of pharmaceutical advertising were 
identified in SA.  Firstly, there is a lack of authorities or regulatory bodies responsible for 
regulating pharmaceutical advertisements.  Secondly, the Regulations regarding the 
advertising of Scheduled medicines to the general public are unclear and could result in 
confusion.  Lastly, regulations regarding the advertising of medicines with a high abuse 
potential are limited.   
 
4.5.4.1   Authorities responsible for the regulation of pharmaceutical advertisements 
 
Although the responsibility of regulating pharmaceutical advertisements hinges on the 
concept of self-regulation, ultimately the responsibility of reviewing any irregularities 
remains the function of the ASA in SA.  The problem is that this Authority is responsible 
for regulating all forms of advertising, not only pharmaceutical advertisements.  The 
MCC, in collaboration with the Government (Department of Health), is, however, 
responsible for determining legal issues such as the requirements scheduled medicine 
advertisements have to adhere to.  Even so, the responsibility of regulating and reviewing 
pharmaceutical advertisements, responding to consumer complaints, resolving these 
complaints, and also ensuring that advertisers take appropriate corrective steps, still 
remains the duty of ASA.   
 
It is doubtful that a single Authority responsible for regulating all forms of advertising 
will be able to ensure that the majority of pharmaceutical advertisements are adhering to 
legal and ethical standards.   
     
4.5.4.2   Regulations regarding the advertising of scheduled medicines 
 
Regulation 45 of the Medicines Act regarding the advertising of medicines can lead to 
many misinterpretations.  This section identifies which scheduled medicines may be 
advertised to the general public (Pharmaceutical Society of South Africa Pharmacy Law 
Compendium, 2005: MRE – 50).  
 146
Regulation 45(2), Subsection (b) discusses the advertising of Schedule 2 to Schedule 6 
medicines.  It therefore clearly states that Schedule 2 to Schedule 6 medicines may not be 
advertised to the general public.  However, Subsection (c) states that the general public 
may be informed of Schedule 2 to Schedule 6 medicines but only with regard to 
providing information about their prices, names, pack sizes, and strengths.  These two 
subsections seem to contradict each other, pending on how the word, “informing” in the 
latter subsection, as well as the word, “advertising”, is interpreted (see page 102 for the 
Medicines Act’s definition of ‘advertisement’).  
  
By looking at Subsection (c) of the definition of advertising, “brought to the notice of 
members of the public in any manner whatsoever, which is intended to promote the sale 
of that medicine”, it seems that Subsection (c) of Regulation 45(2) does indeed provide 
the information listed to members of the public with an intention to promote the sale of 
these scheduled medicines.  Therefore, Subsection (c) can be interpreted as a form of 
advertising, as is stated in the definition, “Any written, pictorial, visual, or other 
descriptive matter or verbal statement or reference...”.  If so, Subsection (c) contradicts 
Subsection (b).   
 
The SAPC is also of the belief that Schedule 2 to Schedule 6 medicines may not be 
advertised to the general public, even if limited to the information underlined in 
Subsection (c).  This is evident from the article, “Pharmacies and Pharmaceutical 
Companies fined in excess of R10,000.00  for contravening advertising regulations”, 
published in the SAPC’s official publication, Pharmaciae (Masango, 2006: 12).  An 
example of a table (see Table 4.2) consisting of a list of oral contraceptives (Schedule 3 
and Schedule 4) was used to illustrate an advertisement that contravenes Regulation 45(2), 
Subsection (b).  Table 4.2 only consists of the names of the oral contraceptives, pack 
sizes, and their prices, information allowed in accordance with Subsection (c) but is still 
regarded by the SAPC as contravening Subsection (b).           
 
In Regulation 45(2), Subsection (c), no mention is made that such advertisements may 
state pharmacological information such as indications or side-effects.  This can be used as 
argument in defence of Subsection (c), where the general public may be informed of a 
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Schedule 2 to Schedule 6 medicine’s name, its price, pack size, and strength, without any 
reference made to any pharmacological information. 
       
Although Regulation 45(2), Subsections (b) and (c), appears to contradict each other, 
similarities to Subsection (c) is evident in Canada and seems to be normal practice.  A 
regulation, similar to Subsection (c), can be found in Canadian Regulations regarding 
pharmaceutical advertising to the general public.  It refers to the fact that only Schedule F 
medicines may be advertised to the general public in Canada, and similarly to Subsection 
(c), only the medicine’s name, price, and quantity thereof, may appear in these 
advertisements.  There is also no reference made to any pharmacological information 
(Gardner, et al., 2003; Hearn, et al., 2005; Hearn & Prendergast, 2005).   
 
The reason why Schedule F medicines are allowed to be advertised to the general public 
in Canada is to allow for competition between pharmacies.  Gardner, Mintzes, and Ostry 
(2003), however, stated that many started to interpret this Regulation as a means to 
publish any DTC pharmaceutical advertisement.  According to Canadian Regulations, the 
types of DTC advertisements seen on a daily basis are product claim advertisements, 
reminder advertisements, and help-seeking advertisements.  All these forms of DTC 
advertisements are prohibited by the Canadian Food and Drug Act but, as a result of this 
Regulation, now appear in print media throughout Canada and are too difficult to regulate 
(Gardner, et al., 2003).  
  
By allowing Schedule 2 to Schedule 6 medicines to be advertised to the general public in 
SA, even with the limitations stated in Regulation 45(2), Subsection (c), more scheduled 
medicine advertisements will be published without adhering to these limitations.  In the 
end it will be too difficult for the ASA to monitor, review and act upon such 
advertisements. 
 
From an ethical point of view, pharmaceutical advertisements of medicines falling within 
this schedule range, do not really have a positive effect on primary healthcare, other than 
its positive effect in the selling of these products.  In the USA and New Zealand where 
DTC advertising of most pharmaceutical products are allowed, researchers found many 
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disadvantages of such practices.  The most important disadvantage found was that 
prescription medicines are portrayed as normal day-to-day consumer goods and not as 
therapeutic goods and therefore can have harmful side-effects if not properly used.   
 
It is therefore important to keep these ethical considerations in mind upon reviewing 
Regulation 45(2), Subsection (c), in future, especially when potentially harmful 
medicines are advertised. The primary aim of such Regulations should be to ensure safety 
in SA’s primary health system.     
 
4.5.4.3   Advertising of medicines with a high abuse potential     
 
In 2007, a handout was sent with the Pharmaciae (Masango, 2007), where pharmacists 
were alerted about the increase of the abuse of codeine-containing analgesics in SA.  The 
advertising of medicines with a high abuse potential directly to the general public, is 
regarded as an unethical practice, as such advertisements do not send a clear message that 
these agents can cause addiction if used incorrectly.  This is especially true for the 
advertising of large quantities of codeine-containing analgesics, as depicted by the 
billboard advertisement (see Figure 4.1).  
 
In the Medicines Act, there is no specific regulation regarding the advertising of medicine 
with a high abuse potential.  The only mention made about codeine-containing analgesics, 
as is also stated in Guideline 2 of the Code of Advertising Practice and Procedural Guide, 
deals with claims allowed in the advertising thereof.  Here, there are referred to the 
phrases, “mild pain” and “moderate pain”, that may only be used in analgesic medicine 
advertisements when referring to pains such as headaches and period pain (ASA, South 
Africa, 1994: G-6).   
 
The Therapeutic Goods Code in Australia and New Zealand, however, places more 
emphasis on codeine-containing analgesics than in the SA regulations.  This Code clearly 
states that no claim may be made that the consumption of analgesics are safe.  
Furthermore, no claim may be made that such agents will sedate or relief tension.  The 
claim, ‘relief tension’, is often seen in analgesic advertisements in SA.  Another 
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requirement mentioned in the Therapeutic Goods Code is that a warning statement must 
appear on advertisements for analgesics that inform the general public that this medicine 
must be used as directed, that it can be dangerous to use this medicine incorrectly, and 
also that consultation with healthcare professionals are of great importance if any 
symptoms persist (Loveday & Williams, 2006). 
 
It is evident that Australia and New Zealand realised the danger and abuse potential of 
analgesics such as those that contain codeine.  SA should follow this precedent set by 
Australia and New Zealand to curb the dangers of analgesic abuse.   
 
4.6   CONCLUSION 
 
From Chapter four and the investigation of pharmaceutical advertisements in print form 
directed at the general public, it can be concluded that SA legislation does aim to ensure 
that the correct legislation is in place to ensure that these advertisements adhere to the 
highest ethical and legal standards.  The empirical study, however, will determine to what 
extent legislation is applied to pharmaceutical advertisements in practice.      
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CHAPTER 5 
 
METHODOLOGY 
 
5.1   INTRODUCTION  
 
The literature review preceding this chapter formed the basis for setting the aim and 
objectives of this study.  The primary aim of this study is to identify consumers’ 
perceptions of pharmaceutical advertisements.   
 
This chapter will outline how the study was carried out. Included in this outline, the 
research method utilised, participant selection processes, and data collection and analysis 
will be discussed.  Reference will also be made to ethical considerations adhered to 
during the study.  The aim of this study was achieved by a predominantly qualitative 
approach combined with quantitative techniques.   
 
The empirical study consisted of the following main activities: 
 
• Identifying and analysing consumers’ perceptions of pharmaceutical advertisements.   
• Decoding pharmaceutical advertisements.    
 
5.2   EMPIRICAL STUDY 
 
      5.2.1  Identifying and analysing consumers’ perceptions of pharmaceutical 
advertisements  
 
Determining how each consumer will perceive an advertisement of any sort will be an 
impossible feat.  However, it is possible to gain insight into how consumers in general 
interpret advertisements.  For this reason a focus group was conducted to determine how 
a sample of consumers within the NMM interpret and perceive pharmaceutical 
advertisements in print form.  Important themes highlighted by the focus group were then 
incorporated into a consumer questionnaire to measure this on a larger scale within the 
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NMM.  Results obtained were used to support the decoding of pharmaceutical 
advertisements as well as to determine whether these advertisements can be 
misinterpreted by consumers.   
   
5.2.1.1   Focus group   
 
Merton and colleagues were the first to coin the term ‘focus group’ in 1956 (Lewis, 1995).  
They stated that a focus group is an activity where the interviewer or facilitator asks the 
participants specific questions about a topic that has been researched beforehand (Lewis, 
1995).  Green and Thorogood (2005: 108) were more descriptive and stated that it is a 
small group of between six to 12 people brought together with the aim of discussing a 
specific topic under the direction of a facilitator.  The main reason for choosing this 
qualitative technique, as identified by Flick (1999: 122), is that focus groups are used 
especially in marketing and media research.  Table 5.1 identifies the main advantages and 
disadvantages of a focus group.  
 
Table 5.1   Main advantages and disadvantages of a focus group 
 
 
ADVANTAGES 
 
DISADVANTAGES 
 
• Has a high face validity 
• Provides data more quickly and at lower cost 
than individual interviews 
• Allows for direct interaction with respondents  
 
• Requires a trained facilitator who has 
knowledge about group dynamics  
• Are less able to control the type of 
information produced 
• Small numbers and convenience sampling 
limits ability to generalise to larger 
populations 
 
   
(Sources:  Barret, 2007; Marczak & Sewel, 1994)   
 
Krueger identified three phases for conducting focus groups, namely:  conceptualisation, 
interview (group discussion), and analysing and reporting (Marczak & Sewel, 1994).  
Figure 5.1 identifies the flow of these three phases as well as what each phase consists of.   
 
 
 152
 
Phase 1:  Conceptualisation 
  
• Purpose of focus group 
• Whom to study 
• Planning focus group 
                                                                   
 
 
Phase 2:  Group discussion 
 
• Participant selection 
• Development of questions  
• Identifying skills required by 
facilitator 
    
                                                                        
 
Phase 3:  Analysing and reporting 
 
• Analysis of discussion 
• Reporting of data 
 
 
Figure 5.1   Three phases used to conduct a focus group 
(Adapted from:  Marczak & Sewel, 1994)   
 
(i)   Phase 1:  Conceptualisation 
 
• Purpose of focus group 
 
The purpose of conducting a focus group was to identify how a sample of consumers 
within the NMM interpret and perceive pharmaceutical advertisements.  The focus group 
allowed for the identification of specific themes that were then incorporated into a 
consumer questionnaire to determine the interpretations and perceptions of a larger 
sample of consumers within the NMM.  Information obtained from these two activities 
was used to support the results obtained from decoding pharmaceutical advertisements.  
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• Whom to study 
 
Consumers are defined by the Concise Oxford English Dictionary (2006: 307) as people 
who buy goods or services for personal use.  It can be assumed that when people want to 
buy goods or use services, they are usually first exposed to these, by means of, for 
example, advertisements.  Consumers can therefore also be seen as people who read 
advertisements.  It was decided to choose a diverse group of consumers from different 
socio-economic backgrounds representing the NMM to participate in the focus group.   
 
• Planning focus group    
 
A detailed plan was developed to outline the procedures followed in organising the focus 
group.  This included a time line which outlined all the activities that needed to be carried 
out as well as the proposed time and date to conduct the focus group.  Specific 
procedures listed in this plan included determining the size of the focus group, booking 
an appropriate venue, as well as a proposed budget to cover the expenses of the focus 
group.  The plan was peer reviewed to ensure its effectiveness.   
 
(ii)   Group discussion    
 
• Participant selection 
 
Participants were selected by means of a convenience sample.  Carl F Auerbach and 
Louise B Silverstein (2003: 18) refer to convenience sampling as “recruiting whomever 
you have access to”.   Eight participants from the NMM were selected to participate in 
the focus group.  However, two participants withdrew their participation, leaving a 
minimum acceptable sample of six participants.  Table 5.2 identifies the demographics of 
the six participants. 
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Table 5.2   Demographics of the six focus group participants 
 
 
PARTICIPANT 
 
 
AGE 
 (in years) 
 
GENDER 
 
OCCUPATION 
 
1 
 
20 
 
F 
 
Student 
 
2 
 
24 
 
M 
 
Accountant 
 
3 
 
24 
 
F 
 
Teacher 
 
4 
 
25 
 
M 
 
Chemical engineer 
 
5 
 
26 
 
M 
 
Leather technologist 
 
6 
 
33 
 
F 
 
Medical representative 
      
As most of the participants were at work during the day, a specific time at night, suitable 
to all, was selected.  Personalised invitations, including a preamble (see Appendix A) 
were sent to each participant a week before the date of the focus group.  Each invitation 
contained all the essential information (for example, the starting time, date, and location).  
An overview of the topic was given to each participant.  Two days after delivering the 
invitations, each participant was contacted (with their permission) to ensure participation.  
Reminders were sent the night before participation.    
 
• Development of questions  
 
A focus group protocol (see Appendix B) was developed to provide an outline to be 
followed during the discussion.  The protocol included an introduction, three group tasks, 
and a conclusion.  Group task one consisted of an open-ended question about how 
participants view any form of advertising.  In group task two, six prompts were used to 
discuss various topics of pharmaceutical advertising.   
 
Group task three consisted of an activity where participants were provided with a few 
minutes to view the following three pharmaceutical advertisements in print form: 
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? Phytocor® and Phytocor® Plus – a complementary and alternative medicine (a natural 
dietary supplement) for people suffering with high cholesterol (see Appendix C);   
? Panado® MedSip – a Schedule 0 medicinal drink for colds and flu (see Appendix D); 
and  
? an erectile dysfunction awareness advertisement for a prescription medicine (see 
Appendix E).   
 
The reason for selecting these three advertisements was that a general representation of 
pharmaceutical advertisements in SA was required.  For this reason advertisements for a 
complementary and alternative medicine (Phytocor® and Phytocor® Plus), a Schedule 0 
medicine (Panado® Medsip), and an awareness advertisement for a prescription medicine 
were selected.   
 
Participants were asked to express their feelings towards each of these advertisements. 
The protocol also provided the time allowed for each group task. 
 
• Skills required by facilitator 
 
The focus group was led by a facilitator who played a key role in its success.  Facilitators 
are concerned with establishing a relaxed atmosphere, enabling participants to participate, 
and also to listen actively (Barnet, 2007; Marczak & Sewel, 1994).  They should have 
characteristics similar to participants and also be skilled in group discussions.  Further 
skills required to facilitate a focus group include being able to be non-judgemental as 
well as having the ability to encourage others to speak (Green & Thorogood, 2005: 126; 
Marczak & Sewel, 1994).   
 
A facilitator with no expertise in pharmaco-legal activities was selected.  This prevented 
participants from being inhibited in discussing their views and therefore ensured a non-
manipulated outcome (Green & Thorogood, 2005: 126).    A female Master’s degree 
student in Psychology was selected to act as facilitator as such students are equipped with 
the necessary skills to lead a successful focus group. 
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The facilitator was provided with the necessary information about the study, verbally and 
in written form.  A discussion regarding the research topic and the focus group protocol 
(see Appendix B) was held with the facilitator a week before the focus group.  This 
allowed the facilitator to have sufficient time to familiarise herself with the format of the 
focus group as well as identifying and discussing any problems that could exist in the 
protocol with the researcher before commencing with the focus group.  
      
(iii)   Analysing and reporting 
 
• Analysis of discussion 
 
The researcher acted as assistant during the focus group.  It was the duty of the assistant 
to take notes, handle the recording equipment to ensure reliable data, and also provide 
refreshments to the participants.  Analysis of the discussion started with group task one 
where the assistant took the necessary notes during the discussion.  Notes taken focused 
on information such as their body language, a description of their enthusiasm, and the 
overall mood during the focus group (Lewis, 1995; Marczak & Sewel, 1994; Strauss & 
Corbin, 1990: 30).  Immediately after the focus group the facilitator and assistant shared 
observations, discussed participants’ responses to the group tasks and the assistant’s notes 
taken during the focus group.   
 
• Reporting of data 
 
Within 24 hours after completion of the focus group, the researcher listened to the audio 
recording to become familiar with the data.  The data were transcribed verbatim and 
printed.  The audio recording was again listened to while following the transcript to 
ensure accuracy as well as to get a feeling of what was said.   
 
Thematic analysis was conducted by using a method mirroring Tesch’s seven step 
technique of descriptive analysis.  This was used to ensure that the process of thematic 
analysis occurred in a systemic and comprehensive manner (Flick, 1999: 192).  The 
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method was applied to each of the group tasks or to each section within a group task that 
was conducted during the discussion.   
 
Thematic analysis applied to this study consisted of two main steps, initial coding and 
focused coding, which were developed by Bogdan and Biklin to identify coding 
categories (University of Texas, 2007).  With initial coding, each response or sentence 
thereof appearing on the transcript was read. The question, ‘What is it about?’, was then 
asked.  Themes were identified and written in the right-hand margin of each transcribed 
page (University of Texas, 2007). 
 
Following initial coding, focused coding was conducted.  With this step, all the themes 
emerging from each question or task were pooled, and those with similar concepts, were 
grouped together to form larger categories.  Thematic headings that describe these similar 
concepts were selected for each of these larger categories.  For those themes that could 
not be grouped into a larger category, in other words, those themes that stood alone, no 
thematic heading was given (University of Texas, 2007).     
 
These steps were applied to each group task or to each section thereof.  Each thematic 
heading, consisting of themes with similar concepts, was discussed by means of 
descriptive analysis.  Descriptive statements were used to discuss the findings.  These 
were obtained by quoting excerpts from the raw data (Marczak & Sewel, 1994).    
 
5.2.1.2   Establishing rigour in thematic analysis 
 
Rigour is described as “strictness”, “discipline”, or “severity” (Oxford Advanced 
Learners Dictionary, 1989: 1091; Concise Oxford English Dictionary, 2006: 1239).  
Therefore, there are general principles to which a qualitative study needs to adhere to in 
order to ensure strictness or discipline.  Judith Green and Nicki Thorogood (2005: 191) 
refer to these general principles as “good practices guidelines” that add credibility and 
also increase faith in the study’s reliability and validity.  The criteria identified by Green 
and Thorogood reflect Lincoln and Guba’s criteria set in 1985 to assess qualitative 
research (Flick, 1999: 120; Green & Thorogood, 2005: 191).  Lincoln and Guba 
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propagated the following criteria:  trustworthiness, credibility, dependability, 
transferability, and confirmability (Flick, 1999: 120).   
 
Green and Thorogood’s criteria were adhered to in order to ensure rigour and included 
the following:   
 
(i)   Transparency  
 
Transparency refers to the explicitness of the methods employed to analyse the data 
obtained from the focus group (Green & Thorogood: 2005: 192).  Lincoln and Guba 
referred to this as dependability in which an actual audit trail is outlined to ensure 
procedural dependability (Flick, 1999: 232).   
 
Transparency was ensured by providing a complete reference in this chapter to: 
 
• participant selection; 
• collection and recording of raw data; 
• protocol (see Appendix B) followed during discussion; and 
• steps followed in conducting thematic analysis. 
 
(ii)   Maximising validity 
 
Kirk and Miller refer to validity as a question of whether the researcher sees what he or 
she thinks he or she sees (Flick, 1999: 224).  According to Green and Thorogood (2005: 
195), validity is the “truth” of the procedure followed.   
 
Validity was maximised by the conducting the following activities:   
 
• A focus group protocol was followed by the facilitator.  This has been added as an 
appendix (see Appendix B) to allow the reader to judge the interpretations made. 
• A validity check was done to ensure that the researcher’s account of the focus group 
was similar to that of the participants.  Here, a participant was randomly selected and 
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provided with the researcher’s focus group interpretation and asked whether this was 
a true reflection of the discussion.   
 
(iii)   Maximising reliability  
 
Reliability relates to the likelihood that a similar piece of research will elicit similar kinds 
of themes.  This criterion improved the credibility of interpretation and also ensured that 
there was an identifiable rationale for the themes identified (Green & Thorogood; 2005: 
194).   
 
Reliability during the process of thematic analysis was maximised by: 
 
• Applying good practices by following accurate transcribing procedures. This was 
achieved by providing the facilitator with a copy of the transcripts to comment on its 
accuracy.   
• The thematic analysis procedure followed was discussed with colleagues and with the 
supervisors of the study. 
 
(iv)   Comparison 
 
Green and Thorogood (2005: 194) stated that qualitative research is driven by 
comparison.  By comparing cases within the same set of data, regularities within the data 
can be identified.  This allows the researcher to explore the contextual meaning of 
accounts.  Comparison also enables the development of theoretical analysis. This 
criterion was achieved by comparing the findings with data obtained from research done, 
not only from the field of pharmaceutical advertising but also from advertising in general.  
 
(v)   Reflexivity  
 
Reflexivity, as defined by Green and Thorogood (2005: 194), is a criterion that 
recognises that the researcher is part of the process of producing the data and providing 
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its meaning.  The aim of this criterion is to remove any potential biases that a researcher 
may bring to the process of data collection and analysis.   
 
To ensure reflexive awareness the following activities were conducted:   
 
• Methodological openness was ensured by giving an explicit account of all the steps 
taken in the data production and analysis thereof.   
• Differentiating between the role of the researcher and the facilitator in the data 
production process.  
 
5.2.2   Consumer survey 
 
To determine how consumers within the NMM interpret, perceive or even misinterpret 
pharmaceutical advertisements, a survey in the form of consumer questionnaires were 
conducted in selected community pharmacies.  The reasons for choosing a consumer 
survey as an information gathering tool was that this method is less invasive and 
therefore reduces bias.  It is also a less time consuming method with regards to the 
researcher as well as the participants (Green & Thorogood, 2005: 36; Oppenheim, 1993: 
114).   
 
5.2.2.1   Sampling process  
 
For the purpose of this study, 10 community pharmacies were selected within the NMM 
(Port Elizabeth, Despatch, and Uitenhage).  According to the latest list of pharmacies 
provided by the SAPC in 2006, 2184 registered community pharmacies are found in SA. 
Of the 2184 community pharmacies, 192 are situated in the Eastern Cape Province, with 
92 of these situated in NMM.   
 
A random sampling technique was used to select 10 community pharmacies from the list 
of 92 within the NMM.  In consultation with a statistician, a sample of 100 participants 
was selected for the consumer survey.  Therefore, 10 customers in each of the selected 
community pharmacies were asked to participate on a voluntary basis.  
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5.2.2.2   Consumer questionnaire 
 
The consumer questionnaire was (see Appendix F) employed to measure consumers’ 
interpretation, perceptions, and possible misinterpretation of pharmaceutical 
advertisements and consisted of four sections.  Section one consisted of basic 
demographic questions about the participant.  Questions were asked about the 
participant’s age, gender, and occupation.  Two additional questions established whether 
the participant belonged to a medical aid, and whether he or she suffered from any 
chronic conditions such as diabetes, hypertension, or asthma.  A demographic 
representation provided the study with a profile of the type of consumer that participated 
in the consumer survey.     
 
To differentiate between the different occupations of the participants in the results 
chapter, 10 major occupational groups were used to classify the participants’ occupations.  
Nine of these groups were based on a simplistic version used by The National Centre for 
Social Research in Britain to classify the major groups of occupations (National Centre 
for Social Research, 2004).  A tenth group, pensioners and unemployed, was added as a 
result of the economic instability in the NMM.  Table 5.3 identifies these groups and 
provides a broad description of each.  These groups were selected to determine if the 
sample of consumers participating in the consumer survey is representative of the NMM 
in terms of their occupations.     
 
Section two consisted of a range of mass media forms such as television, radio, 
newspapers, magazines, and the Internet.  Two additional forms of print media were 
added to these mass media forms, namely pharmacy newsletters and handouts or flyers.   
This section aimed at determining consumers’ preferences regarding the type of media 
they are exposed to.   A time-scale (daily, three to six times per week, one to two times 
per week, once a month, or never) was used to identify the frequency of exposure to such 
media.  The aim of this section was to identify the extent to which consumers are exposed 
to print media, and thus exposed to pharmaceutical advertisements.   
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Table 5.3   Classification of the ten major occupational groups of participants 
 
 
MAJOR OCCUPATION 
GROUPS 
 
 
DESCRIPTION 
  
Managers and senior officials 
 
 
This occupational group consists of middle management such as 
general managers, senior managers, and marketing managers. 
  
 
Professional occupations 
 
 
These are specialists in the fields of science, building, engineering, 
health sciences, and social sciences and include, for example, 
lecturers, teachers, doctors, lawyers, and accountants. 
   
Associate professionals and 
technical occupations 
 
 
These are employees with theoretic and practical knowledge and 
usually include technicians in the fields of healthcare, sciences, 
engineering, building, entertainment, and transport. 
     
Administrative and secretarial 
occupations 
 
 
This occupational group consists of clerical workers, for example, 
receptionists, storekeepers, mailing clerks, and secretaries.   
 
 
Skilled trade occupations 
 
 
This group consists of employees who have trade-specific 
knowledge in fields such as vehicle production, electrical and 
electronics, mechanics, and food preparation.   
  
Caring, leisure, and other personal 
service occupations 
 
 
These are employees involved in child caring, auxiliary nursing, 
travelling, hairdressing, and domestic activities.     
  
Sales and service occupations 
 
 
This occupational group consists of employees that are engaged in 
buying, broking, and selling.   
  
Process, plant, and machine 
operations and drivers 
 
 
This group represents employees that operate vehicles and other 
large equipment to transport goods, materials, or passengers.   
 
 
 
Routine unskilled occupations 
 
 
This group consists of workers that perform routine tasks 
manually or by using hand tools and appliances, for example, 
cleaners, construction workers, mail sorters, waters, traffic 
wardens, security guards.   
   
Pensioners and unemployed 
 
 
This group consists of people who are retired or those who have 
no monetary income.   
 
    
(Source:  National Centre for Social Research, 2004)   
 
Section three and section four consisted of specific statements regarding the themes that 
were pertinent during the focus group.  Statements used in section three dealt with topics 
such as the information provided in pharmaceutical advertisements and the degree of 
understanding thereof, whether such advertisements are false or misleading, and the use 
of colour and pictures.  In section four, two of the three pharmaceutical advertisements 
used in the focus group were selected, namely the Panado® MedSip (see Appendix D) 
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and the erectile dysfunction awareness advertisement (see Advertisement E).  Four 
specific statements accompanied each of these advertisements.  These statements were 
identified from the focus group.  A Likert scale (agree, disagree, and undecided) was 
used in section three and section four to measure participants’ responses to the statements 
used.  
 
5.2.2.3   Survey process 
 
The consumer survey was conducted in the selected community pharmacies by the 
researcher and a field worker.  The field worker was briefed on the research topic and 
how to conduct the consumer survey.  A pilot study was first conducted to ensure 
viability of the questionnaire.  Ten percent of the participant sample (10 participants) was 
used to conduct the pilot study.   
 
In order to reduce interference with business activities, customers who were waiting for 
their prescriptions to be filled, were asked to participate on a voluntary basis.  The 
researcher or field worker provided an overview of the study to each participant after 
which each statement or question was dictated and the necessary responses captured.  In 
section four, participants were exposed to the selected pharmaceutical advertisements and 
provided with a few minutes to familiarise themselves with these advertisements.  
Statements to these advertisements were dictated to each participant and their responses 
were captured.  After completion of each questionnaire, the participant was thanked for 
their participation.   
 
Data obtained from the consumer survey was captured and statistically analysed by 
means of descriptive and inferential statistics.  Microsoft Excel® was used for this 
purpose.   
 
5.2.3   Decoding pharmaceutical advertisements  
 
Pharmaceutical advertising can be seen as a method in which the pharmaceutical industry 
communicates with consumers.  It can thus be assumed that the basic communication 
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model (sender-message-receiver) also applies to pharmaceutical advertisements.  Such 
advertisements will therefore also be encoded (usually by advertising agencies) in a 
similar fashion as verbal messages, and then sent via a medium (such as print media) to 
consumers (for example, pharmacists, doctors, or patients).  Consumers in turn, decode 
advertisements to give meaning.  The difficulty lies in investigating the decoding process 
of consumers, that is, the identification of the consumers’ understanding of and 
perception towards the advertisements.  
  
It is an impossible feat to determine how each consumer will interpret a pharmaceutical 
advertisement.  However, through the process of decoding pharmaceutical advertisements, 
each component, lexical and visual, was interpreted to provide meaning to these 
components.  Simply put, decoding is the process of “finding the meaning” of something 
(Oxford Advanced Learner’s Dictionary, 1989: 310; Concise Oxford English Dictionary, 
2006: 372). 
 
The meaning of the components found in pharmaceutical advertisements was determined 
by employing the most appropriate pre-selected criteria.  These criteria consisted of three 
sections, namely semiotic criteria, colour interpretation, and legal and ethical criteria.  
Each of the three pharmaceutical advertisements discussed in the focus group was 
subjected to the decoding process.   
 
Semiotic criteria used to decode these three pharmaceutical advertisements were selected 
from the semiotic aspects outlined in Chapter three.  Firstly, the most fundamental part of 
an advertisement, the sign, was identified in each of these advertisements.  This was 
followed by the identification of the following basic semiotic concepts that supported a 
sign: 
 
• signifier and signified; 
• connotation and denotation; and  
• index, icon, and symbols.   
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The referent system was also identified in each of the pharmaceutical advertisements.  
Where applicable, other additional semiotics concepts (for example, desire, mirror-phase, 
and appellation) present in the decoding advertisements model (see Figure 3.8, Chapter 
three), were also identified.   
 
To support the results obtained from the semiotics criteria, the meanings behind each of 
the colours incorporated in these pharmaceutical advertisements were identified.  This 
was achieved by using the psychological and symbolic interpretations of these colours 
obtained from Chapter three.   
 
Legal and ethical criteria pertinent to pharmaceutical print advertisements in SA were 
used as criteria to identify if these pharmaceutical advertisements adhere to such 
standards.  These ethical and legal criteria were obtained from the Section 4.3 covering 
the Forensic aspects of pharmaceutical advertising in South Africa in Chapter four.    
 
The criteria used to decode the three pharmaceutical advertisements assisted the 
researcher in determining areas where consumers can misinterpret these advertisements, 
or even where they may be misled.   
 
5.3   ETHICAL MEASURES 
 
Ethical measures were taken in conducting the focus group and consumer survey.  This 
study was approved by the Faculty of Health Sciences’ Research, Technology and 
Innovation Committee (FRTI) of the Nelson Mandela Metropolitan University (NMMU).  
 
5.3.1   Ethical measures followed in focus group 
 
Firstly, it was important to inform each of the six participants about the study and the 
focus group.  This was done verbally, where a brief overview of the research topic was 
given, and also in writing by means of a preamble (Appendix A).  The preamble provided 
each participant with knowledge of the focus group. 
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Informed consent was obtained from each of the six participants before participation was 
allowed.  This was obtained by means of providing participants with consent forms (see 
Appendix G).  The consent form informed each participant of various aspects covered in 
the focus group.  The participant was also informed that participation is voluntary.  
Informed consent was only obtained once the participant understood and signed the 
consent form.  
 
Each participant was informed, in the consent form as well as before the start of the focus 
group, that a voice recorder will be used to record the discussion.  Participants were also 
assured of confidentiality and anonymity during and after the focus group.  No names 
were mentioned during the discussion and the transcribing process.  The voice recorded 
data was destroyed after completion of the study.   
 
During the discussion participants were allowed to express their views.   Their reviews 
were respected by the facilitator and the researcher.  Participants were also informed that 
they could contact the NMMU Psychology Clinic should they require any counselling 
after completion of the focus group.   
 
Following the selection of each of the three pharmaceutical advertisements (see 
Appendices C, D, and E) used for Task three of the focus group and Section four of the 
consumer survey, permission to use these advertisements was asked from each of the 
pharmaceutical companies.  Each pharmaceutical company was asked by means of 
electronic-mail (e-mail) for their permission.  All three pharmaceutical companies 
responded via e-mail and granted permission.     
  
5.3.2   Ethical measures followed in the consumer survey    
 
As the consumer survey was conducted in 10 of the community pharmacies within the 
NMM, the owner and/or responsible pharmacist of each of these pharmacies was 
provided with a preamble (Appendix H) and a consent form (Appendix I).  The preamble 
outlined the study whereas informed consent was obtained by means of signing the 
consent form.  The consent form also clearly stated that participation was voluntary.   
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Participants were not provided with a preamble but were verbally informed about the 
study.  Anonymity was ensured at all times as participants’ names were not recorded and 
no community pharmacy’s name was published.   
 
Participants were also verbally informed that participation is voluntary.  No incentives 
were provided to participants.  Only participants waiting for their prescriptions to be 
filled were asked to participate in the study.  This ensured that business activities were 
not disrupted.  
 
The findings of each of the components in the empirical study are presented in Chapter 
six.  
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CHAPTER 6 
RESULTS 
 
6.1   INTRODUCTION 
 
In this chapter the results regarding the empirical part of the study will be investigated.  
This will include the investigation of the results obtained from the focus group, the 
consumer survey, and the decoding of pharmaceutical advertisements.  The results 
obtained from the focus group and the consumer survey will be used to support the 
decoding of pharmaceutical advertisements.     
 
6.2   FOCUS GROUP 
 
The aim of this focus group was to identify the perceptions of consumers towards 
pharmaceutical advertisements.  Thematic analysis was conducted in each group task or 
topic question (see Appendix B for Focus Group Protocol) to identify themes.  Themes 
with similar concepts were grouped together and placed under a thematic heading.  Those 
themes that did not share the same concept were placed without thematic headings.  
Themes were discussed by quoting excerpts from the discussion.  The excerpts will be 
presented in italics, and where applicable, translated into English. 
 
6.2.1 Summary of focus group  
 
A relaxed atmosphere was created by the intimate location and the willingness of each 
member to participate in each group task.  It was evident that the ice breaker used by the 
facilitator helped the participants to acquaint themselves with the group.  The topic was 
well accepted as participation in each group task was excellent.  It was thus evident that 
the group tasks were well selected.  Body language of participants was in general seen as 
positive as they were open to expressing their perceptions towards pharmaceutical 
advertisements.  Although participants mostly shared their opinions about pharmaceutical 
advertisements in print form, some also discussed other media used to advertise 
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medicinal products such as the Internet and television.  The researcher and facilitator 
concluded that this focus group was a success.  
 
6.2.2 Group tasks    
 
6.2.2.1   Group task one  
 
Participants were asked an introductory question about their opinions on any form of 
advertisement in print form (see Appendix B for Focus Group Protocol).  No specific 
themes emerged from this discussion as most participants only provided short answers.  
Female one responded first and stated that she always looked at the cost of the products 
advertised.  She said:  “How much it costs”.  Male one thought that an advertisement 
must be capable of attracting consumers’ attention.  He said:  “...it must be striking.  You 
must see it immediately...”.  Male three was of the opinion that advertisements provide 
consumers with instructions.  He said:  “It tells you what to do”.  The final opinion, 
similar to that of male three, was provided by female two who thought that 
advertisements should be of a useful nature.  She said:  “It has to be useful”.   
 
6.2.2.2   Group task two 
 
In group task two (see Appendix B for Focus Group Protocol) prompts were used to 
discuss the six topics regarding pharmaceutical advertisements:  emotional advertising, 
misleading advertisements, comprehension of pharmaceutical advertisements, aesthetics, 
buying pharmaceutical products or services advertised or asking healthcare professionals 
about these, and the advertising of prescription medicines.   
 
Table 6.1 lists the themes and its thematic headings, where applicable, that emerged from 
the discussion of these topics.  
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Table 6.1   Themes and thematic headings identified in each topic    
 
  THEMATIC HEADINGS 
 
THEMES 
 
Attention 
   
EMOTIONAL ADVERTISING 
   
Emotional impact  
Desperation and death 
 
MISLEADING 
ADVERTISEMENTS 
  Irrelevant and false issues 
 
Degree of understanding 
 
COMPREHENSION OF 
PHARMACEUTICAL 
ADVERTISEMENTS  
  
Understanding pharmaceutical 
advertisements  Information provided 
 
Attraction 
   
AESTHETICS 
   
Appeal  
Comprehensibility 
BUYING PHARMACEUTICAL 
PRODUCTS OR SERVICES 
ADVERTISED 
   
Buying experiences 
 
Quantities and addiction 
 
 
ADVERTISING 
PRESCRIPTION MEDICINES 
 
Prescription medicine 
advertised to the general 
public 
 
Professionals and the 
pharmaceutical industry 
 
 
  
(a)   EMOTIONAL ADVERTISING 
 
Originally this topic consisted only of one question but the facilitator felt it best to ask a 
two-part question.  Firstly, participants were asked if pharmaceutical advertisements 
affected them on an emotional level, followed by the question about whether they believe 
such advertisements have an impact on the emotions of people suffering from chronic 
diseases.  All participants agreed that these advertisements do make an impact on the 
emotions of consumers, especially those suffering from chronic diseases.  A theme 
emerged from each of these questions and was placed under the heading, emotional 
impact. 
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Emotional Impact 
 
i.   Attention 
 
Participants believed that the aim of pharmaceutical advertisements is to attract the 
consumer’s attention.  One way in which a consumer’s attention can be attracted is by 
means of humour.  According to female three, anything that makes her laugh has an 
effect on her emotions.  Although she used a television advertisement as an example, the 
same can be applied to print advertisements.  She said:  “There’s this advertisement on 
television going:  ‘Eish Joe!’...I laugh every time...something that makes me laugh must 
then touch a sense of mine...that’s a feeling too”.   
 
An interesting opinion was raised about how these advertisements can be emotionally 
appealing to consumers who have the desire to look similar to models appearing in them.  
Male two used advertisements of body builders as an example and said:  “...I am much 
into men’s magazines...If you want to look like that person on the cover, or in the ad...it 
can influence you”.  Male one added:  “Aah, it can show you what you can get out of it.  
If you have mass builders and those things advertised”.  He furthermore stated that the 
models used in the advertisements create this desire which will attract consumers’ 
attention.  He said:  ‘...and you have this nice body and nice woman there...something like 
that has to stick.  Like:  ‘I want to look like that’”.  
 
ii.   Desperation and death 
 
This theme emerged from the second part of the question regarding the emotional impact 
pharmaceutical advertisements can have on people with chronic diseases.  Male one felt 
that such advertisements will easily create attention among people that have chronic 
diseases and those that are dying.  He said:  “It will strike his attention, you know”.   
 
Desperation was also used as an opinion.  Some participants believed that such people 
will be more emotionally affected by pharmaceutical advertisements.  Female two felt 
that vulnerable people, such as the terminally ill, will do anything to live longer.  She 
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stated:  “Kyk as jy wil gesond raak sal jy enige iets, enige iets betaal...Jy glo enige iets” 
(“Look, if you want to be healthy again, you will pay any, any thing...You believe 
anything”).  Male one also believed that desperation plays a major role when the 
terminally ill are exposed to these advertisements.  He said:  “...They strike you as much 
as they say.  The real problem is, I mean, he is gonna die pretty soon.  So, he will do 
anything to live a bit longer”.  Female two felt that the thoughts of death can evoke many 
negative emotions.  She had the following opinion of the terminally ill:  “...that will 
frighten anyone...Fear of death and losing everything will make you do anything”.  Male 
one felt that people who are dying will respond to advertisements which advertise 
products that may give them hope of living longer.  He said:  “...if there’s something that 
will, that, that will help me to live longer immediately...go and buy it”.   
 
Female three was also of the opinion that false and misleading claims can often be made 
in advertisements, especially those directed at the terminally ill.  She stated:  “...There is 
a lot of bogus out, out there”.  Female three used the controversial HIV ‘cure’ widely 
advertised by the Minister of Health in South Africa to explain:  “...I recently looked at a 
lot of HIV things out there and I got to a site where they had Manto’s picture up...’Bolox’ 
better than ARV-drugs...En beetroot and garlic, en ek weet nie wat alles nie” (...And 
beetroot and garlic, and I don’t know what else).  Female three argued:  “Hulle gaan dit 
vat (They will take it).  Dan dink hulle nou (Then they think):  ‘It’s gonna cure it!’”.   
 
Male one felt that economics also play a role in why advertisers will direct their 
advertisements at vulnerable people.  He stated:  “They want to make money.  So, what 
are they gonna do?  If I have Aids or [pauses] you have cancer...They will sell it.  Becau-  
se they will tell you:  ‘No, but it’s curing it’”.  Female two believed that advertisements 
are often directed at people who are unable to differentiate between what is true and what 
is false.  She said:  “Especially uneducated people...plays on uneducated people...Like we 
here know exactly that there isn’t a cure for Aids...But there might be millions of people 
out there who still don’t know that Aids isn’t curable”.  She also explained that this will 
mislead the terminally ill and said:  “...they will fall for everything and anything that you 
tell them.  And that is, it plays on their emotions”.  
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(b)   MISLEADING ADVERTISEMENTS  
 
Participants were asked whether they believe that pharmaceutical advertisements are 
misleading.  All participants felt that pharmaceutical advertisements can often mislead 
consumers.  One theme, irrelevant and false issues, emerged from the discussion. 
   
Irrelevant and false issues 
 
Participants discussed this issue by giving opinions about pharmaceutical advertisements 
that provide irrelevant and lacking information as well as false claims.  They seemed to 
believe that this may result in consumers being unable to make conscious and informed 
decisions when interested in buying pharmaceutical products. 
  
Female two felt that pharmaceutical advertisements are of a misleading nature.  She said: 
“The first thing that hit me, that it’s, it’s very misleading”.  Her argument was that 
pharmaceutical products are falsely represented in advertisements as definite cures.  She 
said:  “It will help you immediately with what you have...And it works for you.  And that’s 
not always the case”.  Female two furthermore stated that advertisers do not mention the 
important information.  She said:  “...it comes across as there’s no side-effects”.   
 
Another issue raised by the group dealt with slimming products and muscle-gaining 
supplements.  Participants complained that advertisements for these products incorporate 
photographs of male and female models to create the image that a person will look 
similar after using it.  Male one said:  “And they always have this build men and this nice 
woman walking around with this mass builders”.  He argued that consumers are often    
misled by these advertisements because such products should mainly be used in 
conjunction with a diet or an exercise program.  Male one said:  “You can lose this 
amount of weight if you use this guide or practice this much.  ‘I don’t want to practice!’”  
Female one agreed:  “...in die advertensie sê hulle nie daar is ‘n dieet nie.  Eers wanneer 
jy koop en jy lees die aanwysings...” (“...in the advertisement they don’t say that there is 
a diet.  Only when you buy the product and read the instructions...”).     
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It was male one’s opinion that these advertisements are therefore designed in such a way 
as to mislead consumers into buying what is advertised.  He said:  “At the end of the day 
they never look like I did...it’s a lot of times misleading but that’s how they strike 
you...that’s how they get you to go and buy the product”.  Female two agreed:  “Ja (Yes), 
they hit a nerve”.  She also referred to such advertisements appearing on television and 
stated that important information is deliberately placed in small print at the bottom of the 
screen in order to be read with difficulty.  Female two also alluded to the fact that 
beautiful people are placed in these advertisements to deter consumers from reading 
important information.   She said:  “And like on TV they put it in tiny, tiny letters in the 
bottom of the screen:  ‘In conjunction with a kilojoule controlled diet’...You not looking 
at it.  You’re busy looking at the beautiful person on the screen...”.   
 
Male two believed that such advertisements make exaggerated and false claims by stating 
goals that are unlikely.  He said:  “...you can lose weight in three days.  You can try 
that...”.  Male one said that he received such an advertisement in the form of an 
electronic mail (e-mail).  He shared:  “I, I actually got a nice e-mail the other day about 
how I can lose 25 kilo’s in seven days”.  Participants were amazed by such a claim being 
made.   
 
Male three also referred to the muscle-gaining supplements being advertised in 
magazines and raised concern about information not stated.  He asked:  “I also think, 
those USN products, do they tell you what the side-effects are, who should and shouldn’t 
use them?...Does it indicate all those things?”.  Male one responded and stated that these 
advertisements are not forthcoming.  He said:  “They don’t tell you on the, the 
advertisement”.  Female two confirmed that such information is not found on the 
advertisement but rather on the product’s package.  She said:  “On the package, ja (yes)”.  
 
(c)   COMPREHENSION OF PHARMACEUTICAL ADVERTISEMENTS  
 
The topic during this discussion was to identify whether the participants were of the 
opinion that pharmaceutical advertisements are difficult to understand.  Most participants 
seemed to agree that pharmaceutical advertisements can often be difficult to understand.  
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Two major themes emerged from the discussion and were placed under a thematic 
heading, understanding pharmaceutical advertisements.   
 
Understanding pharmaceutical advertisements  
 
i.   Degree of understanding  
 
Female three stated that pharmaceutical advertisements in print form are not always 
clearly understood.  She said:  “...that ones are very, very difficult to understand...”.  
Male one agreed but reasoned that a proper explanation cannot be given due to limited 
space.  He stated:  “...because they don’t always have the space...it’s normally short and 
sweet...just enough to get your attention”.  
 
ii.   Information provided 
 
Male two felt that many consumers are unaware of what is advertised.  He said:  “You 
don’t know what it is or what does it do, what it is for...”  Male three agreed and used 
Benylin® advertisements as an example:  “...you get to the pharmacy, and it’s Benylin 
this and Benylin that”.  Female two agreed and said:  “Ja, then there’s a whole range”.   
 
Female three believed that pharmaceutical advertisements led consumers into buying 
certain products for certain conditions and symptoms.  She used the treatment of sinusitis 
as an example and said:  “You have a sneeze – Sinutab!...Of wat is daai goed se naam? 
(Or what is the name of that stuff?)  Sinumax!...so, that actually says that you must ask 
for Sinumax when you have a sinus headache...”.  Male one agreed and was of the 
opinion that consumers believe everything stated in pharmaceutical advertisements.  He 
explained:  “’That one I saw in the advert is the one I want’.  ‘But why you want?’  ‘No, 
because in the advertisement it says it helps for this and that”.  
 
 
 
 
 176
(d)   AESTHETICS 
 
The group was asked whether colour and pictures appearing in pharmaceutical 
advertisements attract their attention.  Participants agreed that colour and pictures easily 
attract their attention.  Although confirming this, no mention was made to the role of 
colour during this topic’s discussion as participants focused more on the role of pictures.  
Two themes emerged and were placed under the thematic heading, appeal.   
 
Appeal  
 
i.   Attraction 
 
Participants seemed to believe that advertisements are more attractive if a picture is 
added.  Female two confirmed and said:  “Pretty pictures”.  She also added that these 
pictures make advertisements more interesting to read.  Here, she compared 
pharmaceutical advertisements to University text books:  “Like even at University, a text 
book with just a bunch of writing in it, I don’t even open it...if it hasn’t nice pictures in it”.   
 
ii.   Comprehensibility  
 
Some participants felt that pictures in advertisements improve the degree of 
understanding.  Female two said:  “And some pictures are a lot better to understand than 
a whole bunch of big words”.  She added that pictures improve the readability of the 
advertisement by saying:  “...and its less effort to read it”.  Male two used a well-known 
phrase to support female two’s opinion:  “...a picture can tell a thousand words”.   
 
(e)  BUYING PHARMACEUTICAL PRODUCTS AND SERVICES ADVERTISED 
 
Participants were asked whether they have visited a pharmacy or asked a pharmacist or 
general practitioner about a specific product advertised.  Participants were divided in 
their opinions.  Many expressed their experiences regarding medicines bought and those 
seen in pharmaceutical advertisements.  The theme, buying experiences, emerged.    
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Buying experiences 
 
Although female one expressed how she bought a product after seeing it in a 
pharmaceutical advertisement, other participants discussed how they received different 
products than those seen in advertisements.  Female one shared her experience by 
explaining how she bought a hair supplement after reading about it in an advertisement.  
She said:  “...Ek het al.  Ja, daai Nu Hair®, daai funny goed wat keer dat jou hare nie 
uitval nie (I have.  Yes, that Nu Hair®, that funny stuff that prevents your hair from 
falling out)”.   
 
Female three explained that customers often get different medicines to those seen in 
advertisements due to unforeseen reasons.  She said:  “...on an occasion when I went for 
a certain product, I got a different product because that specific product was out of stock.  
So, it’s not always the case that you go to the pharmacy and ask for that...”.  Male one 
agreed:  “...ja (yes), a lot of times when you go actually in looking for something, you end 
up walking out with something else...”.   
 
In contrast to these opinions, female one explained why she thinks customers often get 
different products:  “Ja, maar gewoonlik as jy in die apteek in gaan sê jy nie gewoonlik jy 
wil daai produk hê nie,  Jy sê wat makeer...dan gee hy vir jou (Yes, but usually if you go 
to the pharmacy you don’t say what you want.  You say what’s wrong...then he will give 
you)”.  In response male two said:  “Some people know exactly what they want...they will 
just tell the pharmacist they want that”.   
 
Female three also provided another point of view.  She seemed to believe that another 
reason why customers often get different products than those advertised is because of the 
fact that pharmacies have limited shelf space and that they want to sell slow-moving 
products.  Female three explained:  “you have shelf space and all that type of things, nê.  
If you want to get rid of stock, if that thing is for coughing then you will seek that one for 
a dry cough rather than, than the other one...because obviously, number one, you don’t 
have the stock, and number two, you want to get rid of the stock”. 
 
 178
From this discussion, even though the majority of participants discussed how customers 
receive different products than those advertised, it can be concluded that most of the 
participants believe that consumers often buy products after seeing and reading about it in 
pharmaceutical advertisements. 
 
(f)   ADVERTISING PRESCRIPTION MEDICINES 
 
According to the Medicines and Related Substances Act, Regulation 45 (2)(b) regarding 
the advertising of medicines, Schedule 2 to Schedule 6 medicines may not be advertised 
to the general public in South Africa.  With this in mind, participants were asked if 
prescription medicines should be advertised to the general public.   
 
The group was in agreement that such advertisements should not be directed to the 
general public.  Female two boldly stated that these advertisements are partly responsible 
for the escalation of drug addiction.  She stated:  “There are enough addicts already”.  
Two themes emerged and were placed under the thematic heading, prescription medicine 
advertised to the general public. 
 
Prescription medicine advertised to the general public 
 
i.   Quantities and addiction 
 
Participants seemed to be concerned about pharmaceutical advertisements not providing 
specific information that is needed.  This issue emerged from female three’s opinion that 
customers can only buy a certain quantity of scheduled medicines.  She said:  “...But 
most of the time I can only buy five Myprodol’s.  So, what’s the use?...They should say 
something in there, maybe you can only get five.  Maybe they should specify that because 
‘I don’t understand why I can only get five tablets’...’I want 20!’”.  Female two agreed 
that customers want to buy more than the amount allowed.  She said:  “It’s all or nothing, 
ja (yes)”.  Female three explained that customers can often become agitated.  She 
explained:  “’Ek betaal dan vir dit!  Hoekom kan ek nie kry nie? (I pay for it!  Why can’t 
I get it?)...I think that’s the general thought of the public out there”.  Female two agreed:  
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“Ja (Yes).  They get upset when you say:  ‘You only get five’.  Female one added that 
customers want to know why they can only buy a certain number of capsules.  She said: 
“Hulle wil weet hoekom dit geskeduleerd is...Hoekom kan hulle dit nie gebruik nie?  ‘Is 
daar dan iets in?’...(They want to know why it is scheduled...Why can’t they use it?  Is 
there something in it?...)”.   
 
Male one underlined that these advertisements can be misleading if necessary 
information, like quantity, is omitted.  He stated:  “...That’s why they not totally, clearly, 
totally advertising that you only get five.  That’s where it gets misleading”.  Male one 
added:  “I see Myprodol® and it works for headaches, pain, and fever.  And I sommer 
(just) say:  ‘If I wanna buy a lot ‘a Adco-dol®. I’ll buy a 100 Adco-dol®’s”.   
 
Another issue mentioned by female three dealt with the assumption made about 
customers who buy larger quantities of medicines for use at home.  She believes that 
customers are often labelled as addicts when they buy larger quantities.  Female three 
said:  “And you might not use it as an addict.  Maybe you want just to keep it in your 
house...Now they treating everyone as a potential addict.  And they say:  ‘Mam, I can 
only sell you 20.  Five days!’”.  Male one also stated that healthcare professionals assume 
that customers are addicts when buying larger quantities.  He explained:  “’What is in it 
that I can only get five?  Do you think I am an addict?  Are you accusing me of being an 
addict?’”.   
 
Female two speculated that consumers want larger quantities of medicines because they 
are unaware of the pharmacy laws that prohibited the selling of large quantities of 
Schedule two medicines.  She said:  “People don’t know the law”.  Male two agreed and 
said:  “Exactly!”.  
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ii.   Professionals and the pharmaceutical industry  
 
Participants continued with the issue of addiction and seemed to believe that healthcare 
professionals such as doctors should also be involved with this issue.  Here, female two 
argued that it is dangerous to advertise prescription medicines to the general public as 
people may become addicted.  For this reason she thought it be best not to advertise in 
print media and suggested that doctors should advertise these scheduled medicines.  
Female two said:  “...Like prescription drugs are either addictive or they have serious 
consequences for the patient to take them.  So, in a sense, the doctor should be the 
advertiser of it...’If you need it I’ll give it to you.  If you don’t need it, don’t need it, take 
this’”.  Male one added:  “...you must also behave in a professional manner”.  He 
believed, however, that it is difficult for these pharmacists to act in a professional manner 
because of the amount of pressure caused by these pharmaceutical advertisements.  Male 
two said:  “...So, what can you now do if they just advertise it?”. 
 
Pharmaceutical companies were also blamed of being unprofessional as it was believed 
that these companies use suspicious advertising techniques.  Participants used the erectile 
dysfunction treatment, Viagra® and those produced by the pharmaceutical company, Lilly 
(Cialis®), as examples to explain how such scheduled treatments are advertised without 
breaking the law.  Female three referred to the fact that these advertisers omit the names 
of the treatments as scheduled medicines may not be advertised to the general public.  
She referred to these types of advertisements as “a preview”.  By also referring to the 
issue that the names of these medicines are omitted in advertisements, female two felt 
that these companies find ways to manipulate the law in order to advertise these 
treatments.  She said:  “They are using it as a loop-hole...”.  Female three argued:  “They 
know why they are doing that...What they want, what actually to do is, eh, give you an 
open mind.  ‘Listen here, if you have erectile problems, there is something that give you 
36-hours of freedom’”. 
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6.2.2.3   Group task three 
 
Participants were exposed to three pre-selected pharmaceutical advertisements:  a 
complementary and alternative cholesterol-lowering product, Phytocor® and Phytocor® 
Plus (see Appendix C), a Schedule 0 cold and flu treatment, Panado® MedSip (see 
Appendix D), and an erectile dysfunction awareness advertisement (see Appendix E).  
After providing them with time to read through these advertisements, participants were 
asked to express their impressions about each advertisement.   
  
Six themes emerged during the discussion of these three advertisements.  Two common 
themes, Visual characteristics and Print characteristics, were shared between the 
Phytocor® range and Panado® MedSip advertisements.  These two themes were grouped 
under one thematic heading, Visual and lexical aspects.      
 
Visual and lexical aspects 
 
i.   Visual characteristics   
 
It was apparent that the presence of a picture, a hand holding a large, red heart, resulted in 
the Phytocor® advertisement being more attractive as three members discussed this issue.  
Male three brought attention to this issue, although not connected to the narrative of this 
advertisement, and said:  “...ek hou van die hartjie.  So Valentynsdag” (...I like the little 
heart.  So Valentine’s day)”.  The picture also attracted the attention of female one and 
she said:  “Dit vang mens se oog dadelik (It immediately catches one’s eye)”.  Female 
one also said:  “Wel, ek sal hom koop net vir die prentjie (Well, I will buy it just because 
of the picture)”.  Female three added:  “...that is the first thing they see...the nice 
picture...”.   
 
Another visual aspect that emerged from the Phytocor® advertisement was the 
descending green line.  Male three speculated that there will probably be a reason for this 
green line by saying:  “There will be a reason for the green line going down...All the 
positives down to the negatives going straight down the line”.   
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The picture that was presented in the Panado® MedSip advertisement did not attract such 
attention as the first advertisement.  Some participants, however, mentioned this picture 
only later on in the discussion.  Female one briefly referred to the picture by asking:  
“Wat lê daar by the koppie?  Heuning? (What is that lying there?  Honey?)”.     
 
Colour played a more prominent role in the Panado® MedSip advertisement than in the 
Phytocor® advertisement.  Female two was in favour of the bright yellow colour.  She 
referred to this colour as “eye catching”.  Male two and female three, however, disliked 
this colour.  Female three stated:  “...this yellow doesn’t do it for me...I would never have 
looked at this thing.  I must be honest”.  Although various bright colours were apparent in 
the Phytocor® advertisement, little attention was given to it during the discussion.  The 
only mention made to it was when male three briefly referred to the colour of the descen-  
ding line.  He said:  “...a reason for the green line...”.  
  
ii.   Print characteristics  
 
This theme focused on the words, sentences, and phrases found in the first two 
advertisements.  An issue raised in both advertisements was that some of the print was too 
small to read, especially the fine print that appeared at the bottom of both advertisements.  
Male one confirmed this by saying:  “The fine print is too small”.  He reinforced his view:  
“She [pointing to female one] can’t even read the normal stuff without her glasses.  How is 
the person who can’t even read that, if she can’t”.  Female showed her inability to read the 
fine print by saying:  “Wel, ek sal hom koop net vir die prentjie (Well, I will buy it just 
because of the picture)”.  
  
Male one felt that the fine print represents the product’s negative facts.  He said:  “...the 
negatives are too small.  Take the positives, it is the whole page...the negatives are too 
small”.  According to him the advertiser can then not be blamed if any side-effects occur 
when taking this medication.  He said:  “...when you have a problem they’ll tell you 
[sarcastically]:  ‘Well, didn’t you read the fine print?’”.  Male one again stated that a 
person who has difficulty reading will not be able to do so.  He again said:  “How is she 
supposed to?”.   
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Some participants also referred to the fine print that appeared in the Panado® MedSip 
advertisement.  Female two said that this medicinal drink should be administered at 
recommended doses, as stated in this advertisement.  Female one then again referred to 
the fact that the print was too small to read.  She said:  “Ja, maar dit is ook baie klein 
(Yes, but this is also very small)”. 
 
Another characteristic that emerged from both of the first two advertisements was their 
sales pitch.  In the Phytocor® advertisement participants thought that phrases will attract 
vulnerable consumers.  Female two alluded to this and said:  “...something that you get in 
everyone of these ads is the punch line, ‘Protect your heart’, and so someone who has 
heart trouble, that’s the first thing they see...and then it hits home”.  Female three agreed 
with female two and reinforced this by sarcastically saying:  “Phytocor, Phytocor”.   
 
Female two raised the same point by referring to the phrase, “Just like chicken soup”, in 
Panado® MedSip.  She stated that such a phrase will easily attract consumers’ attention.  
Female two said:  “You see the punch line and that is it”.  Female three also argued that 
consumers’ attention will only be focused on such a phrase.  She said:  “Jy, jy lees nie 
hier nie (You, you don’t read here)”.  Female two mentioned that this phrase in the 
advertisement is aimed at mothers.  She said:  “...effective remedy, safe, ‘star’, effective 
remedy for pain and fever MOMS choose...So, it hits moms”.  She explained that such a 
phrase can play on the emotions of a mother and said:  “...’In order to be a good mom 
you need to give your child this’...”.  Female two felt that this can result in a feeling of 
inadequacy on the mother’s part if she does not give her child Panado® Medsip.  Female 
two said:  “...She’s gonna say to herself:  ‘Well, am I a good mother if I don’t give my 
child this?’”.   
 
Two additional themes emerged from each of the last two advertisements.  Table 6.2 
identifies the themes and its thematic headings. 
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Table 6.2   Panado® MedSip and Erectile dysfunction awareness advertisements:  
Themes and thematic headings 
 
  THEMATIC HEADINGS 
 
THEMES 
 
Traditional remedies  
PANADO® MEDSIP 
 
Conventional treatment 
versus  
alternative treatment 
 
Medicines and food 
Legal pharmaceutical 
advertising 
 
ERECTILE DYSFUNCTION 
AWARENESS 
ADVERTISEMENT 
 
Legal and ethical 
considerations Emotional pharmaceutical 
advertising 
 
 
(a)   PANADO® MEDSIP 
 
Conventional treatment versus alternative treatment  
 
i.   Traditional remedies   
 
Female two was the first person to address the fact that the Panado® MedSip 
advertisement was targeted at people who believe in traditional remedies.  She said:  
“And there’s like a traditional thing:  ‘Have chicken soup and you’ll get better’”.  The 
group agreed with female two’s opinion.  Female one supported the notion that this 
advertisement reflects the believe that chicken soup is a good remedy for colds and flu.  
She confirmed this by saying:  “Baie mense hou van boererate... (Many people like 
traditional remedies...)”.  Furthermore, she referred to the other ingredients which are 
synonymous with various traditional remedies.  She added:  “...En daar’s heuning en 
ginger in... (...And there’s honey and ginger in...)”.  As a result of such ingredients being 
present in this advertisement, participants seemed to believe that it will be popular among 
consumers.  Female three said:  “Baie mense gaan dit vat, ja (Many people will take it, 
yes)”.  One participant also made reference to the fact that traditional remedies are 
popular among older people.  Female one said:  “...kyk hierso, ou mense hou van 
boererate (...look here, old people like traditional remedies)”.  A participant also 
mentioned that lemon and ginger is a good combination for colds and flu.  Male one said:  
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“Wel, as ek siek is drink ek lemon and ginger (Well, when I am sick I drink lemon and 
ginger)”.   
 
ii.   Medicines and food 
 
Mention was made of the comparison of medicine to food in this advertisement.  The first 
opinion given was about the fact that chicken soup was compared with Panado® MedSip.  
Female one said:  “Wel, hulle sê chicken.  Chicken is baie lekker, so (Well, they say 
chicken.  Chicken is very nice, so)”.  There was suggested that, if this medicinal drink 
was compared with chicken soup, it may taste good.  Female two supported this opinion 
by also referring to the taste and effectiveness of chicken soup.  She said:  “...Oh, if I am 
sick, ‘Panado MedSip tastes just like chicken soup’, which will make me better...”.   
 
Male two thought that the comparison of medicine to food can often mislead consumers.  
He said:  “...dit kan ook misleading wees (...it can also be misleading)” and also 
sarcastically added:  “So, dis lekker sout (So, it’s nice and salty)”.  He reinforced these 
opinions by saying:  “Taste just like:  ‘Ek gaan nou lekker daai sip, nê? (That will be a 
nice drink, hey?)”.  Female three also supported this opinion and thought that such 
misinterpretations could be dangerous.  She said:  “Wat as jy nou tannies kry, nê, wat nou 
sê [voice change]:  ‘Jis jong (Damn), just like chicken soup, only without the chicken.’  
Wat as sy nou dit in haar pot ingooi...jy kan sulke mense kry...Miskien is daar mense wat 
nog nooit Panado® gehad het nie... (What if you get aunties that say [voice change]:  
‘Gee, just like chicken soup, only without the chicken.’  What now if she threw it in her 
pot...you can get such people...Maybe there are people that never have had Panado®...)”.  
She added that such misinterpretations can occur as many people do not read the 
important information and only attend to phrases that appear in advertisements.  Female 
three said:  “Want somtyds, jy, jy, uhmm, laat die kleiner dingetjies uit.  ‘Just like chicken 
soup’ (Because sometimes you, you, uhmm, leave the smaller things out.  ‘Just like 
chicken soup’)”.  Female two agreed and said:  “You see the punch line, and that’s it”.   
 
In contrast to this male one felt that it is not wrong to compare medicines to food.  He 
stated:  “I, uhmm, don’t think there’s a problem by comparing it with food...coz a lot of 
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people like food...If you see this you think now:  ‘This is gonna taste nice, coz chicken 
soup tastes nice’”.  However, later on in the discussion he agreed that such comparisons 
to food can be misleading.  He said:  “you think, well, ja (yes)...how stupid have I been”.  
Participants used various other medicines to support this argument.  Male two said:  “Kyk 
na Dicloflam...Dit het mos ‘n black currant flavour (Look at Dicloflam...It has a black 
currant flavour)...It doesn’t taste like it but they say on the box, ‘black currant flavour’”.   
 
Various reasons were provided by the group why medicines are compared to food.  Male 
one argued:  “If you compare it to food people are gonna buy it”.  Female two argued 
that, by referring to the taste in the advertisement, mothers are targeted in making 
decisions based on what will taste the best for their children.  She said:  “...children are 
very susceptible, like if you put something in their mouth and it tastes bad, ‘I’ll never put 
it in my mouth again!’  It’s like a learning curve”.  Female two used Ponstan® suspension 
to explain:  “...I remember when I was little I wanted Ponstan all the time...coz it tastes 
nice...”.   
 
Male three raised a serious concern about comparing medicines to food.  He said:  “Ja 
(Yes), but remember no, chicken won’t kill you but that [pointing at Panado® MedSip] 
can kill you...”  The group agreed with this concern that was raised. 
 
(b)   ERECTILE DYSFUNCTION AWARENESS   
 
Legal and emotional considerations  
 
i.   Legal pharmaceutical advertising  
An issue that was raised in the discussion of this awareness advertisement dealt with legal 
prescribing practices.  This issue was raised by female three:  “It says here:  ‘So ask your 
doctor or pharmacist about the treatment that allows your partner the freedom to get 
close again.’  The doctor part I can understand but the pharmacist part... coz the 
pharmacist can’t prescribe...”.  She explained that such wording used in pharmaceutical 
advertisements can irritate consumers.  Female three continued by saying:  “...the 
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pharmacist tells the patient:  ‘There is a product here but you must ask your doctor’...the 
patient is gonna say:  ‘No, no, but it says so!  Why can’t you give me?  It’s mos nou net 
(just) for erection problems, you know?’” 
 
Although not part of print advertising, there was a discussion on Internet advertising as 
the website address, www.36hours-of-freedom.co.za, appeared in the advertisement.  
This issue was highlighted by male one who said:  “...they sommer (just) give you the 
website address...’36 hours of freedom’.  Ek dink ek moet daar ingaan (I think I must go 
in there)”.  A concern about such advertisements on the Internet was raised which 
resulted from the phrase, ‘Ask your doctor or pharmacist’.  Female three said:  “...but I 
have seen it being advertised on the Internet met ‘n pryslys (price list).  Then you can 
actually order”.  Her concern was that in this print advertisement counselling by a 
pharmacist or doctor was encouraged but that certain medicines can be ordered from the 
Internet without such counselling.  
 
Many of the members thought that it is legal to create awareness about treatments 
available to consumers suffering from erectile dysfunctions as long as the scheduled 
medicine’s name was not advertised.  However, some members still complained that such 
awareness advertisements may be misleading.  Female three said:  “...even though they 
not stating the name of the product, this one is very misleading”.   
 
Female two raised another dilemma that can arise as a result of the absence of the 
medicine’s name.  She said:  “...someone is gonna go into the pharmacy and somme (just) 
say:  ‘Give me Lilly!’  They not gonna know what you talking about...”  
 
ii.   Emotional pharmaceutical advertisements   
 
Apart from the legal aspects of pharmaceutical advertising, the group also discussed 
certain emotion-based aspects.  Participants felt that pharmaceutical companies convey a 
false image to consumers of their role in various health issues.  The group also thought 
that such advertisements target emotionally laden consumers suffering from these 
conditions.  
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Mention was made of the fact that it was thought that the company in question boasts 
about their role in the treatment of erectile dysfunction.  Female two raised this issue and 
said:  “...it also tries to make the company look good...it says [sarcastic voice]:  ‘Brought 
to you by Lilly in the interest of healthy relationships’”.  Her argument was mirrored by 
what she said:  “They try to come across by saying [sarcastic voice]:  ‘We care for you.  
We don’t want to make money, we care for you’”.  She reinforced these feelings and said:  
“...So, kind ‘a sucking up to customers”.   
 
Female two also argued that this advertisement targets consumers who have an emotional 
connection to its theme.  She said:  “...this ad also hits the emotions”.  Female two 
explained:  “...they give you the impression that, that this product will fix your 
relationship, or fix your marriage.  To someone who’s desperate to fix their marriage or 
something, this is the only solution”.  Most participants agreed with this argument.  Male 
two labelled this form of advertising as “unprofessional pressure”.  Female one shared 
the same thoughts:  “Pressure!  Ek sien dit as pressure (I see this as pressure)”.  Female 
two felt that this was a negative form of advertising:  “...it’s kind ‘a cruel in a way”.   
 
Furthermore, male one alluded that the picture in this advertisement portrays happiness.  
He said:  “These two people actually look happy”.  Female two, however, replied:  “They 
not gonna put two norse (unhappy) looking people there”.   
 
6.2.3 Conclusion 
 
Valuable information was obtained as a result of the themes that emerged from each of 
these group tasks.  The information obtained was incorporated into a consumer 
questionnaire to determine the perceptions of consumers within the Nelson Mandela 
Metropole.  Both these activities were used to assist in the decoding of pharmaceutical 
advertisements as well as in the discussion.  
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6.3   CONSUMER SURVEY 
 
6.3.1   Introduction 
 
In this section the results obtained from the consumer survey conducted in the NMM will 
be analysed to identify trends pertinent to this study.  A questionnaire directed at 
customers in community pharmacies within the NMM was used as research tool to 
identify these trends. 
 
The questionnaire (see Appendix F) consisted of four sections, demographics, mass 
media preferences of participants, pharmaceutical advertisements in general, and the 
evaluation of pharmaceutical advertisements.  Each of these sections consisted of 
questions or statements posed to the participants.  The results obtained will be discussed 
under each of these sections.    
 
6.3.2   Demographics  
 
A sample size of 100 participants (n = 100) was decided on. Fifty-four percent of the 
participants were females, while 46% were males.  Figure 6.1 identifies the age 
distribution of the participants.  It is evident the largest percentage of participants (40%) 
consisted of young adults between the ages of 18 years and 30 years.  The rest of the 
participants were older than 30 years.  The youngest participant, in accordance with the 
ethical criteria, was 18 years and the oldest participant 75 years.   
 
Participants were classified according to 10 major occupation groups.  Nine of these 
groups were based on a simplistic version used by The National Centre for Social 
Research in Britain to classify the major groups of occupations (National Centre for 
Social Research, 2004).  A tenth group, pensioners and unemployed, was added as a 
result of the economic instability in the NMM.    
 
Table 6.3 identifies these 10 groups as well as the number of participants (in decreasing 
order of frequency) belonging to each of these groups.  It is evident that the sample of 
participants was representative in terms of occupations.  The main group to which 
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participants belonged was the routine unskilled occupations group.  Thirty-two percent of 
the participants belonged to this occupation group.   
   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1   Age distribution of the participants (n = 100) 
 
Table 6.3   Major occupation groups to which participants belong   
 
40
28
16
16
18 - 30 years 31 - 40 years 41 - 50 years Older than 50 years
  
MAJOR OCCUPATION GROUPS NUMBER OF PARTICIPANTS 
  
Routine unskilled occupations 
  
 
32 
 
Associate professionals and technical occupations 
 
 
11 
 
Pensioners and unemployed  
 
 
11 
 
Professional occupations  
 
 
10 
 
Administrative and secretarial occupations 
 
 
9 
 
Sales and service occupations  
 
 
8 
 
Skilled trade occupations  
 
 
8 
 
Managers and senior officials 
 
 
5 
 
Caring, leisure, and other personal service occupations 
  
 
3 
 
Process, plant, and machine operations and drivers 
 
 
3 
 
TOTAL 
 
100 
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Additional information obtained from the consumer survey was that only 33% of the 
participants belong to a medical aid while 42% of the participants suffered from a chronic 
condition.  No significant patterns regarding participants belonging or not belonging to a 
medical aid could be identified.    
 
 
 6.3.3   Media preferences of consumers 
 
Section two focussed on identifying participants’ media preferences and how frequently 
they were exposed to these.  Seven preferences were provided that included television, 
radio, newspapers, magazine, pharmacy newsletters, handouts and flyers, and the Internet.  
The focus of this study, however, was on print media where the focus fell mainly on 
magazines and to a lesser extent on newspapers, pharmacy newsletters, handouts and 
flyers.  Pharmaceutical advertisements directly from the manufacturer appear nowadays 
in magazines with a limited number appearing in newspapers.  The two advertisements 
used in this consumer questionnaire were published in well-known magazines.  
 
Figure 6.2 identifies the number of participants exposed to each of the seven media 
preferences as well as the frequency of exposure.  It is evident that these participants 
watched more television (80%) and listened more to the radio (77%) on a daily basis than 
any other leisure activity.  With respect to print media, only 18% of the participants read 
magazines on a daily basis.   
 
The reason for this finding may be due to the fact that magazines (for example, You, 
Huisgenoot, Fair Lady, and Drum) usually appear on a weekly or monthly basis.  This 
finding is reinforced by the fact that 31% of the participants read magazines once or 
twice a week with 16% reading magazines once a month.  Twenty-one percent of the 
participants indicated that they never read magazines.  The same holds true for pharmacy 
newsletters which are usually only published by community pharmacies on a monthly 
basis.  Forty-three percent of the participants read their pharmacy newsletters once a 
month.  In contrast to this, 47% never read pharmacy newsletters.  Following the 
popularity of television and radio, 41% of participants read newspapers on a daily basis 
while 33% read newspapers once or twice a week.   
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From these results it can be deduced that 63% of the participants could be exposed to 
pharmaceutical advertisements on a weekly basis (daily, three to six times per week, and 
once to twice a week) as they read magazines throughout the week.  Forty-eight percent 
of the participants read newspapers throughout the week.   
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
Figure 6.2   Participants’ exposure to media preferences (n = 100) 
 
Figure 6.3 identifies the number of males and females exposed to the seven media 
preferences in a period of a week.  It is evident that there is not a major difference 
between males and females exposed to these media preferences on a weekly basis, 
although females were exposed more to most of these media preferences.  However, 
these differences between males and females could be attributed to the fact that there 
were more females (n =54) than males (n = 46) in the sample.  Interestingly, a similar 
number of males (31%) and females (32%) appeared to read magazines on a weekly basis, 
whereas the same number of males (39%) and females (39%) read newspapers on a 
weekly basis. 
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Figure 6.3   Number of males and females exposed to the seven media preferences on 
a weekly basis (n = 100)   
 
It is also important to determine the exposure of different age groups to the media 
preferences on a weekly basis.  Figure 6.4 identifies the media preferences of different 
age groups.  It is evident that young adults between the ages of 18 years and 30 years 
were most exposed to television, radio, newspapers, and the Internet.  Within this age 
group, 30% of the participants revealed that they were exposed to magazines on a weekly 
basis.  The same number (n = 30) of participants within this age group reflected that they 
were exposed to newspapers during the same period.  
  
Seventeen percent of participants within the 31 to 40 year age group read magazines on a 
weekly basis while 22% read newspapers on a weekly basis.  It was also evident that 
participants older than 50 years read slightly more newspapers but read fewer magazines 
on a weekly basis than participants in the age group 41 to 50 years.  Thirteen percent of 
participants older than 50 years read newspapers while 12% of the participants between 
the ages of 41 years and 50 years read newspapers on a weekly basis.  Nine percent of the 
participants within this age group read magazines while only seven percent of the 
participants older than 50 years read magazines on a weekly basis.     
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Figure 6.4   Exposure of different age groups to the seven media preferences on a 
weekly basis (n = 100)   
 
6.3.4   Pharmaceutical advertisements in general  
 
Ten statements regarding pharmaceutical advertisements were posed to each participant.  
These statements were obtained from the themes that emerged from the focus group and 
dealt with four specific topics namely, the comprehension of pharmaceutical 
advertisements, misleading advertisements, emotional advertising, and aesthetics used in 
such advertisements.  
 
6.3.4.1   Comprehension of pharmaceutical advertisements  
 
From this topic, the comprehension of pharmaceutical advertisements, two themes 
emerged in the focus group, the information provided, and the degree of understanding of 
pharmaceutical advertisements.  Three statements regarding the theme, information 
provided, were posed to each participant while one statement was posed regarding the 
degree of understanding of pharmaceutical advertisements.  Table 6.4 identifies the 
statements posed to each participant with its number in the consumer survey appearing in 
brackets.      
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Table 6.4   Statements regarding specific themes posed to participants   
 
  
THEMES STATEMENTS POSED IN SECTION 3 OF QUESTIONNAIRE 
  
 
Information provided 
 
• I find pharmaceutical advertisements informative (3.1) 
• I ask my doctor or pharmacist for more information after seeing a 
pharmaceutical advertisement (3.2) 
• Pharmaceutical advertisements lack important information (3.3) 
  
Degree of 
understanding  
 
 
• Pharmaceutical advertisements are difficult to understand (3.4)   
       
 
The results obtained from these statements are given in Figure 6.5.  From the results it is 
evident that a large percentage (68%) of the participants found pharmaceutical 
advertisements to be informative.  Sixty-five percent indicated that they will consult with 
a doctor or pharmacist to obtain more information after being exposed to a 
pharmaceutical advertisement, while 62% of the participants did not believe that these 
advertisements lack vital information.   
 
  
 
 
 
 
 
 
 
 
  
 
 
Figure 6.5   Participants’ opinions regarding the understanding of pharmaceutical 
advertisements (n = 100) 
 
68 65 62
43
22 21 24
50
10
14 14
7
3.1 3.2 3.3 3.4
STATEMENTS
N
UM
BE
R
 O
F 
PA
RT
IC
IP
A
NT
S
 
Agree Disagree Undecided
 196
However, there were mixed responses to whether participants believed that 
pharmaceutical advertisements were difficult to understand.  There was only a small 
discrepancy between those participants that agreed and those that disagreed.  Half of the 
participants felt that pharmaceutical advertisements were not difficult to understand while 
43% (n = 43) of the participants felt that pharmaceutical advertisements were difficult to 
understand.   
       
6.3.4.2   Misleading advertisements  
 
The topic, misleading advertisements, resulted in only one theme, irrelevant and false 
issues, being identified in the focus group.  With regard to this theme only two statements 
were posed in this section of the questionnaire.  The first statement was a general 
statement while the second statement dealt with slimming advertisements which raised 
concern during the focus group.  Table 6.5 identifies the two questions that were posed to 
the participants. 
  
Table 6.5   Statements regarding misleading advertisements posed to participants 
     
THEME 
 
STATEMENTS POSED IN SECTION 3 OF QUESTIONNAIRE 
 
 
Irrelevant and false 
issues 
 
• Pharmaceutical advertisements are misleading (3.5) 
• Pictures of models used in slimming advertisements or other 
pharmaceutical advertisements create a false impression (3.6) 
   
    
As can be seen in Figure 6.6, the majority of participants felt that pharmaceutical 
advertisements are misleading.  Sixty-two percent believed that pharmaceutical 
advertisements were misleading while only 29% did not agree.  An overwhelming 89% 
of the participants believed that pictures of models appearing in slimming advertisements 
and other forms of pharmaceutical advertisements create a false impression of the 
products advertised.       
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Figure 6.6 Participants’ opinions regarding misleading pharmaceutical 
advertisements (n = 100)  
 
6.3.4.3   Emotional advertising  
 
From this topic, emotional advertising, the thematic heading, emotional impact, emerged 
from the focus group.  Two statements regarding this thematic heading were posed to the 
participants.  Table 6.6 identifies the two statements posed to each participant.   
 
Table 6.6   Statements regarding emotional pharmaceutical advertisements posed to 
participants  
  
62
89
29
69 5
3.5 3.6
STATEMENTS
N
UM
BE
R
 O
F 
PA
RT
IC
IP
A
NT
S
Agree Disagree Undecided
  
THEMATIC HEADING STATEMENTS POSED IN SECTION 3 OF QUESTIONNAIRE 
 
 
 
Emotional impact 
 
• Pharmaceutical advertisements are directed at consumers who are 
emotionally vulnerable (3.7) 
• Disease awareness advertisements create unnecessary fear (3.10) 
 
 
The results obtained in Figure 6.7 revealed that 48% of the participants did not believe 
that pharmaceutical advertisements were directed at emotionally vulnerable consumers 
such as those suffering from chronic conditions.  It is, however, important to note that 
18% of the participants were unsure if such advertisements are directed at emotionally 
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vulnerable consumers.  Forty-eight percent of the participants did not believe that disease 
awareness advertisements create unnecessary fear amongst consumers thereby showing 
that such advertisements also did not have an emotional impact (fear) on consumers.  
Fourteen percent of the participants were undecided.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7   Participants’ opinions to the emotional aspects of pharmaceutical 
advertisements (n = 100) 
 
The results in Figure 6.8 identifies if there was a possibility that pharmaceutical 
advertisements with emotional undertones may affect consumers suffering from chronic 
conditions such as diabetes, hypertension or asthma more than those consumers not 
suffering from these conditions.  As mentioned, 42% of the participants suffered from 
chronic conditions while 58% were healthy.  Of the 42% suffering from chronic 
conditions, 60 % (n = 25) agreed that they believe that pharmaceutical advertisements 
were directed at consumers who are emotionally vulnerable.  Forty percent (n = 17) of the 
participants suffering from chronic conditions believed that disease awareness 
advertisements create unnecessary fear amongst consumers.   
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Figure 6.8   Opinions regarding emotional advertising directed at participants 
suffering from chronic conditions (n = 42) 
 
In contrast to these results, 38% (n = 22) of the participants that did not suffer from any 
chronic conditions believed that pharmaceutical advertisements were directed at the 
emotionally vulnerable.  However, it must be noted that 41% (n = 24) of the participants 
not suffering from any chronic conditions, were undecided on this issue.  Furthermore, 
half of the participants not suffering from any chronic conditions believed that disease 
awareness advertisements did not create unnecessary fear amongst consumers while only 
36% (n = 21) agreed with statement 3.10.  
     
6.3.4.4   Aesthetics  
 
The focus group discussion regarding the use of aesthetics in pharmaceutical 
advertisements delivered two themes under the thematic heading, appeal.  The two 
themes that emerged were attraction and comprehensibility.  Two statements were posed 
to each participant and Table 6.7 identifies these statements. 
 
From the results seen in Figure 6.9 it was evident that the participants found colour and 
pictures in pharmaceutical advertisements attractive and eye catching.  These beliefs were 
echoed by the fact that the majority (85%) of the participants’ attention were attracted by 
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colourful pharmaceutical advertisements while 79% of the participants felt that 
pharmaceutical advertisements were interesting when pictures appear in them.       
 
Table 6.7 Statements regarding the use of aesthetics in pharmaceutical 
advertisements 
 
  
THEMATIC HEADING STATEMENTS POSED IN SECTION 3 OF QUESTIONNAIRE 
 
 
 
Appeal 
 
• Colourful pharmaceutical advertisements attract my attention (3.8) 
• Pharmaceutical advertisements are interesting when pictures appear 
in it (3.9) 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9   Participants’ opinions regarding the aesthetic appeal in pharmaceutical 
advertisements (n = 100)  
 
6.3.5   Evaluation of pharmaceutical advertisements  
 
Each participant was exposed to two of the three pharmaceutical advertisements 
(Panado® MedSip (see Appendix D) and erectile dysfunction awareness (see Appendix 
E)) used in the focus group.  Four statements regarding each advertisement were posed to 
each participant.  Table 6.8 identifies the four statements.  
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Table 6.8   Statements regarding the two pharmaceutical advertisements to which 
participants were exposed to 
 
 STATEMENTS POSED IN SECTION 4 OF THE 
QUESTIONNAIRE 
 
 
 
Panado® MedSip 
 
• I like the phrase “just like chicken soup” (4.1)  
• Panado® MedSip has the same qualities as the old traditional 
remedies portrayed in this advertisement (4.2) 
• It is dangerous to compare medicines to food (4.3) 
• The yellow colour makes this advertisement attractive (4.4)  
 
 
 
 
 
Erectile dysfunction awareness  
 
• The advertised medicine alluded to can improve someone’s 
troubled relationship or marriage (4.5) 
• My pharmacist can give this medicine without me having to see 
a doctor (4.6) 
• I will visit the website given in the advertisement to get more 
information about the medicine (4.7) 
• It is good to create awareness of conditions such as erectile 
dysfunction (4.8)   
 
 
 
6.3.5.1   Panado® MedSip 
 
The first statement (Statement 4.1) posed to participants aimed to identify their feelings 
toward the phrase “just like chicken soup” appearing in this advertisement.  An 
overwhelming 63% of the participants were not in favour of this phrase.  Participants 
were also asked (Statement 4.2) whether they perceived Panado® MedSip as having the 
same inherent qualities as the old traditional remedies (chicken soup and honey, lemon, 
and ginger) portrayed in the advertisement.  An alarming 49% percent of the participants 
were of the belief that Panado® MedSip can be compared as being similar to the food and 
old traditional remedies used for colds and flu, although it contains an active ingredient 
(paracetamol) that can be potentially harmful if not used accordingly, especially in 
children.  Thirty-five percent of the participants believed that Panado® MedSip did not 
have the same qualities as the old traditional remedies.      
 
Continuing with the topic in Statement 4.2, Statement 4.3 identified if participants 
believe that it could be potentially dangerous to compare medicines to food in 
advertisements.  In contrast to the results obtained in Statement 4.2, the majority of the 
participants believed that it can be dangerous to advertise such a comparison.  Sixty-eight 
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percent of the participants felt that the comparison of medicines to food can be dangerous 
while only 25% disagreed.   
 
Statement 4.4 dealt with the bright yellow background used in this advertisement.  
Seventy-one percent found that this bright colour resulted in this advertisement being 
more attractive.  Twenty-five percent disliked the use of this colour.  These positive 
results obtained supported the findings of the topic, aesthetics (see Statement 3.4) which 
showed that the use of colour and pictures in pharmaceutical advertisements assist in 
attracting consumers’ attention as well as to create interest.              
 
6.3.5.2   Erectile dysfunction awareness  
 
The aim of Statement 4.5 was to determine if the treatment alluded to in the 
advertisement can be misinterpreted as being able to improve a troubled relationship or 
marriage, as is portrayed by the picture of the happy, loving couple.  An alarming 45% of 
the participants believed that this treatment has the ability to do so while only 37% 
disagreed.   
 
Another controversial aspect in community pharmacy was explored with the aid of 
Statement 4.6.  This statement determined if participants were under the impression, after 
reading the sentence “so ask your doctor or pharmacist about the treatment” that the 
Schedule 4 prescription-only treatment can be obtained from a pharmacist without having 
to see a doctor.  The results obtained identified only a 10% discrepancy between those 
participants that thought that this treatment can be obtained without a prescription and 
those participants knew that a person first had to visit a doctor.  Thirty-seven percent of 
the participants believed that they can obtain this treatment directly from their pharmacist 
while 47% knew that they first had to go to their doctor to obtain a prescription.  Sixteen 
percent (n = 16) of the participants were undecided. 
 
To identify if participants would seek further information regarding this treatment by, for 
example visiting the website (www.36hours-of-freedom.co.za) provided in the 
advertisement, Statement 4.7 was posed to them.  Only 31% of the participants agreed 
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that they will visit this website to seek additional information about the treatment while 
54% stated that they will not visit such a website.  
 
In the final Statement (Statement 4.8) participants were asked whether they felt that 
awareness should be created about intimate conditions such as erectile dysfunction.  
Sixty-seven percent of the participants felt that public awareness should be created, while 
26% felt that such intimate conditions should not be publicised in pharmaceutical 
advertisements.   
 
6.3.6   Conclusion   
 
The results obtained from this survey highlighted the fact that a large number of 
consumers are exposed to print media, mainly magazines.  This increases the probability 
that the rate of exposure to pharmaceutical advertisements will be high as a large number 
of consumers read magazines on a weekly basis.  It was evident that more young adults 
are exposed to pharmaceutical advertisements.  This is substantiated by the fact that in 
this study the largest percentage of participants between the ages of 18 years and 30 years 
appeared to read magazines and newspapers on a weekly basis.  No differences regarding 
the exposure to print media were found between males and females.  
 
Many consumers found pharmaceutical advertisements to be informative and not lacking 
in any information although consensus was not reached on the degree of difficulty 
regarding the comprehensibility thereof.  It is evident that more than half of the 
consumers will consult doctors or pharmacists on treatments advertised.  However, 
contrary to these beliefs, the majority of consumers felt that pharmaceutical 
advertisements can be misleading.  An overwhelming number of consumers also felt that 
slimming advertisements and similar pharmaceutical advertisements could create a false 
impression raising concern about the pictures of models that appear in these 
advertisements.  
 
Almost half of the consumers believed that pharmaceutical advertisements are not 
directed at emotionally vulnerable consumers such as those suffering from chronic 
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conditions, although more than half of the consumers suffering from chronic conditions 
felt that this tendency does occur.  Many consumers, including those suffering from 
chronic conditions, were of the opinion that advertisements creating awareness of 
diseases, or conditions such as erectile dysfunction, did not result in fear amongst 
consumers.   
 
The majority of consumers found colourful pharmaceutical advertisements attractive and 
also believed that pictures make such advertisements more interesting.  This was evident 
in the Panado® MedSip advertisement as the majority of consumers were attracted to the 
bright yellow colour.  It can therefore be assumed that consumers’ attention will be easily 
attracted by pharmaceutical advertisements that have aesthetic appeal.   
 
A result of concern obtained from the Panado® MedSip advertisement was that 48% of 
the consumers believed that a medicine containing paracetamol can have similar qualities 
to old traditional remedies that contain food (for example, chicken, honey, lemon, or 
ginger) as basis.  However, in contradiction to this, many consumers believed that it 
could be potentially dangerous to compare medicines to food in advertisements.    
 
What also raised concern was that 45% of the consumers believed that a treatment such 
as the one alluded to in the erectile dysfunction awareness advertisement, could improve 
troubled relationships.  Furthermore, 37% of the consumers believed that they could 
obtain this treatment directly from their pharmacist without having to consult a doctor.  
 
The results obtained from the consumer survey will be used to support the proceeding 
section, decoding of pharmaceutical advertisements. 
 
6.4   DECODING PHARMACEUTICAL ADVERTISEMENTS 
 
6.4.1   Introduction 
 
The term decoding is simply defined as finding the meaning of something, as in this case, 
the meaning of pharmaceutical advertisements (Oxford Advanced Learner’s Dictionary, 
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1989: 395; Concise Oxford English Dictionary, 2006: 372).  In semiotic terms, however, 
Underwood (2003) explained that decoding is the basic recognition and comprehension 
of what it says and also the interpretation and evaluation of its meaning with reference to 
the relevant codes. 
 
In this section pharmaceutical advertisements (see Appendices C, D, and E) used in the 
focus group and consumer survey were decoded to interpret and evaluate each of their 
meanings by using semiotics as basis.  A basic synopsis of each of the three 
pharmaceutical advertisements was first provided followed by the decoding process.  In 
the decoding process various semiotic aspects discussed in Chapter three were identified.  
The main concept, the sign of each advertisement, was identified first followed by the 
signifier and signified.  Other concepts identified were denotation and connotation as 
well as the referent system employed in each of these pharmaceutical advertisements.  
Various concepts in the decoding advertisement model (see Figure 3.8, Chapter three) 
were also identified in each advertisement, where applicable.  The semiotic concept, 
ideology, was finally identified to provide an overall meaning to each pharmaceutical 
advertisement.         
 
Furthermore, the colours that appeared in each advertisement were interpreted on the 
basis of its psychological and symbolic meanings as discussed in Chapter three (see 
Table 3.3, Table 3.4, and Table 3.5).  Lastly, each advertisement was analysed in terms of 
its legal and ethical requirements identified in Chapter four.  Here, regulations used for 
this investigation consisted mainly of the Regulations stipulated in the Medicines and 
Related Substances Act 101 of 1965, as amended (referred to hereafter as the Medicines 
Act).       
 
The meanings obtained from the semiotic concepts identified, the interpretation of the 
colours, and the legal and ethical aspects these pharmaceutical advertisements have to 
adhere to were used to provide a more in-depth understanding thereof.  By using the 
results obtained from the focus group (Section 6.2) and consumer survey (Section 6.3) to 
support these findings, areas in the three pharmaceutical advertisements where 
misinterpretation could occur, were identified.      
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6.4.2   Phytocor® 
 
6.4.2.1   Synopsis  
 
This is a visually attractive advertisement depicting the natural cholesterol lowering 
agents, Phytocor® and Phytocor® Plus.  Four colours were used in this advertisement, 
namely white, green, blue, and red.  Pictorially the advertisement consists of a red heart 
held by a hand with a fading face at the right hand side of the apex of the heart.  The 
handheld heart is firstly surrounded by a white halo, followed by a green half moon.  On 
the right half of the advertisement a green beam descends from top to bottom.  This beam 
contains the lexical portion of the advertisement and identifies the natural ways of 
protecting a person’s cardiovascular system.  It also identifies which vitamins and 
minerals are important to ensure a healthy cardiovascular system.  These vitamins and 
minerals form part of the Phytocor® range.  On the left side a lexical component can be 
found that explains the differences between Phytocor® and Phytocor® Plus.  At the 
bottom of the advertisement (the blue area) the pharmaceutical company’s name was 
revealed.  This blue area also identifies the ingredients of Phytocor® and Phytocor® Plus 
as well as the references to each of the statements made.         
 
6.4.2.2   Semiotic criteria  
 
Table 6.9 identifies the sign, signifier, and signified apparent in this advertisement.  Here, 
the sign can be seen as both symbolic and iconic.  As there is a conventional relationship 
between the signifier and the signified (a heart conventionally illustrated by the basic sign, 
♥), the sign can be seen as symbolic.  However, since the image of the heart only 
represents a human heart by convention, the sign can also be seen as iconic as this image 
is not that of a real human heart (Myers, 1997: 137; Underwood, 2003).  Furthermore, the 
sign denotes a red heart figure embraced by a person’s hand (Underwood, 2003).  
However, the connotation made to this sign is that the heart is a precious organ that 
should be protected and cared for, as is depicted by a person’s hand that holds the heart 
(Cook, 1992: 101). 
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Table 6.9   The sign, signifier, and signified in the Phytocor® advertisement  
 
 
Sign  
 
The image of the heart can be seen as the sign. 
  
 
Signifier  
 
The image signifies a representation of a heart held by a person’s hand.     
 
 
Signified 
  The importance of protecting and caring for the human heart can be seen as 
the signified.  
  
 
(Adapted from:  Chandler, 2005b) 
  
The focus group participants believed that this red heart results in this advertisement 
being more attractive.  It also attracted the participants’ attention as one said:  “that is the 
first thing they see...the nice picture...”.  It was evident that the heart is the main pictorial 
component in this advertisement as the participants did not refer to the bright colours that 
appeared.      
 
Similarly, as was identified by Goldman and Montagne (1986), the layout of the 
Phytocor® advertisement resembles the concept followed by antidepressant 
advertisements found in 1986.  The layout of antidepressant advertisements consisted of 
three main components, the signifying image, name and image of the package design, and 
a framing caption.  The Phytocor® advertisement makes use of a photograph of a hand 
holding a heart used within the frame to act as the focus point and can thus be seen as the 
signifying image.  The name and image of the package design is also present in this 
advertisement.  Goldman and Montagne (1986) explained that the final component, a 
framing caption, connects the meanings of the signifying image to the brand.  In addition 
to this advertisement’s heading, “protect your heart”, the entire lexical component of the 
advertisement connects the meaning of the image to the brand advertised.  Here, the 
heading and the other lexical component appearing in the green beam, supplements the 
signifying image by explaining how people can protect their hearts – by means of 
Phytocor® or Phytocor® Plus. 
   
It is difficult to identify a referent system in this advertisement.  However, an assumption 
can be made that time can be a referent system (Williamson, 2005: 152).  It can be argued 
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that if a person does not protect his or her heart now, the future may look bleak for his or 
her heart and health in general.  Another point of view is that nature can also be involved 
and can therefore also be the referent system, back to nature (Williamson, 2005: 123).  
Although not pictorially illustrated, the concept of nature is explained in the lexical 
components by referring to the alternative treatment for high cholesterol as well as 
referring to the Phytocor® range as a natural dietary supplement.  This product range is 
claimed to be natural due to its active ingredient, policosanol, and other ingredients such 
as freeze dried omega 3 fatty acids, folic acid, zinc, and B vitamins.   
 
Two factors that were identified in the decoding advertisement model (see Figure 3.8, 
Chapter three) played a role in these two possible referent systems identified in this 
advertisement, namely appellation and desire.  With appellation the consumer can place 
himself or herself in the position of wanting (desire) to protect and look after his or her 
heart (Williamson, 2005: 40).  This will ensure that the advertisement has a meaning to 
the consumer.  The need to protect your heart is a desire a consumer will have (Creating 
meaning and images, 2002).  
 
These two factors help to shape the consumer’s ideology towards this advertisement.  The 
assumption can thus be made that if a consumer uses this natural dietary supplement, in 
conjunction with the lifestyle choices provided in the advertisement, his or her heart will 
be protected.   
 
6.4.2.3   Colour interpretation 
 
Although little was discussed by the focus group about colour in this advertisement, four 
colours played a role in this advertisement, namely white, green, red, and blue.  White is 
seen as a bright colour that creates a sense of space in this advertisement.  This colour 
also has the ability to advertise the highlights of the advertisement, in this case the 
highlight being the image of the heart (Wells, et al., 1995: 474; Wright, 2006).  
Furthermore, white is associated with goodness and purity, thereby reinforcing the fact 
that this dietary supplement is natural (Van Wagner, 2006).  As white is seen as a colour 
of safety in medicinal products, in this advertisement it may allude to the fact that 
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lifestyle choices such as these natural dietary supplements will assist to safely protect a 
person’s heart (Wright, 2006).  However, most importantly, white is associated with low 
weight, low-fat food that accentuates the lifestyle choices mentioned in the lexical 
portion in the green beam, “eating a healthy diet...to protect our hearts” (Van Wagner, 
2006).   
 
The green colour in this advertisement brings the element of nature to this advertisement 
as this colour is associated with nature (Van Wagner, 2006).  Therefore, with the use of 
this green colour it becomes apparent that the referent system applied in this 
advertisement may indeed be that of back to nature.  Green also symbolises freshness, a 
natural characteristic of these supplements, and health, a characteristic that is needed to 
protect a human heart (Van Wagner, 2006).  This colour also has, as with white, a strong 
emotional correspondence with safety (Wright, 2006).  Therefore, green and white 
reinforces the fact that these natural dietary supplements provided, safely protects the 
heart.  It can also be speculated that this can be the reason why the green colour appears 
as a half moon surrounding the left apex of the heart.  Green is also thought of as having 
healing powers that can be linked to the Phytocor® range which has the ‘power’ to protect 
a person’s heart (Hoyer & MacInnes, 2001: 92).  
 
The colour red only appears in limited areas in this advertisement but plays a major role 
in providing meaning to this advertisement.  It appears in four areas in this advertisement, 
the word “your” in the heading, the heart, the top half of the products’ packaging, and the 
products’ names at the bottom.  Red is a warm, intense colour which can illustrate the 
physiological nature of the human heart.  This is also a bright colour that highlights the 
crux of this advertisement (Wells, et al., 1995: 474; Wright, 2006).  By linking all the red 
components in the advertisement, a sales formula can be formulated:  
 
 
your  +  ♥  = Phytocor® and Phytocor® Plus 
                                    
 
The answer to this formula, Phytocor® and Phytocor® Plus, is illustrated pictorially, by 
means of the boxes appearing in the green beam, and also in writing appearing in the 
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bottom white portion above the blue portion.  This sales formula can be interpreted as 
‘your heart needs Phytocor® or Phytocor® Plus’ to be healthy.   
 
Red is also a colour that refers to danger (Van Wagner, 2006).  Here, the danger can be 
due to not protecting your heart which can result in heart diseases as is stated in the first 
paragraph in the green beam, “protect against cardiovascular disease”.  Another danger 
that red is associated with is the ability to increase blood pressure, an abnormality that 
has a dangerous impact on the heart (Nolan, 2003).  In accordance with this 
advertisement, lifestyle changes and the Phytocor® range of supplements can protect a 
person’s heart against these dangers.  
 
The other colour that appears in three places in this advertisement is blue.  It appears in 
the words “protect” and “heart” in the heading, the bottom of the products’ packaging, as 
well as the bottom of the advertisement.  The blue words appearing in the heading, 
“protect” and “heart”, can also be formulated into a sales formula: 
    
protect + heart = Phytocor® by Pharma Dynamics 
                              
Here, the answer appears pictorially (the bottom blue portion of the products’ packaging 
contains the name, Phytocor®) while the pharmaceutical company’s name appears in the 
blue portion at the bottom of the page.  This sales formula can be interpreted as ‘you can 
protect your heart with Phytocor® that is manufactured by Pharma Dynamics’.   
 
These sales formulas, or “punch lines” as referred to by the focus group participants, 
were seen as tools to attract vulnerable consumers.  One participant pointed out, 
“something that you get in each of these ads is the punch line, ‘Protect your heart’, and 
someone who has heart trouble, that’s the first thing they see...and then it hits home”. 
       
Blue is also a cool, masculine colour which is often the colour of choice in men (Hoyer & 
MacInnes, 2001: 92; Van Wagner, 2006).  However, in the context of this advertisement, 
it may be speculated that the colour blue is used to underline the fact that cardiovascular 
diseases are more associated with males than females and thus maybe more directed 
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towards men.  Blue also symbolises trust, confidence, faith, and loyalty, characteristics 
important to the pharmaceutical company (Van Wagner, 2006).  They want consumers to 
trust, be confident, and have faith in their range of supplements. The pharmaceutical 
company is also seeking for brand loyalty.  
 
The colour blue is also believed to have a calming effect on the body and is thought to 
have the ability to lower a person’s pulse rate (Van Wagner, 2006).  These factors are 
vital in protecting the heart.  
 
6.4.2.4   Legal and ethical criteria 
 
As this advertisement is of a natural dietary supplement and not of a medicine, the legal 
requirements (in accordance with Regulation 45(4) of the Medicines Act regarding the 
advertising of medicines) to which print advertisements of medicines must adhere to do 
not apply.  In guidelines provided for the advertising of OTC medicines by the Self-
Medication Manufacturers’ Association of SA, there were referred to certain claims that 
may not be made in natural products such as the Phytocor® range.  The claims regarding 
natural products that should not be made in print advertisements are (ASA, 2004):   
 
 
• “No suggestions should be made claiming that a product’s safety or efficacy is due to the fact that it 
is natural, unless such claims can be substantiated by clinically proven results. 
• No claim should state that a product is natural unless all its ingredients are naturally occurring, also 
including herbal products where all its active ingredients must be that of plants or extracts of 
plants.”  
 
                       
No claims regarding this supplement’s safety, as a result of it being natural, were made.  
All claims regarding its effectiveness were substantiated by clinically proven results.  
References to these claims were stated in the fine print appearing in the blue portion at 
the bottom of the advertisement.  Regarding the second claim stated in Figure 6.10, all 
the ingredients in the Phytocor® range occur naturally.  Therefore, claims can be made 
that the Phytocor® range of supplements are natural.   
 
Two ethical issues were, however, identified in this advertisement.  The first ethical issue 
was identified in the last paragraph above the pictures of the products’ packaging in the 
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green beam.  This deals with the word “optimal” in the sentence “...an optimal 
formulation...”.  In this sentence it seems that this word is used in similar fashion than 
superlative words such as “the best”.  According to the Oxford Advanced Learner’s 
Dictionary (1989: 869) optimal can be defined as “best or most favourable”.  The 
sentence can thus be read as ‘the best (or most favourable) formulation...’.  In accordance 
with the Marketing Code, such a claim is prohibited as there are too many variables to 
prove such a claim (Code of Practice, 2004).   
 
Another ethical issue that can be misinterpreted by consumers appeared in the last 
paragraph on the left side of the advertisement below the image of the heart.  In the 
statement “Phytocor® is available without a prescription, from pharmacies and selected 
health shops”, it is unclear if a prescription is needed to obtain Phytocor® Plus as this 
forms part of the natural supplement range provided to lower cholesterol.  This creates 
the impression that only Phytocor® can be obtained without a prescription.   
 
What is positive to see in this advertisement is that this pharmaceutical company does not 
only encourage their product to be used but also informs the consumers about additional 
lifestyle choices that can be made, for example, “...not smoking, eating a healthy diet, 
and exercise...”.  These examples can assist a person in protecting his or her heart.   
 
6.4.3   Panado® MedSip 
 
6.4.3.1   Synopsis 
 
The Panado® MedSip advertisement is a bright yellow pharmaceutical advertisement with 
red writing and a white medicine box.  Panado® MedSip is a medicinal drink consisting 
of the active ingredient, paracetamol.  It is indicated for “the symptoms of colds and flu” 
such as “pain and fever”.  The product is available in two flavours, honey-lemon and 
ginger and is claimed to contain vitamin C.  It claims to be tartrazine-free and gives the 
impression that it is directed at children as the advertisement states “moms choose 
Panado”.  Furthermore, the advertisement gives the impression that it is a ‘natural’ 
product due to the illustration of the lemon, ginger, and honey in front of the product.  
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However, the main theme of the advertisement seems to be the connotation of Panado® 
MedSip to chicken soup with the sentences, “Just like chicken soup, only without the 
chicken.  And it’s not soup”.   On the right-hand edge of the advertisement, the company 
also advertise the Panado® product range available to consumers.   
 
6.4.3.2   Semiotic criteria 
 
Table 6.10 highlights the sign and its two components, the signifier and signified, 
identified in this advertisement.  The sign can furthermore be seen as an iconic sign as the 
product illustrated is not real and is represented only in an advertisement (Myers, 1997: 
137; Underwood, 2003).  It denotes that this medicinal product represents a medicine that 
can be dissolved in water to form a medicinal drink (Underwood, 2003).  The 
connotation to this sign is that this medicinal drink is safe and can be effectively used to 
treat pain and fever in both children and adults (Cook, 1992: 101).  This connotation 
comes from years of Panado® advertisements where phrases such as “GP’s choice” are 
well-known by consumers. 
 
Table 6.10   Identification of the sign, the signifier, and signified in the Panado® 
MedSip advertisement  
     
Sign  
 
The illustration of Panado® MedSip can be deemed the sign of this advertisement.   
 
  
Signifier 
  
The box of Panado® MedSip with the medicinal sachets inside can be deemed the 
signifier.   
   
Signified  
 
The signified can be seen as the representation of a medicinal drink that can make 
you feel better when you have symptoms of cold or flu. 
 
 
(Adapted from:  Chandler, 2005b) 
   
However, the connotation to Panado® MedSip as being safe and effective, is indirectly 
achieved by means of the referent system, cooking nature and the wording at the top of 
the advertisement, “Just like chicken soup...”.  Judith Williamson’s (2005:103) theories 
state that advertisements “cook” nature by illustrating the transference of raw materials 
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into the final product.  In this advertisement it is illustrated with the raw, natural products 
(lemon, ginger, and honey) being transferred to the final product, Panado® MedSip.  
 
Although the pharmaceutical company manufacturing this medicine may argue that the 
pictorial representation of the honey, lemon, and ginger identifies the two flavours this 
product is available in, the results obtained from the focus group indicated that this 
representation can mislead consumers into thinking that this is a natural product.  One of 
the participants in the focus group indicated that these natural ingredients are a popular 
combination in old traditional remedies used for the treatment of colds and flu.  This 
participant therefore misinterpreted the illustration by thinking that these are the 
ingredients of Panado® MedSip, although it only indicates the two flavours available.  
Forty nine percent of the consumers that participated in the consumer survey also 
believed that Panado® MedSip has similar qualities to the old traditional remedies 
referred to in the advertisement.  Only 35% of the consumers thought that such a 
connotation cannot be made.  Many of the participants in the focus group believed that 
consumers will be attracted to this product as many like to use old traditional remedies.         
 
The wording at the top of the advertisement also reinforces the connotation.  By 
interpreting these two sentences, it can be assumed that the reference made to chicken 
soup merely reinforces the fact that Panado® MedSip represents the same traditional 
qualities.  Chicken soup is seen as an old traditional remedy for colds and flu.  Both these 
referent systems reinforce the fact that Panado® MedSip is a safe and effective treatment 
for colds and flu.  Sixty-eight percent of the consumers in the consumer survey, however, 
believed that it is dangerous to compare medicines to food in advertisements.  This was 
echoed by one of the focus group participant who pointed out that food does not hold a 
danger when consumed but that paracetamol, the active ingredient in Panado® MedSip, 
can be potentially dangerous when not used accordingly.    
 
Finally, it can be assumed that the ideology (the assumption made) of this advertisement 
is that Panado® MedSip is a medicinal drink that shares the same qualities (safety and 
efficacy) as chicken soup and the naturally occurring lemon, honey, and ginger.         
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6.4.3.3   Colour interpretation  
 
There are three prominent colours in the Panado® MedSip advertisement, yellow, white, 
and red.  Two of these colours, yellow and red, are warm colours or hues.  Each colour 
represents different meanings that support the message of the advertisement.   
 
The yellow colour is a bright colour that attracts a person’s attention immediately (Nolan, 
2003; Van Wagner, 2006).  It is associated with joy, happiness, and energy, all attributes 
which can illustrate good health (Van Wagner, 2006).  Good health is what the Panado® 
range of medicines, including Panado® MedSip, strives for.  Yellow is a visible colour 
that is often employed for its attention getting attributes (Wells, et al., 1995: 474).  This 
colour is therefore employed to increase visibility, especially as it was found in a well-
known magazine where advertisements have to be more visible.  In the focus group 
participants felt that colour used in pharmaceutical advertisements do attract the attention 
of consumers.  One of these participants described this yellow colour as “eye catching”.  
This was reinforced by the fact that 71% of the consumers in the consumer survey were 
in favour of the yellow colour used in this advertisement.    
 
Although it seems that yellow is the main attention getting attribute of this advertisement, 
the Panado® MedSip box with its white colour also draws attention.  This can also be 
seen as a reason for choosing yellow as background colour.  White also highlights the 
Panado® MedSip box (Wells, et al, 1995: 474; Wright, 2006).  This colour is associated 
with goodness, again underlining the fact that the Panado® range of medicines strives to 
be a good medicine in terms of safety and efficacy (Van Wagner, 2006).  The goodness is 
reinforced by comparing the qualities of chicken soup and the natural ingredients of 
lemon, honey, and ginger to Panado® MedSip.  Furthermore, the use of white suggests 
safety (Wright, 2006).  This complements the concept of safety talked about at the bottom 
halve of the advertisement (“For a safe, effective remedy from pain and fever...”).  
      
All the wording in this advertisement is in red.  Red is a bright and intense colour which, 
as in this advertisement, is used as an accent colour (Wells, et al., 1995: 474).  The red 
wording thereby emphasises the important facts about Panado® MedSip.  It can be 
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assumed that the chicken soup concept is the main idea of the advertisement as it appears 
in bold, large red letters.  It emphasises the fact that Panado® MedSip stands for the same 
qualities as the goodness of chicken soup.  Red is also associated with energy and 
strength, which again reinforces the attributes evident in a healthy person and which can 
be attained from Panado® MedSip (Van Wagner, 2006).   
 
This colour also evokes an emotion of love, in this advertisement, the love of a mother 
for her child (Van Wagner, 2006).  A mother will therefore show her love by using a 
“safe, effective remedy” for the “symptoms of colds and flu”.  If a mother loves her child 
she will use Panado® MedSip.   One of the female focus group participants also believed 
that the emotion of love does play a role in this advertisement and stated that the phrase, 
“For a safe, effective remedy from pain and fever, moms choose Panado®”, is aimed at 
the emotion of mothers.  She also said: “...’In order to be a good mom you need to give 
your child this’...” and “’Well, am I a good mother if I don’t give my child this?’”.    
 
It is also evident is that the brand name, Panado®, is in the boldest red font.  This clearly 
shows that Panado® is the only brand that emphasises good health. 
  
 6.4.3.4   Legal and ethical criteria 
 
The Panado® MedSip advertisement does comply with the legal requirements to which 
pharmaceutical advertisements in print form must adhere to.  In accordance with 
Regulation 45(2)(a) of the Medicines Act regarding the advertising of medicines, this 
medicine may be advertised to the general public as it is a medicine that contains a 
Schedule 0 substance (Pharmaceutical Society of South Africa Law Compendium, 2005: 
MRE – 50).  The “S0” (Schedule 0) sign can be seen in red next to the brand name on the 
white box.   
 
This print advertisement also contains all the requirements stated by Regulation 45(4), 
Subsections (a), (b), and (c), to which such advertisements have to adhere to 
(Pharmaceutical Society of South Africa Law Compendium, 2005: MRE – 51).  The 
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Panado® MedSip advertisement does state the proprietary name and approved name as 
well as the quantity of its active ingredient (500 mg paracetamol).   
 
A
arguments.  The Self-Medication Association of SA provided guidelines regarding OTC 
medicines.  The following three claims stipulated in these guidelines can be used as 
arguments in this advertisement (ASA, 2004):  
 
lthough this advertisement adheres to the legal standards, ethically there were various 
 
• “Suggestion should be made that OTC products are medicines and not foodstuff, cosmetics, or any 
other type of non-medical product.  
• No misleading statements dealing with the nature, ingredients, or indications of such products 
should be made. 
• No suggestions should be made claiming that a product’s safety or efficacy is due to the fact that it 
is natural, unless such claims can be substantiated by clinically proven results.” 
 
 
 
At first glance this Panado® MedSip advertisement does not appear to be an 
advertisement for a medicinal product but rather a natural product.  This is due to the 
depiction of lemon, honey, and ginger in front of the medicine box.  As was alluded to by 
the results obtained in the focus group and consumer survey, these depictions may 
mislead consumers into thinking that Panado® MedSip contains natural ingredients such 
as honey, lemon, and ginger.  The honey, lemon, and ginger with the chicken soup phrase 
may also cause consumers to think that Panado® MedSip is safe and effective.  
 
6.4.4   Erectile dysfunction awareness  
 
6.4.4.1   Synopsis  
 
This pharmaceutical advertisement can be categorised as a disease awareness 
advertisement, although erectile dysfunction cannot be classified as a disease per say but 
rather a condition.  The advertisement creates the impression of awareness amongst 
consumers about the sexual condition, erectile dysfunction.  It consists of a pictorial 
component, in the form of a photograph that depicts a seemingly loving and happy couple.  
The pictorial component is complemented by a lexical component describing the negative 
impact erectile dysfunction has on couples.  An unknown treatment alluded to is 
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advertised as the answer to this problem and consumers are informed that they can ask 
their doctor or pharmacist for more information about it.  This campaign is also known 
for controversial statements such as “36- hours of freedom”.     
    
6.4.4.2   Semiotic criteria  
 
In Table 6.11 the sign, signifier, and signified of this advertisement are identified.  The 
sign denotes a couple that is in a relationship (Underwood, 2003).   It connotes a loving 
relationship with passion, love, and intimacy (Cook, 1992: 101).  The sign identified can 
furthermore be classified as a symbolic sign due to the fact that the relationship between 
the signifier and the signified is purely conventional or even culturally specific (Myers, 
1997: 137; Underwood, 2003).  This relationship is conventional and cultural as it is 
generally accepted that the couple depicted in the photograph will engage in sexual 
intimacy.    
  
Table 6.11 Sign, Signifier and signified in the erectile dysfunction awareness 
advertisement  
  
   
Sign 
  The image of the happy couple on the left hand side can be 
regarded as the sign of this advertisement.  It is seen as the sign as 
it represents an image that has meaning attached to it.   
  
 
 
Signifier 
  The signifier is the form which the sign (the image) takes.  The 
signifier can be seen as the actual colour photograph seen in this 
advertisement as it is the form the image (sign) takes. 
    
 
 
Signified 
  
The signified represents the concept that the image signifies a 
couple that radiates love and happiness, traits present in a 
successful relationship.    
    
 
(Adapted from:  Chandler, 2005b) 
 
The referent system that plays a role in this advertisement, as was identified in Panado® 
MedSip, is cooking nature.  Here, however, as was stated by Williamson (2005: 120), the 
referent system refers to “cooked sex”.  In this sense, ‘cooking nature’ involves people 
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and their passion for each other.  Thus, sex becomes a referent system which is 
symbolically represented by the sign (the image of the happy couple).   
 
Three of the five factors, identified in the decoding advertisement model (see Figure 3.8), 
appellation, mirror-phase, and desire, played a role in the development of this referent 
system.  These factors came into effect as result of the sign.  With respect to this 
advertisement, appellation is when the consumer is forced to put himself, or herself, in 
place of the happy couple depicted in the photograph (Williamson, 2005: 40).  By doing 
so, the consumer gives meaning to this advertisement.   
 
The mirror-phase, however, refers to the consumer’s ability to wish for (desire) what is 
portrayed in the photograph (Williamson, 2005: 61).  Consumers acknowledge that they 
do have a problem (they have erectile dysfunction).  By looking at and reading the 
advertisement, they realise that there is a treatment available that can help to satisfy their 
desire of having a relationship that radiates the same type of love and happiness as 
portrayed.  These three factors identified the emotional effect this advertisement may 
have on males suffering from erectile dysfunction.  
 
It was evident from the results obtained in the focus group that advertisements, such as 
this advertisement, target emotionally laden consumers suffering from conditions like 
these.  This was reflected by one of the participant’s words “...this ad hits the 
emotions...To someone who’s desperate to fix their marriage or something, this is the 
only solution”.  One participant described this form of advertising as “unprofessional 
pressure” whereby another said “...it’s kind ‘a cruel in a way”.  Of concern, however, 
was that 45% of the consumers in the consumer survey believed that the treatment 
alluded to can provide a marriage or relationship with the same qualities portrayed by the 
photograph. 
      
A similar approach to one of Jean-Marie Floch’s (2001: 79) 12 visual characteristics, 
layout in conjunction versus layout in disjunction, was followed in encoding this 
advertisement.  As with the example of the functional and dysfunctional family used by 
Floch to illustrate this visual characteristic, the paragraph of words (the lexical 
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component) in the awareness advertisement explained the negative aspects of erectile 
dysfunction whereas the photograph (the pictorial component) illustrates what a 
“functional” relationship should look like.  
        
A unique aspect of this advertisement is the swoosh of the treatment’s logo (see the lower 
right hand corner) that is incorporated into the photograph.  In the photograph it seems to 
be a transparent whitish colour and not the green and yellow colour seen in the logo.  
This seems to symbolise that the pharmaceutical company’s treatment ensures that 
couples are happy.  This idea is reinforced by the sentence “Brought to you by Lilly in the 
interest of healthy relationships”.   
 
This view was also echoed by the focus group participants.  One participant said, “...it 
also tries to make the company look good...They try to come across by saying [sarcastic 
voice]:  ‘We care for you.  We don’t want to make money, we care or you’... So, kind ‘a 
sucking up to customers”.   
 
6.4.4.3   Colour interpretation 
 
Colour does not play a major role in bringing the advertisement’s message across to 
consumers.  Areas in the advertisement where colours were employed are the photograph, 
the main slogan “THINK PASSION NOT PRESSURE”, the treatment’s logo, and the 
pharmaceutical company’s name at the bottom right hand corner.   
 
The colours used in the photograph seem to make it more attractive and accent its role as 
signifier in the advertisement.  Green, red, and yellow colours are present in the rest of 
the advertisement.  The main slogan consists of the same green colour present in the 
treatment’s logo which can again be speculated as reinforcing the idea that their treatment 
is responsible for reigniting the passion in a couple’s relationship.   
 
Green is a cool colour or hue which is a colour of nature (Van Wagner, 2006).  This 
reinforces Williamson’s (2005: 120) concept that sex is part of human nature.  It also 
symbolises growth, harmony, health, and fertility (Nolan, 2003; Van Wagner, 2006; 
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Wright, 2006).  These traits are necessary for and should be present in a healthy 
relationship.  This advertised treatment claims to restore these traits in a relationship 
where such traits were lacking as a result of erectile dysfunction.  Green is also thought 
of as having healing powers.  Although it is highly unlikely that males can be ‘healed’ 
from erectile dysfunction, this treatment is advertised as solution to such problems 
relationships maybe faced with.  Green is also found to be the most restful colour on the 
eyes and is therefore thought to improve vision (Hoyer & MacInnes, 2001: 92).  This can 
also be one of the reason for using the green colour in the main slogan – to accentuate the 
message that there should not be pressure in a loving relationship but rather passion, a 
trait that this treatment can provide.   
 
The logo of the treatment consists of yellow and green.  As with the Panado® MedSip 
advertisement, the yellow colour is a bright, warm colour or hue (Van Wagner, 2006; 
Wells, et al., 1995: 474).  In this case this colour is associated with joy and happiness as 
well as having attention-getting attributes (Van Wagner, 2006).  Joy and happiness are 
also traits that are important to a good relationship.   
 
The pharmaceutical company’s name appears in red at the bottom of the right hand 
corner of the advertisement.  It is a bright, warm colour or hue used as an accent colour to 
stimulate consumers into making quick decisions (Wells, et al., 1995: 474; Wright, 2006).  
Here, the quick decision can be for consumers to recall the pharmaceutical company’s 
name.  The red colour is also thought to evoke erotic feelings which can be expected 
when passion occurs (Van Wagner, 2006). 
 
6.4.4.4   Legal and ethical criteria 
 
There are no exact regulations regarding disease awareness advertising in SA, other than 
the regulations for the advertising of medicines found in the Medicines Act.  However, 
this advertisement raised various ethical concerns.   
 
The unnamed treatment alluded to in this awareness advertisement is of a well-known 
medication with Schedule 4 status and, in accordance with Regulation 45(2)(b) regarding 
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the advertising of medicines in the Medicines Act, may not be advertised to the general 
public in any manner whatsoever (Pharmaceutical Society of South Africa Pharmacy 
Law Compendium: MRE – 50).  However, a website address and telephone number are 
provided to consumers to obtain more information.  Upon further investigation, the 
website address provided (www.36hours-of-freedom.co.za), was investigated to see if the 
medication is named on this website.  No medication name was stated on this website.  
  
Although it may be the case that this advertisement stays within the legal boundaries, 
questions do arise about the techniques used to overcome this legal drawback.  This 
advertisement can be seen as an indirect form of direct-to-consumer advertising which 
involves the use of advertising techniques such as word-of-mouth.  In this case, the 
doctor or pharmacist acts as the advertiser for the pharmaceutical company.  It is thus the 
doctor or pharmacist that informs the public about the Schedule 4 treatment, thereby 
overcoming the limitation of Regulation 45(2)(b).   
 
By reading this advertisement a person gets the sense that erectile dysfunction, and the 
medication available to treat it, is the sole answer for troubled relationships.  Furthermore, 
one gets the sense that the pharmaceutical company is an expert on relationships and the 
emotional burden this condition places on a relationship.  This is visually reinforced by 
the ‘swoosh’ of the treatment’s logo that embraces the loving couple in the photograph, 
the words in the last sentence of the paragraph, “the treatment that allows you and your 
partner the freedom to get close again”, and the phrase at the end, “Brought to you by 
Lilly in the interest of healthy relationships”.   
  
Another issue that caused international controversy among the medical fraternity and 
advertising watchdogs is the well marketed phrase “36-hours of freedom”.  This is clearly 
a misleading and deceptive claim made by the pharmaceutical company.  Although this 
distasteful claim is pharmacologically sound and understood by healthcare professionals, 
consumers can misinterpret this claim in various ways.   
 
One other statement made, “ask your doctor or pharmacist”, can mislead consumers into 
thinking that the treatment can be directly obtained from the pharmacist.  It is nowhere 
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stated that the treatment has a Schedule 4 status and could only be obtained by means of a 
prescription.  This issue was also discussed by the focus group where one of the 
participants raised concern and said “...the doctor part I can understand but the 
pharmacist part...coz the pharmacist can’t prescribe...the patient is gonna say:  ‘No, no 
but it says so!  Why can’t you give me?’...”.  This participant was of the opinion that the 
wording “ask your doctor or pharmacist” in this advertisement can aggravate consumers, 
especially if they cannot get this treatment directly from their pharmacists.  Only 47% of 
the consumers in the consumer survey were aware that they cannot get this treatment 
directly from the pharmacist without a prescription. 
                                     
6.4.5   Conclusion 
 
From these results, it is evident that by decoding these pharmaceutical advertisements it 
was possible to identify the intended meaning of each and also determine whether there 
were any areas in which misinterpretation can occur.  In each of the three pharmaceutical 
advertisements areas were identified where misinterpretation can occur.  In the Phytocor® 
advertisement it was determined that consumers will not be sure if they need a 
prescription for the Phytocor® Plus product as the advertisement only states that 
Phytocor® can be obtained without a prescription.   
 
Two aspects of the Panado® MedSip advertisement were found to be misleading.  The 
first aspect was that consumers may interpret this medicine advertised as one for a natural 
product due to the pictorial representation of the lemon, honey, and ginger.  This, 
however, only identifies the flavours this product is available in, honey-lemon and ginger.  
The second misinterpretation that can occur is that consumers can interpret Panado® 
MedSip as a safe medicine due to the comparison with chicken soup and the natural 
products.  Panado® MedSip, however, contains the active ingredient, paracetamol, which 
can be dangerous if not used as recommended.  These concerns were also raised in the 
focus group and were also evident in the consumer survey.   
 
Various ethical issues that were raised in the erectile dysfunction advertisement can result 
in misinterpretation.  This pharmaceutical advertisement created the impression that the 
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treatment can restore broken relationships apparently caused by erectile dysfunction.  The 
phrase, 36-hours of freedom, appearing on the website address can be misleading and 
misinterpreted by consumers in various ways.   
 
The final ethical issue that raises concern in this awareness advertisement dealt with the 
phrase “...ask your doctor or pharmacist...”.  Consumers may misinterpret this phrase by 
thinking that this treatment can be obtained directly from the pharmacist.  As this is a 
treatment that contains a substance of Schedule 4 status, it can only be obtained by means 
of a doctor’s prescription.  
 
An in-depth discussion of the results obtained from these sections, as well as the 
investigation of the legislation pertinent to pharmaceutical advertisements in Chapter four, 
is presented in Chapter seven.   
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CHAPTER 7 
DISCUSSION AND CONCLUSION 
 
7.1   INTRODUCTION   
 
The primary aim of this study was to identify how consumers perceive pharmaceutical 
advertisements.  Five more specific objectives (see Section 1.3) were developed to 
achieve this aim.  The five specific objectives can be categorised into three main 
categories, namely legal and ethical considerations in pharmaceutical advertising in SA, 
the interpretation of pharmaceutical advertisements, and the problematic areas in 
pharmaceutical advertisements found in SA.   
 
The main category, legal and ethical considerations in pharmaceutical advertising in SA, 
was investigated by achieving three of the five specific objectives.  This legal and ethical 
investigation formed part of Chapter four (see Section 4.5).  The empirical part of the 
study was used to identify consumers’ interpretation of pharmaceutical advertisements.  
All of the above activities were used to identify any problematic areas that may exist in 
pharmaceutical advertisements.    
 
7.2   PERCEPTIONS TOWARDS PHARMACEUTICAL ADVERTISEMENTS IN  
        SOUTH AFRICA 
 
The literature study and results obtained from the consumer survey indicate that 
consumers will be exposed to a considerable number of pharmaceutical advertisements in 
print form.  It was also evident that more pharmaceutical advertisements will be found in 
magazines than any other form of print media.  Brewer (1998: 208) and Wells and 
colleagues (1995: 353) stated that magazines have a much longer lifespan, has increased 
consumer exposure, and also a high read potential as consumers usually share their 
magazine with friends and family.  These advantages cause magazines to be an excellent 
print medium to advertise pharmaceutical advertisements.  Another advantage is that 
 226
most magazines circulate nationally which leads to an even greater exposure to 
pharmaceutical advertisements (Brewer, 1998: 208). 
  
The All Media and Products Survey (AMPS®) conducted by the SA Advertising 
Research Foundation (SAARF) identified that, between July 2002 and June 2003, 40.7% 
of the SA adult population read magazines and that they read an average of 3.19 
magazine titles within this period (South African Advertising Research Foundation, 
2007).  The consumer survey conducted for this study indicated that 63% of the 
consumers read magazines on a weekly basis.  These statistics reinforce the fact that a 
high number of consumers read magazines thus increasing the likelihood that they will be 
exposed to pharmaceutical advertisements.  
 
It was also evident from the literature that there are two major factors used to effect 
consumers’ perceptions towards advertisements.  These two factors are persuasion and 
emotions.  As was proven in this study, persuasion and emotions are often employed in 
pharmaceutical advertisements.       
 
How consumers interpret pharmaceutical advertisements hinge on their perceptions 
towards such advertisements.  Perception is an internal psychological process that forms 
part of the consumer’s decision-making process of purchasing a product or a service 
(Belch & Belch, 2004: 105).  The process of perception involves how consumers sense 
the information in pharmaceutical advertisements, how they attend to this information, 
and ultimately how they interpret and give meaning to such information (Belch & Belch, 
2004: 105).   
 
Clow and Baack (2005: 120) stated that the common goal of an advertisement is to 
persuade.  Therefore, the assumption can be made that pharmaceutical advertisements are 
a persuasive form of communication.  As a result, pharmaceutical companies influence 
and convince consumers to buy their products.  Tellis (2004: 12) also stated that, because 
of this persuasive nature, advertisements have the capacity to change consumers’ 
opinions, behaviour, and attitudes.   
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The Elaboration Likelihood Model can be used to determine the route of persuasion 
followed when interpreting pharmaceutical advertisements (Belch & Belch, 2004: 159; 
Tellis, 2004: 113; Vidal, 1998).  A central route is followed when consumers are able to 
process information obtained from advertisements.  However, when consumers are 
unable to process information obtained in advertisements, a peripheral route is followed. 
In this route responsive cues are incorporated into the advertisement to reinforce the 
message of the advertisement.  Responsive cues such as the structure of the advertisement, 
the number of arguments included, and imagery are incorporated into such 
advertisements.  These are seen as positive cues which have the task of persuading 
consumers to form a positive attitude towards the brand of the product (Belch & Belch, 
2004: 159; Tellis, 2004: 113; Vidal, 1998). 
 
Considering the results obtained from the consumer survey, it is evident that a 
considerable number, 43% of the consumers, felt that pharmaceutical advertisements are 
difficult to understand.  It can be argued that these consumers will then follow the 
peripheral route of processing information obtained from pharmaceutical advertisements.  
These consumers will therefore react towards the positive cues incorporated into the 
pharmaceutical advertisements to form an understanding of the message provided.  
Therefore, if consumers are unable to fully interpret pharmaceutical advertisements, they 
will react to these positive cues to form a meaning.   
 
Wells and colleagues (1989: 20) furthermore stated that persuasion is also concerned with 
emotions.  Raven (2004:9) went one step further and proved that emotion plays a role.  
Tellis’s (2004: 148) findings supported Raven’s study as he also determined that emotion 
plays a role in advertising.  He determined that when consumers react to stimuli in 
advertisements, they will take action by one of three modes of persuasion by emotion, 
namely the associative mode, implicit mode, and the explicit mode. 
 
The two major factors playing a role in shaping consumers’ perceptions towards 
advertisements, persuasion and emotions, also play a role in the pharmaceutical 
advertisements selected for the focus group and consumer survey.  These factors, together 
with various other concepts identified in the literature, are incorporated into these 
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advertisements to change the attitudes, opinions and behaviour of consumers towards 
these pharmaceutical products.   
 
The proceeding sections will identify how such factors are incorporated in each of the 
three pharmaceutical advertisements selected.  
 
7.2.1   Phytocor®          
 
In the Phytocor® advertisement discussed in the focus group, a red heart, various bright 
colours, and arguments are used as positive cues.  The heart (pictorially and lexically 
illustrated), in support with the blue and the red colour, formed two important sales 
messages, your heart needs Phytocor® and Phytocor® Plus to be healthy and you can 
protect your heart with Phytocor® that is manufactured by Pharma Dynamics.  Various 
arguments were used in the advertisement to reinforce these sales messages. 
 
Raven (2004) identified in her study that emotion can also be employed in 
pharmaceutical advertisements.  She identified five powerful emotional factors employed 
in DTC advertisements (Raven, 2004).  In the Phytocor® advertisement two of these 
emotional factors can be identified, namely the value of health and fear of disability and 
death.  Here, by means of the picture of the red heart, awareness of the value of a 
person’s heart is created.  The advertisement also informs consumers of the lifestyle 
choices necessary to protect their hearts.  It can be speculated that it aims to warn 
consumers that, by not following a healthy lifestyle, they can die.    
 
In this advertisement the associative mode of persuasion by emotion plays a role (Tellis, 
2004: 148).  This mode is a method in which emotions are aroused by means of stimuli 
which are tangentially related to the product advertised.  Here, the pictorial representation 
of the red heart creates an emotional appeal.  Consumers will therefore associate the 
company’s name and this brand with the specific emotion created by the red heart.         
 
Furthermore, in accordance with Maslow’s Hierarchy of Needs, these positive cues can 
be also seen as motivational cues to persuade consumers that this dietary supplement will 
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satisfy a physiological need and a need for safety.  This dietary supplement offers to 
protect consumers’ hearts, thereby satisfying their need for good health as well as 
satisfying their physiological need for survival (Belch & Belch, 2004:109; De Beer, et al., 
1998: 214).            
 
Other than persuading consumers that they should use the Phytocor® range of 
supplements in conjunction with a healthy lifestyle to protect their hearts, these positive 
cues should not lead to any possibility of misinterpretation. 
    
7.2.2   Panado® MedSip  
 
In the Panado® MedSip advertisement various imagery were incorporated, namely colour, 
the theme of being natural, as well as the argument that this medicinal drink has the same 
qualities as chicken soup.  Although 64% of the consumers disliked the phrase “Just like 
chicken soup”, 71% of the consumers were attracted by the bright yellow colour of the 
advertisement.  As was found in the interpretation of the colour yellow, and as this 
advertisement was found in a magazine, it becomes more apparent that this colour was 
chosen to attract attention between all the other advertisements.  This advertisement is of 
high quality and is also colourful, qualities present in magazines as stated by Brewer 
(1998: 208) and Wells and colleagues (1995: 353).         
 
Through the decoding process it was possible to identify that the referent system, cooking 
nature was used in this advertisement.  This referent system is pictorially represented by 
the honey, lemon, and ginger in front of the Panado® Medsip package.  Hence, there is 
the possibility that consumers could misinterpret this referent system by thinking that this 
medicinal drink is natural and has all the qualities of honey, lemon, and ginger.   
 
Results from the consumer survey support this possibility.  Forty-nine percent of the 
consumers believed that Panado® MedSip has the same qualities as the traditional colds 
and flu remedies portrayed pictorially by the honey, lemon, and ginger and lexically by 
the comparison with chicken soup.  With this belief of having similar qualities as 
naturally occurring substances, the assumption can also be made that it is safe.  However, 
 230
this can be seen as a dangerous misinterpretation as this product contains paracetamol 
and should by no means be treated as being as safe as the natural products portrayed.  
Sixty-eight percent of the respondents in the consumer survey shared this same argument 
and believed that it can have dangerous consequences when medicines are compared to 
food in the mass media.  This belief was also shared by one of the participants in the 
focus group.  
 
The emotional factor identified by Raven (2004: 9), responsibility of a person to take 
care of his or her own health and that of their loved ones, plays a role in this 
advertisement.  Here, the mother may feel emotionally responsible for the welfare of her 
child and, if the child has cold or flu symptoms, she should give him or her Panado® 
MedSip.  By awakening a mother’s responsibility towards her children, it is evident that 
the associative mode of persuasion by emotion is applied in this advertisement (Tellis, 
2004: 149).    
 
Positive cues are also used as motivation for consumers to buy a “safe” and “effective” 
remedy for the symptoms of colds and flu.  In accordance with Maslow’s Hierarchy of 
Needs, this form of motivation can be seen as offering a remedy that can satisfy the need 
for safety, in this case, the need for good health (Belch & Belch, 2004:109; De Beer, et 
al., 1998: 214).   
 
7.2.3   Erectile dysfunction awareness    
 
The focus group participants felt that the photograph in the advertisement creates the 
impression that the treatment offers to fix a troubled relationship or marriage.  The 
semiotic criterion, the mirror-phase, employed by Williamson (2005: 60) to decode 
advertisements, reinforces these findings by identifying that consumers will desire the 
same love and happiness as portrayed by the photograph.  It was evident from the 
consumer survey that this photograph achieved its purpose as 45% of the consumers 
believed that this treatment has the ability to improve a troubled relationship or marriage.     
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One of the emotional factors that Raven (2004: 9) identified in DTC advertisements, 
vulnerability of people, is the type of emotion reflected in this advertisement.  The 
vulnerability refers to a couple or partner that desires the love and happiness portrayed in 
the photograph.  This form of emotion aroused by a photograph is seen as an associative 
mode of persuasion (Tellis, 2004: 158).  Here, the photograph develops an emotional 
message that persuades consumers to use the treatment. 
 
The positive cues incorporated into this advertisement can also be used as motivational 
tools to support its claims, to improve a troubled relationship or marriage as a result of 
erectile dysfunction.  In accordance with Maslow’s Hierarchy of Needs, this treatment 
aims to satisfy a social need (Belch & Belch, 2004:109; De Beer, et al., 1998: 214).  Here, 
the social need is a need for love.   
 
7.3   PROBLEMATIC AREAS IN PHARMACEUTICAL ADVERTISEMENTS  
        FOUND IN SOUTH AFRICA 
 
With respect to the three pharmaceutical advertisements analysed, various areas can be 
seen as problematic.  In the erectile dysfunction awareness advertisement two major 
ethical problems were identified.  The first problem identified was that the photograph 
can give a false perception about the treatment offered for erectile dysfunction.  
Consumers may conclude that this treatment will not only help them with the medical 
problem but also restore their troubled relationships.  Another problem that can be 
identified is that the advertisement do not clearly state that this treatment is only available 
by means of a prescription.  This can frustrate consumers if they are told by pharmacists 
that they should first visit their doctors to obtain a prescription.                  
  
In the Panado® MedSip advertisement a major ethical problem was identified.  The 
pictorial representation of the naturally occurring honey, lemon, and ginger, in 
combination with the lexical portion describing the chicken soup, can give a false 
impression that this medicinal drink is natural and not a medicine that contain 
paracetamol as active ingredient.  Furthermore, it can create the impression that this 
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medicinal drink is just as safe as these natural products but in fact, because of its active 
ingredient, can be potentially dangerous if used incorrectly. 
 
In the Phytocor® advertisement two ethical problems were identified.  As indicated in the 
results chapter (see Chapter six, Section 6.4.2.4), the word “optimal” can create the 
impression that this dietary supplement is superior to any other supplement to protect a 
person’s heart against cardiovascular disease.  The word, “optimal” has a similar function 
as superlative words (for example, “the best”) which are prohibited by the Marketing 
Code in SA from being used in pharmaceutical advertisements (Code of Practice, 2004).  
The other ethical problem identified was that Phytocor® can be obtained without a 
prescription but no mention was made about Phytocor® Plus.  This can create confusion 
amongst consumers as they can assume that Phytocor® Plus cannot be obtained without a 
prescription.  This is despite the fact that Phytocor® Plus is also a dietary supplement 
where normally no prescription is required to obtain it.  
 
Problematic areas in the SA pharmaceutical advertising law were identified and discussed 
in Chapter four.  Three problematic areas were identified.  Firstly, it was determined that 
there are too few authorities to regulate pharmaceutical advertisements.  Another area of 
great concern was the confusion caused by Regulation 45(2), Subsections (b) and (c), of 
the Medicines and Related Substances Act 101 of 1965, as amended, regarding the 
advertising of medicines to the general public.  Subsection (b) states that Schedule 2 to 
Schedule 6 medicines may not be advertised to the general public whereas Subsection (c) 
states that these scheduled medicines may be advertised to inform the general public of 
its price, name, pack size and strength (Pharmaceutical Society of South Africa Pharmacy 
Law Compendium, 2005: MRE - 51).  The third problem identified a lack of legislation 
regarding the advertising of medicines with a high abuse potential. 
 
7.4   CONCLUSION   
 
The aim of this study was to identify how consumers in SA perceive pharmaceutical 
advertisements in print form.  From the literature study it is evident that there is a lack of 
information regarding the study of pharmaceutical advertisements in SA.  An intensive 
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literature review revealed that, as of yet, no in-depth study have been conducted to prove 
how consumers in SA may be affected by pharmaceutical advertisements in print form.      
 
Various approaches such as semiotics, colour interpretation, and decoding were 
employed in this study to illustrate probabilities of how consumers may perceive 
pharmaceutical advertisements.  By using these various approaches, it was possible to 
determine how consumers can interpret pharmaceutical advertisements and that there is 
the possibility for misinterpretation.  The results identified that pharmaceutical 
advertisements in print form are often interpreted incorrectly which resulted in 
misinterpretation.   
 
With the aid of the literature and findings of this study, it was found that various cues are 
used in pharmaceutical advertisements to lead consumers into interpreting these 
advertisements in such a way as to result in a positive outcome for the sponsor.  It was 
also found that pharmaceutical advertisements persuade consumers to react positively 
towards the products advertised.  Furthermore, it was found that many pharmaceutical 
advertisements employ emotional appeal to persuade consumers.  Colour was also 
employed in pharmaceutical print advertisements, not only to attract attention but also to 
reinforce their persuasive messages.   
 
A literature review regarding pharmaceutical advertising law in SA indicated that the 
correct measures are in place to regulate these advertisements.  However, it was evident 
that, due to a lack of regulatory authorities, it is highly unlikely that pharmaceutical 
advertisements will be properly regulated.  Various problematic areas were also identified 
in SA legislation.  
 
The data collected during this study succeeded in achieving this study’s primary aim and 
more specific objectives.  Valuable information was obtained and indicated that ongoing 
research regarding this topic is needed.   
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7.4.1   Recommendations  
 
Due to the shortage of regulatory authorities in SA, it is recommended that more be done 
to regulate pharmaceutical advertisements.  Because of economic constraints and a lack 
of skilled workforce in SA, it may be advisable to establish more self-regulatory 
authorities within the pharmaceutical industry.  By doing so, regulation of pharmaceutical 
advertisements can be improved which will ultimately protect the consumer.   
 
Furthermore, it is also necessary to focus on the problematic areas identified in SA 
legislation regarding pharmaceutical advertisements.  One problem that needs specific 
attention is the discrepancy between Subsection (b) and (c) of Regulation 45(2) of the 
Medicines and Related Substances Act 101, as amended, regarding the advertising of 
medicines to the general public.  There is thus a need to review these two Subsections 
and debate the controversy that exists to prevent future confusion.   
 
7.4.2   Limitations to the study 
 
Due to various factors the empirical portion of the study could only be conducted in the 
NMM.  Although the results obtained from this study did achieve the primary aim set, it 
will be advisable to conduct such a study nationally.   
 
It can also be argued that the participants selected for the focus group were only 
representative of an age group not older than 33 years.  A more representative view 
would have been obtained if a sample of different age groups was selected.  
 
There is also a lack of primary resources regarding pharmaceutical advertising, semiotics, 
and the process of decoding pharmaceutical advertisements.  Little international research 
has been conducted regarding the use of semiotics in the decoding process of 
pharmaceutical advertisements to determine the perceptions towards pharmaceutical 
advertisements.  Such research has not been done in SA as of yet.  This resulted in the use 
of the Internet to obtain the necessary information.   
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7.4.3   Suggestions for future research 
 
The focus group and consumer survey conducted identified various areas that require 
future research.  Two aspects were prominent in the focus group discussion, namely the 
advertising of slimming products and pharmaceutical advertisements on the Internet.  In 
the focus group, as well as the consumer survey, results unanimously indicated that 
consumers believed that slimming advertisements were misleading.  It can therefore be 
suggested that the effect of slimming advertisements should be investigated. Results 
obtained from such a study can determine if such advertisements have any negative 
effects on consumers’ health.  Legislation regarding the advertising of medicines on the 
Internet can also be investigated as there are many problematic areas regarding this. 
 
Furthermore, as was reflected in the consumer survey, the major media preferences of 
consumers are television and radio.  Similar studies can be conducted on pharmaceutical 
advertisements found in these media. 
   
Lastly, in-depth techniques can be performed to determine more effectively what the 
effects of pharmaceutical advertisements on consumers are.  Laboratory techniques such 
as neuromarketing will identify how consumers are affected on a psychological and 
physiological level by pharmaceutical advertisements.  
 
7.4.4   Concluding remarks 
 
It is a fact that pharmaceutical advertising is a popular and lucrative marketing tool that 
will grow exponentially with time in SA.  However, results obtained from this study 
indicate that pharmaceutical advertisements require more regulation as it is a persuasive 
form of communication which can be misinterpreted and often mislead consumers.   
 
It must be realised that, due to these disadvantages, pharmaceutical advertisements 
should not be used as the primary choice of information to educate consumers about their 
healthcare needs.  As with the advertisements for cigarettes and alcohol, the educational 
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value of pharmaceutical advertisements directed at consumers are doubtful.  Consumers 
should in fact be educated about the disadvantages of pharmaceutical advertisements.      
 
Here, the value of pharmacists’ healthcare skills should be realised.  Pharmacists’ 
counselling skills should ideally be used as primary educational tool to convey valuable 
healthcare information to consumers.           
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APPENDIX A:  FOCUS GROUP PREAMBLE                              
 
 
Department of Pharm
 
acy                                     
                             Nelson Mandela Metropolitan University                                     
                             Tel: +27 (0)41 504-2128  
                             Fax: +27 (0)41 504-2744                                     
        E-mail of researcher: bck-2001@hotmail.com 
 
 
Date:  ________________________ 
 
Ref:  N 01/11/03/07 [H06Hp-032/Approval] 
 
Contact person:  Brent Claud Knoesen                               
 
Dear participant 
 
You are invited to participate in a focus group as part of a research study which aims to identify how 
consumers perceive pharmaceutical advertisements.  A focus group is a group interview method where 
participants are selected to discuss a broad range of ideas regarding a specific topic.  
 
The researcher will provide you with the necessary information to assist you in your understanding of the 
study and will explain to you what you should expect as a participant.  Although you will be required to 
provide written consent, participation in the focus group is voluntary and you are under no obligation to 
participate.  You also have the right to withdraw at any given time.  However, if you do withdraw, you 
should inform the principal investigator of such a decision.  Furthermore, although this study has been 
approved by the Research Ethics Committee (Human) (RECH) of the Nelson Mandela Metropolitan 
University, the study may be terminated at any time by the principal investigator, University, or the RECH 
of the University that initially approved the study.  It is also important for you to know that, although your 
identity will remain confidential at all times, these research results may be presented at scientific 
conferences or in specialist publications.    
 
Furthermore, should you wish to continue receiving any further therapeutic intervention subsequent to your 
participation in the focus group, the University Psychology Clinic (UCLIN) can be contacted on (041) 504-
2330 in this regard.   
 
 
Yours sincerely,   
 
Brent Claud Knoesen 
(Principal Investigator) 
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APPENDIX B:  FOCUS GROUP PROTOCOL 
 
 
FOCUS GROUP PROTOCOL 
 
(Duration:  1 hour and 15 minutes to 1 hour and 30 minutes) 
 
• Introduction (5 minutes) 
 
Ice breaker is used to allow participants to become acquainted.    
 
• Group task one (10 minutes) 
 
The following general question is asked: 
What do you think of advertisements in print form (in other words advertisements found in, for example, 
magazines and newspapers)? 
 
• Group task two (30 minutes):  General discussion  
 
Prompts for general discussion: 
 
1.   Do you think pharmaceutical advertisements play on consumers’ emotions? 
2.   Do you think that pharmaceutical advertisements mislead consumers? 
3.   Are pharmaceutical advertisements often difficult to understand? 
4.   Do colour and pictures attract your attention when looking at advertisements? 
5.   Have you ever asked your general practitioner or pharmacist about a pharmaceutical product  
      advertised or even bought the product? 
6.   Do you feel that prescription medicines should be advertised to the general public? 
 
• Group task three (25 minutes):  Opinions about pre-selected advertisements  
 
Three pharmaceutical advertisements are shown to the group and their opinions are asked about them. 
 
• Conclusion/Debrief (5 minutes) 
 
The group is asked if there is anything else they want to add to the discussion or want to ask about the study.  
Participants are thanked for their participation.   
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APPENDIX C:  PHYTOCOR® 
 
 
(Source:  Pharma Dynamics, 2006) 
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APPENDIX D:  PANADO® MEDSIP 
 
 
 
 
 
 
              
 
 
 
 
 
 
 
      
          
 
 
 
 
 
 
 
 
(Source:  You, 2006d: 45) 
 
 
 
 
 
                                                
 258
APPENDIX E:  ERECTILE DYSFUNCTION AWARENESS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Source:  Fair Lady, 2006: 17) 
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APPENDIX F:  CONSUMER SURVEY QUESTIONNAIRE 
 
 
 
 
 
 
PHARMACEUTICAL ADVERTISING   
 
CONSUMER QUESTIONNAIRE     
 
Please mark your answer with an ‘X’ in the appropriate box or write your answers 
to the questions or statements in the spaces provided.   
 
1. DEMOGRAPHICS   
 
1.1 Age   (years) 
 
1.2 Gender  Male Female 
 
1.3 Occupation   
 
1.4 Do you currently belong to a 
medical aid? 
  Yes
 
No
 
 1.5 Do you suffer from any chronic conditions (for example, 
diabetes, high blood pressure, or asthma)? 
 
2. LEISURE PREFERENCES IN TERMS OF MASS MEDIA 
 
   Daily 3-6 times per week 
1-2 times 
per week 
Once a 
month 
 
Never
2.1 I watch television 
   
                   1 
 
 
 
 
                                              2 
 
 
 
 
                                       3 
 
 
 
 
                             4 
 
 
 
 
                     5 
2.2 I listen to the radio 
 
 
 
 
 
                   1 
 
 
 
 
                                              2 
 
 
 
 
                                       3 
 
 
 
 
                             4 
 
 
 
 
                     5 
2.3 I read newspapers 
 
                1 
 
 
                                              2 
 
 
 
 
                                       3 
 
 
 
 
                             4 
 
 
 
 
                     5 
2.4 I read magazines 
 
 
 
 
 
                   1 
 
 
 
 
                                              2 
 
 
 
 
                                       3 
 
 
 
 
                             4 
 
 
 
                     5 
2.5 I read my pharmacy newsletter 
 
 
 
 
 
                   1 
                                 2 
 
 
 
 
                                       3 
 
 
 
 
                             4 
 
 
 
 
                     5 
2.6 I read handouts and flyers 
 
 
 
 
 
                   1 
 
 
 
 
                                              2 
 
 
 
 
                                       3 
 
 
 
 
                             4 
 
 
 
 
                     5 
2.7 I use the Internet 
 
 
 
 
 
                   1 
 
 
 
 
                                              2 
 
 
 
 
                                       3 
 
 
 
 
                             4 
 
 
 
 
                     5 
  
Yes No
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3. PHARMACEUTICAL ADVERTISING IN GENERAL 
 
Please mark each statement with an ‘X’ by using the following scale:  
 
  
    A
gr
ee
 
 D
is
ag
re
e 
 U
nd
ec
id
ed
  
 
 
3.1 
 
I find pharmaceutical advertisements  
informative 
 
 
 
 
         
         
 
 
 
 
             
                  
 
 
 
                           1 
 
 
 
 
             
                  
 
 
                         2 
 
 
 
             
                  
 
 
                        3     
3.2  I ask my doctor or pharmacist for more information 
after seeing a pharmaceutical  advertisement 
 
 
 
 
         
         
 
 
 
 
              
                  
 
 
                          1     
 
 
 
 
              
                  
 
 
                         2 
 
 
 
 
             
                  
  
                         3 
 
3.3  
 
Pharmaceutical advertisements lack important  
information  
 
 
 
 
 
 
 
 
 
 
              
                  
 
                 1 
 
 
 
 
 
 
 
              
                 
 
 
                         2 
  
 
 
 
 
 
 
 
 
 
 
                         3 
3.4 Pharmaceutical advertisements are difficult to 
understand  
  
 
 
 
              
                  
 
 
                           1 
 
 
 
 
              
                  
 
 
                         2 
 
 
 
 
             
                  
 
 
                         3  
3.5 
 
Pharmaceutical advertisements are misleading 
 
  
 
 
 
              
                  
 
 
                           1 
 
 
 
 
              
                  
 
 
                         2 
 
 
 
 
             
                  
 
                3  
3.6 
 
Pictures of models used in slimming 
advertisements or other pharmaceutical 
advertisements create a false impression 
  
 
 
 
             
                  
 
                      1 
 
 
 
 
             
                  
 
                    2 
 
 
 
 
              
                  
 
                    3 
 
3.7 
 
Pharmaceutical advertisements are directed at 
consumers who are emotionally vulnerable 
  
 
 
 
 
 
 
             
                 
 
                  1 
 
 
 
 
 
 
 
             
                 
 
                2 
 
 
 
 
 
 
 
              
                  
 
                3  
3.8 
 
Colourful pharmaceutical advertisements attract 
my attention 
  
 
 
 
             
                  
 
 
                           1 
 
 
 
 
             
                  
 
 
                         2 
 
 
 
 
              
                  
 
 
                         3  
3.9 
 
Pharmaceutical advertisements are interesting 
when a picture appears in it 
  
 
 
 
              
                  
 
 
                           1 
 
 
 
 
              
                  
 
 
                         2 
 
 
 
 
   
 
 
 
                         3  
3.10  
 
Disease awareness advertisements create 
unnecessary fear              
  
    
 
 
 
 
 
 
 
                           1 
 
    
 
 
 
 
 
 
 
                         2 
   
 
 
 
 
 
 
 
 
                         3 
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4. EVALUATION OF PHARMACEUTICAL ADVERTISEMENTS  
 
Take time to look at each advertisement.  Mark each statement with an ‘X’ by using 
the following scale:   
 
   
 A
gr
ee
 
 D
is
ag
re
e 
 U
nd
ec
id
ed
 
  
Panado® MedSip 
 
    
4.1 I like the phrase, “just like chicken soup”       
 
                         1 
    
                         2 
 
 
 
 
                         3 
4.2 Panado® MedSip has the same qualities as the old 
traditional  remedies portrayed in this 
advertisement 
    
 
 
 
 
 
                        1     
 
 
 
 
 
 
 
 
                         2 
 
 
 
 
 
 
 
 
                         3 
4.3 It is dangerous to compare medicines to food                     1 
 
 
 
 
                         2 
 
 
 
 
                         3 
4.4 The yellow colour makes this advertisement 
attractive 
 
 
 
 
 
 
                         1 
 
 
 
 
 
                         2 
 
 
 
 
 
                         3 
  
Erectile dysfunction awareness advertisement    
 
 
    
4.5 The advertised medicine alluded to can improve 
someone’s troubled relationship or marriage   
    
 
 
                         1 
 
 
 
 
 
                         2 
 
 
 
 
 
                         3 
4.6 My pharmacist can give this medicine without me 
having to see a doctor 
    
 
 
                         1 
                    2 
 
 
 
 
 
                         3 
4.7 I will visit the website given in the advertisement to 
get more information about the medicine  
    
 
 
                         1 
 
 
 
 
 
                         2 
 
 
 
 
 
                         3 
4.8 It is good to create awareness of conditions such as 
erectile dysfunction 
    
 
 
                         1 
 
 
 
 
 
                         2 
 
 
 
 
 
                         3 
  
 
THANK YOU FOR YOUR PARTICIPATION 
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APPENDIX G:  FOCUS GROUP CONSENT FORM 
 
Department of Pharmacy 
                                     Nelson Mandela Metropolitan University 
          Tel:  +27 (0) 41 504-2128 
           Fax:  +27 (0) 41 504-2744 
        E-mail of researcher:  bck-2001@hotmail.com 
 
Date:  __________________ 
 
Dear Participant 
 
INFORMED CONSENT FORM 
 
I, ................................................................................. , identity number ............................................................... , 
hereby confirm my participation in the research project undertaken by Brent Claud Knoesen (principal 
investigator) of the Department of Pharmacy in the Faculty of Health Sciences at the Nelson Mandela 
Metropolitan University. 
 
The following aspects have been explained to me, the participant: 
 
1.1   The primary aim of this study is to identify how consumers perceive pharmaceutical advertisements. 
1.2   To achieve this aim I will participate in a focus group where the impact of pharmaceutical advertisements on 
        consumers will be discussed. 
1.3   The potential risks involved in participating in the focus group are minimal.    
1.4   My confidentiality as participant will be ensured as no names of any participants will be published. 
1.5   My participation in this focus group is voluntary.  No pressure was exerted on me to consent to participate  
        and I may withdraw at any stage during the focus group.   
1.6   I am aware that a voice recorder will be used to tape the discussion.  The voice recorded data will be used for 
        transcribing purposes only and will be held confidential at all times. 
1.7   Participation in this focus group will not result in any cost to me. 
 
I, ......................................................................................, hereby voluntary consent to participate in the focus 
group as part of the above mentioned research project. 
 
Signed and confirmed at  ...........................................................................  on  ..............................................  2007. 
    
  ___________________________ 
                  (Participant) 
 
   
          Brent Claud Knoesen                                                                                  ___________________________ 
        (Principal investigator)                                                                                                 (Witness) 
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APPENDIX H:  PREAMBLE TO COMMUNITY PHARMACY 
 
 
Department of Pharmacy 
Nelson Mandela Metropolitan University 
Tel:  +27 (0)41 504-2128 
Fax:  +27 (0)41 504-2744 
E-mal of researcher:  bck-2001@hotmail.com 
 
 
Date:  ________________________ 
 
Ref:  N 01/11/03/07 [H06Hp-032/Approval] 
 
Contact person:  Brent Claud Knoesen 
 
Dear community pharmacy owner and/or responsible pharmacist  
 
You are invited to participate in a research study which focuses on how consumers perceive pharmaceutical 
advertisements.  This entails a consumer survey with 10 customers in your community pharmacy.  The 
principal investigator will provide you with an overview of the study and how it will be conducted.   
 
Your participation, and that of your customers, is voluntary and you are under no obligation to participate.  
You also have the right to withdraw at any given time but in doing so, the principal investigator should be 
informed of such a decision.  However, to participate, you as owner and/or responsible pharmacist of the 
community pharmacy will be required to provide written consent.   
 
Confidentiality and anonymity of you as community pharmacy owner and/or responsible pharmacist, your 
community pharmacy, and that of your customers will be ensured at all times.  No names will be published 
in the dissertation or any article thereof, or mentioned at any science conference.   
 
This study has been approved by the Research Ethics Committee (Human) (RECH) of the Nelson Mandela 
Metropolitan University.  The study may however, be terminated at any time by the principal investigator, 
University, or the RECH of the University that initially approved the study.   
 
Yours sincerely,  
 
Brent Claud Knoesen 
(Principal investigator)  
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APPENDIX I:  CONSENT FORM TO COMMUNITY PHARMACY                                                         
                                                   
                                                           Department of Pharmacy                              
Nelson Mandela Metropolitan University                                    
                             Tel: +27 (0)41 504-2128  
                             Fax: +27 (0)41 504-2744                                     
        E-mail of researcher: bck-2001@hotmail.com 
 
 
Date:  ______________________ 
 
 
Ref:  N 01/11/03/07 [H06Hp-032/Approval] 
 
Contact person:  Brent Claud Knoesen  
 
Dear community pharmacy owner and/or responsible pharmacist  
 
INFORMED CONSENT FORM 
 
I, .......................................................................... (identity number:  ........................................................ ), the 
owner and/or responsible pharmacist of ............................................................................ (community pharmacy 
name), hereby confirm my participation in the research study undertaken by Brent Claud Knoesen (principal 
investigator) of the Department of Pharmacy in the Faculty of Health Sciences at the Nelson Mandela 
Metropolitan University. 
 
The following aspects have been explained to me, the owner and/or responsible pharmacist: 
 
1.   The aim of the research study is to determine how consumers perceive pharmaceutical advertisements. 
2.   The procedure of the consumer survey will involve a convenience sample of 10 customers in my community  
      pharmacy.    
3.   The potential risks involved in participating in the consumer survey are minimal.  
4.   My confidentiality, and that of my community pharmacy and its customers, will be ensured at all times as no  
      names will be published.     
5.   Participation of my community pharmacy and its customers are voluntary.   
6.   No pressure was exerted on me or my customers to participate.   
7.   Any new information and/or benefits resulting from this research study will be shared, either verbally, or in   
      the form of a guideline or published article.   
 
I hereby consent to participate in the consumer survey of this research study.  
 
__________________________________ 
(Owner and/or responsible pharmacist) 
   
             Brent Claud Knoesen                                                                     _______________________________ 
           (Principal investigator)                                                                                        (Witness)  
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GLOSSARY 
 
ASA  Advertising Standards Authority  
DTC  Direct-to-consumer 
MCC  Medicines Control Council 
NDP  National Drug Policy 
NMM  Nelson Mandela Metropole  
OTC  Over-the-counter 
SA  South Africa 
SAPC  South African Pharmacy Council 
USA  United States of America 
WHO  World Health Organisation 
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